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The extracellular environment is an essential mediator of blood vessel health and 
provides both chemical and mechanical stimuli to influence endothelial cell behavior. 
While historically there has been significant emphasis placed on the chemical 
regulators of angiogenesis, the role of the mechanical environment is less well known.  
Interestingly, the mechanical properties of tissues are altered in many disease states, 
leading to impaired vascular function.  
 
Herein, we tune the mechanical properties of collagen-based scaffolds using non-
enzymatic glycation to show that angiogenesis is differentially regulated by matrix 
stiffness.   Importantly, our methods de-couple matrix stiffness from matrix density 
and fiber structure in collagen gels.  Endothelial cell spreading increases with matrix 
stiffness, as do the number and length of angiogenic sprouts.  Increased stiffness also 
promotes increased branching in sprouts that form from spheroids, and it disrupts 
endothelial barrier function.  
 
In the first steps towards translating these findings in vivo, we used a murine tumor 
model of stiffening to show that vascular density and the localization of mural cells 
 are altered within murine mammary tumors where collagen cross-linking has been 
disrupted.  Additionally, we studied breast tumors isolated from patients and found 
that a specific splice variant of fibronectin, a protein known to be required for neo-
vessel formation which is typically associated with angiogenic blood vessels, is 
present within the vasculature of human breast tumors but not in patient-matched 
normal tissue.  Together, these data show that the tumor vasculature is inherently 
different than that of normal tissue and suggest that matrix stiffness may play a role in 
these alterations.   
 
To study the interplay and balance between chemical factors and matrix stiffness, we 
developed a versatile microfluidic platform to expose cells cultured on substrates of 
well-characterized, tunable stiffness to well-defined, stable chemical gradients. The 
utility of this platform was validated by imposing a chemical gradient onto vascular 
smooth muscle cells to show that podosomes preferentially form upstream in a 
gradient. We anticipate that this device, with modifications, can be adapted for the 
study of angiogenesis in response to simultaneous chemical cues and matrix stiffness. 
 
Taken together, these data demonstrate that matrix stiffness regulates the formation 
and function of angiogenic vasculature.  The data suggest that therapeutically targeting 
stiffness or endothelial cell response to stiffening may help maintain and restore vessel 
structure and function to minimize metastasis and aid in drug delivery.   
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CHAPTER 1 
 
INTRODUCTION 
 
Portions of this chapter were published as a commentary titled “Controlling the 
mechanical properties of three-dimensional matrices via collagen cross-linking” in 
Organogenesis[1] or as a book chapter titled “Matrix Stiffness: A regulator of cellular 
behavior and tissue formation” in Engineering Biomaterials for Regenerative 
Medicine: Novel Technologies for Clinical Applications[2] 
 
1.1 Abstract 
The mechanical properties of the extracellular matrix play an important role in 
maintaining cellular function and overall tissue homeostasis.  Recently, a number of 
hydrogel systems have been developed to investigate the role of matrix mechanics in 
mediating cell behavior within three-dimensional environments.  However, many of 
the techniques used to modify the stiffness of the matrix also alter properties that are 
important to cellular function including matrix density, porosity, and binding site 
frequency, or rely on amorphous synthetic materials.  In this dissertation, I will 
describe the fabrication, characterization and utilization of collagen gels that have 
been non-enzymatically glycated in their un-polymerized form to produce matrices of 
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varying stiffness. We show that the mechanical properties of the resulting collagen 
gels can be increased 3-fold without significantly altering the collagen fiber 
architecture.  Applying these scaffolds to the question of angiogenesis, we find that 
endothelial cell spreading and outgrowth from multi-cellular spheroids changes as a 
function of the stiffness of the matrix.  Our results demonstrate that non-enzymatic 
collagen glycation is a tractable technique that can be used to study the role of 3D 
stiffness in mediating cellular function.  This introductory chapter will review some of 
the current methods that are being used to modulate matrix mechanics and discuss 
how the use of non-enzymatic collagen glycation can contribute to our knowledge of 
the factors regulating angiogenesis. 
 
1.2 Introduction 
The tissues and organs of the body are comprised of cells and extracellular matrices 
that are arranged to perform specific biological, chemical, and physical functions.  
Cells within tissues interact with the extracellular matrix and each other to receive and 
impart both chemical and mechanical cues that influence their behavior.  Importantly, 
these interactions contribute to overall tissue homeostasis and cellular function and, if 
they are disturbed, can contribute to aberrant cell behavior and disease.  
 
Altered tissue mechanical properties have been correlated with a number of disease 
states including cancer
1
, diabetes
2
, cardiovascular disease
3
, wound healing
4
, and 
asthma.
5
  Each of these maladies is characterized by a unique set of conditions but, in 
all cases, the interaction of the cells with their extracellular environment is altered.  
 2 
 
The composition, density, arrangement, and extent of cross-linking have all been 
shown to influence how cells interact with, move through, and remodel their 
surroundings.
6
  Since it is difficult to control all of these parameters independently in 
an in vivo setting, a number of in vitro hydrogel systems have been designed to study 
their role in a controlled environment.   
 
Studies using two-dimensional substrates have shown that changes in matrix stiffness 
are correlated with altered cellular morphology
7,8
, traction force generation
9–11
, cell-
cell connectivity 
3,12–14
, differentiation 
15
, chemotactic response
16
 and matrix 
deposition.
17
  However, since most cells in the body reside within a three-dimensional 
environment, it is important to recapitulate their natural extracellular environment to 
assess cellular function.    
 
Common methods to create three-dimensional matrices with tunable mechanical 
properties include altering the density and/or extent of cross-linking of natural or 
synthetic hydrogels, or creating mixed matrices comprised of multiple synthetic and/or 
natural hydrogels.  Modifying the density of the matrix is a relatively simple way to 
alter the mechanical properties of a hydrogel system to allow for the investigation of 
three-dimensional cellular behavior.  This technique has commonly been used with 
native biological proteins such as collagen
18,19
 and fibrin
20
 but is also used in other 
synthetic hydrogel systems such as poly(ethylene glycol).
21
  Cross-linking approaches 
to control stiffness are most commonly used in synthetic hydrogel systems, but similar 
methods have been reported using natural matrices.
22,23
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While each of these techniques is capable of altering the stiffness of the matrix, they 
all have inherent advantages and disadvantages for studying the role of mechanical 
properties within a three-dimensional cell culture system.  Specifically, changing the 
matrix density or cross-linking of a hydrogel can also influence porosity and hydraulic 
permeability
18,20
, fibril arrangement and structure
19
, and binding domain frequency
6
 
within the hydrogels.  Consequently, it can be difficult to decouple the relative effects 
of the mechanical properties from the other physical and chemical factors that are 
concurrently affected. 
 
This chapter will provide a brief overview of some of the current approaches to 
modulate matrix stiffness for three-dimensional studies of cellular behavior and 
review their general advantages and disadvantages.  
 
1.3 Modulating 3D Hydrogel Mechanical Properties 
Naturally-Derived Hydrogels 
A number of native proteins and polymers have been utilized to make three-
dimensional hydrogels for the investigation of cell response to matrix stiffening.  
Among the many extracellular matrix components that are present within the body, 
type I collagen, fibrin, and hyaluronic acid are among the most commonly used for 
creating three-dimensional matrices.
18,20,24
  Importantly, these matrices allow cells to 
be seeded within a natural environment that is capable of being both degraded and 
remodeled as is done in vivo by cells.   
 4 
 
 
The most basic approaches utilizing natural matrices are those that increase the 
stiffness of the matrix by increasing the density (Figure 1.1).  A number of studies 
have modified the density of collagen or fibrin hydrogels to study the influence of 
matrix mechanics on cellular behavior.  By increasing the density of collagen matrices 
from 2 mg/ml to 20 mg/ml, the compressive modulus increases approximately 10-fold 
from approximately 175 Pa to 1800 Pa.
18,25
  Similarly, by increasing the density of 
fibrin matrices from 2.5 mg/ml to 10 mg/ml, the compressive modulus increases from 
approximately 1.3 kPa to 9 kPa.
20
   
 
The stiffness of some natural polymers can be modulated using differential cross-
Figure 1.1. Methods commonly used to modulate matrix stiffness.  The mechanical 
properties of both synthetic and natural matrices are commonly tuned by altering the 
number of cross-links and/or the density of the scaffold.  Mixed matrices comprised of 
both synthetic and natural materials can be used to create hybrid in vitro environments 
that mimic the properties of in vivo tissues. 
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linking to investigate cell behavior (Figure 1.1).  For example, methacrylated 
hyaluronic acid is a matrix that is currently being used to dynamically modulate the 
stiffness of hydrogels via a two-step cross-linking process.
26
  First, hydrogels are 
chemically cross-linked and then can be seeded with cells before a secondary photo 
cross-linking reaction is initiated.  This is an especially interesting procedure because 
it allows the mechanics of the matrix to be temporally controlled from approximately 
1.5 to 7.5 kPa while cellular behavior is simultaneously investigated.  Unfortunately, 
since methacrylated hyaluronic acid is not naturally porous, methods had to be 
developed to create pores within the matrix. Poly(methyl methacrylate) microspheres 
are encapsulated during the initial polymerization reaction and subsequently dissolved 
before cells are seeded within the matrices to create large (~300 um) pores within the 
hydrogel. This potentially limits the ability of these matrices to truly recapitulate a 
three-dimensional, in vivo-like environment.   
 
While hydrogels formed from naturally-derived materials provide an optimal 
environment for cell culture, it can be challenging to use natural matrices for studies of 
the effects of matrix stiffness.  Specifically, since the matrix materials are biologically 
designed for cell adhesion, it is relatively difficult to decouple the role of binding site 
availability from matrix density.  Additionally, the fibrous arrangement and structure 
of the matrices can be modified with changes to the density or cross-linking which 
further complicates the analysis of resultant cellular responses.  Further, even when 
both the density and cross-linking of natural hydrogel matrices are modified, the 
resultant matrix stiffness is only tunable across a relatively narrow range (usually 
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100’s  to 1000’s of Pa).  Taken together, these complexities can make it difficult to 
pinpoint whether the cellular responses are due to changes in matrix stiffness or other 
factors. 
 
Synthetic Hydrogels 
To overcome some of the disadvantages inherent to hydrogels comprised of naturally-
derived matrices, synthetic hydrogels have been created.  The primary advantage of 
using synthetic hydrogels is that they can be formulated to investigate both mechanical 
and chemical properties on cellular function.  Indeed, many synthetic hydrogel 
systems offer independent control of mechanical properties, adhesive binding sites, 
and chemical cues.  One of the most popular synthetic materials used currently is 
poly(ethylene glycol) (PEG)
21,27–29
 although other materials such as 
poly(caprolactone)
30
 and poly(methyl methacrylate)
31
 have also been used.  Since 
these synthetic hydrogels were originally developed for other purposes and do not 
naturally contain cell binding domains, moieties such as Arg-Gly-Asp peptides (RGD) 
or laminin-like domains must be incorporated to facilitate cell adhesion.  This allows 
for precise control and modulation of the frequency and availability of adhesive 
regions within the hydrogel.   
 
Modulating the density and cross-linking of synthetic hydrogels are techniques that are 
commonly used to alter their mechanical properties (Figure 1.1).  The density of PEG 
hydrogels has been used to investigate the role of three-dimensional cellular 
behaviors.
21
  Additionally, a number of PEG hydrogel systems have been developed 
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that incorporate matrix metalloproteinase (MMP)-sensitive cross-links so that cells are 
capable of degrading their surrounding environment.
27,28
  Systems have also been 
developed to selectively cross-link PEG gels using multiphoton microscopy resulting 
in hydrogels with micro-domains similar to those found in tissue structures.
32
  
 
While synthetic hydrogels provide a highly tunable system for investigating cell 
behavior, they are generally amorphous and unlike the fibrous extracellular matrices 
within the body.  Thus, while it is feasible to independently tune properties such as the 
stiffness, binding site availability, and degradability, synthetic hydrogels are sub-
optimal because the cells are unable to actively remodel them and they do not 
recapitulate the fibrous nature of the in vivo environment.  
 
Mixed Matrices 
To overcome some of the disadvantages inherent to investigating matrix stiffness with 
hydrogels comprised of synthetic or natural materials alone, mixed matrices have been 
developed (Figure 1.1).  For example, collagen has been combined with PEG 
33
, 
agarose 
34
, or fibrin
35
 to create matrices with tunable mechanical properties.   In each 
of these cases, the density, extent of cross-linking, or ratio of each component are 
altered to control the mechanical properties.  As such, it is possible that the cellular 
behavior will be influenced by the matrix composition which is not completely 
decoupled from stiffness.  While the data generated from cells embedded within these 
matrices may be complex, these systems lay an important foundation for the 
development of in vitro hydrogels that more closely mimic the properties of in vivo 
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tissues.    
 
1.4 Non-enzymatic Collagen Glycation  
We recently reported the use of non-enzymatic glycation of un-polymerized collagen 
to investigate the effects of matrix stiffening on endothelial cells.
25
  Non-enzymatic 
glycation is a natural process whereby reducing sugars and proteins interact to produce 
extracellular matrix cross-linking within biological tissues.
36
  These sugars create 
chemical alterations within the protein structures that ultimately result in protein-to-
protein cross-links that mechanically alter the tissues.  Specifically, the interaction of 
reducing sugars such as glucose or ribose with amino groups on proteins create Schiff 
bases which are able to rearrange into Amadori products.
37
   The Amadori products 
can then form protein-to-protein cross-links that are commonly known as advanced 
glycation end products (AGE).
38
  These AGE cross-links slowly accumulate on 
proteins in vivo during aging, and the rate and extent of accumulation is accelerated in 
individuals with diabetes.
38
  
 
In vitro, non-enzymatic collagen glycation can be used to cross-link protein solutions 
prior to hydrogel polymerization (pre-glycation) or can cross-link polymerized protein 
matrices (post-glycation).
23
  Post-glycation is the primary method whereby proteins in 
vivo are cross-linked.  However, the high sugar concentrations necessary to achieve 
measurable changes in stiffness in vitro limit this technique to seeding cells on the 
surface of the matrices after the glycation reaction has been completed because cells 
cannot withstand the osmotic imbalance created by the glycating solutions.
39
  During 
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pre-glycation, active sites are created within the collagen gels that will later become 
cross-links during collagen polymerization.  Since the collagen solutions are treated 
with the glycating solutions prior to polymerization, cells can be embedded within the 
gels during the polymerization process and are not subjected to the osmotic 
imbalances created by the glycating solutions.  Thus, by using the process of pre-
glycation, the effects of 3D stiffness on cells embedded within collagen matrices can 
be investigated.  
 
Many studies have investigated the effects of collagen glycation on endothelial cell 
behavior. In prior studies, investigators have seeded cells atop of post-glycated 
matrices or injected cells into matrices following glycation
39–42
.  While these studies 
have provided valuable information, post-glycation is limited in its ability to 
investigate the effects of matrix stiffness on the behavior of cells embedded within the 
matrix. In our work, we utilized non-enzymatic pre-glycation (henceforth referred to 
as glycation) to investigate the effects of 3D matrix stiffness on collagen fiber 
structure and arrangement as well as on endothelial cell spreading and organization.
25
   
To glycate matrices, collagen solutions were incubated with 0 – 250 mM ribose for 5 
days at 4ᴼC prior to polymerization.  At the end of this incubation, the collagen 
solutions were mixed with sodium hydroxide to neutralize the pH, and complete 
medium or a suspension of endothelial cells was added to bring the final collagen 
density to 1.5 mg/ml.  Collagen solutions were polymerized at 37ᴼC and 5% CO2.  
Using these matrices, we investigated the mechanical properties, polymerization 
dynamics, collagen fiber distributions and structures, as well as individual and 
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collective endothelial cell responses.   
 
In parsing out the effects of matrix stiffness on cell behavior, it is critical to also 
control for architecture and fiber arrangement within the collagen matrices. Our study 
was the first to examine the resultant fiber arrangements within pre-glycated 
polymerized matrices.  Importantly, we found that there exists a range of ribose 
concentrations (0 – 100 mM) where the equilibrium compressive modulus of collagen 
can be increased approximately 3-fold from ~175 – 515 Pa while the arrangement and 
size of collagen fibrils is not significantly affected.  Increasing the concentration of 
ribose to 150 mM or greater also results in increased matrix stiffness but the fibrous 
properties of the matrices change as well.  Similarly, we found that the fibril formation 
rate was similar for collagen solutions that had been glycated with 0 – 100 mM ribose 
while the rates for solutions glycated with 150 – 250 mM ribose were significantly 
delayed and correlated with larger collagen fibers.  Since it is known that the 
arrangement of fibrous features within matrices can influence cellular function, we 
focused on gels glycated with 0 – 100 mM ribose for our studies of endothelial cell 
behavior. 
 
Disadvantages of collagen glycation 
Although the non-enzymatic glycation of collagen mimics the stiffening of matrices 
naturally occurring in vivo, there are several drawbacks to using this method to 
investigate the effects of matrix stiffness on cell function.  Specifically, collagen 
glycation alters the chemical composition of the matrix by creating AGE cross-links.  
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A variety of cell types, including endothelial cells, are known to have RAGE and the 
interactions between AGE and RAGE have been shown to influence cell behavior and 
cell-cell interactions.
43
  Specifically, AGE/RAGE interactions have been implicated in 
altering endothelial cell response to shear stress
40
, mechanical stretch
44
, and barrier 
function.
45
  A number of methods have been developed to inhibit the interaction of 
RAGE with AGE including blocking antibodies and pharmaceutical drugs.
46–48
  
However, like other cell-membrane receptors, RAGE can be replenished to the cell 
surface, making the long-term use of blocking antibodies less effective and very 
expensive.  Additionally, the pharmaceutical drugs that have been used to inhibit the 
RAGE/AGE interaction are not specific to RAGE and also influence a wide variety of 
other cellular pathways and behaviors.
48–50
  Thus, while glycation can recapitulate the 
mechanical stiffening that occurs naturally within the body, it can also engage RAGE. 
The respective contributions of these two factors to overall cell behavior can be 
difficult to decouple.   
 
Advantages Collagen Glycation and Implications for Human Disease  
Although it is challenging to completely decouple the role of matrix stiffness from 
AGE/RAGE signaling in our hydrogel system, collagen glycation does have many 
advantages over other current methods of matrix stiffening.  Specifically, we 
demonstrated the ability to increase the stiffness of the collagen gels 3-fold 
independently of the overall collagen fiber arrangements.  Our study was limited to 1.5 
mg/ml gels but it is possible that increasing the density of the collagen gels will allow 
for a wider range of moduli to be achieved.  
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Since accumulation of AGE cross-links within tissues during aging is universal, using 
non-enzymatic glycation to investigate the role of matrix stiffening is relevant to 
understanding conditions in vivo.  In fact, the presence of AGEs has been suggested to 
play a causative role in diseases such as diabetes
51
, rheumatoid arthritis
52
, 
atherosclerosis
53, Alzheimer’s54, and cataracts.55  Our data has demonstrated that 
endothelial cells respond to the changes in matrix stiffness induced by non-enzymatic 
glycation.  Importantly, our lab has also correlated aging with increased vascular 
stiffness and endothelial monolayer permeability which may contribute the increased 
prevalence in cardiovascular disease.
3
 Thus, using non-enzymatic collagen glycation 
to investigate the impact of altering three-dimensional matrix stiffness on cellular 
behavior has the potential to inform how we manage and treat different disease 
conditions.    
 
1.5 Angiogenesis and Disease 
During angiogenesis, endothelial cells degrade the basement membrane and migrate 
from a pre-existing vessel into the surrounding extracellular matrix to form new blood 
vessels.  Historically, there has been significant emphasis placed on the chemical 
regulators of angiogenesis such as vascular endothelial growth factor (VEGF)
56
.  
Indeed, it is well-known that VEGF plays an important role in endothelial cell 
migration, proliferation and angiogenesis.  However, previous work from our lab has 
shown that the stiffness of the two-dimensional matrices regulates endothelial cell 
network formation and traction force generation, suggesting that matrix mechanical 
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properties also influence the formation of vascular structures
9,12
. In this dissertation, 
we will use non-enzymatic collagen glycation to study the role of three-dimensional 
matrix stiffness on angiogenesis.   
 
In a number of disease conditions including cancer, diabetes, and aging, increased 
tissue stiffness is correlated with altered vascular formation and function
57,58
.  In 
general, tumor tissues have altered mechanical properties as compared to native, 
healthy tissue
59–62
.  In fact, breast cancer is often first detected by the patient or 
physician finding a palpable mass or lump that is stiffer than the surrounding tissue.  
Large tumors are associated with an increase in local ECM stiffness and angiogenesis, 
an in growth of newly sprouted blood vessels that facilitate increased tumor mass
58
.  
The increase in ECM stiffness is primarily due to increased collagen deposition and 
cross-linking within the tumor stroma
60
, but a disruption in the tensional homeostasis 
of the cells may also contribute
1
.  Additionally, the greater prevalence of reducing 
sugars such as glucose and ribose within the blood of diabetic patients leads to 
increased cross-link density of collagen and elastin, and consequently increased 
stiffness of the vasculature when compared with non-diabetics
2,63
. Importantly, in both 
cancer and diabetes, blood vessels are more malformed, tortuous, and leaky when 
compared to vessels within healthy tissues
64,65
. 
 
Herein, we utilize glycated collagen gels to study the role of three-dimensional 
stiffness on blood vessel formation.  Since collagen is the primary component of the 
extracellular matrix and AGE cross-links are found within tumors and known to 
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mediate tissue stiffening in diabetes and aging
51,66,67
, stiffening collagen gels with non-
enzymatic glycation is a physiologically-relevant model for studying angiogenesis. 
 
1.6 Conclusions 
Researchers today have many options to consider when choosing a hydrogel system to 
investigate the role of matrix mechanics on cellular behavior.  Naturally-derived 
matrices contain many of the essential elements required for cellular culture and can 
closely mimic the three-dimensional cellular environment.  However, synthetic 
matrices tend to be more customizable so that the intricacies of individual parameters 
such as cellular adhesion and mechanosensing can be more closely studied.  We have 
presented non-enzymatic collagen glycation as a highly tractable technique that 
utilizes a cross-linking mechanism that recapitulates in vivo tissue stiffening and is 
relevant to a number of disease states.  Future work in the development of these 
materials should combine the advantages of these techniques to create matrices that 
allow for independent modulation of hydrogel parameters while mimicking the native 
extracellular environment.  In my own work, as described in this dissertation, these 
materials were used to investigate the role of matrix stiffening on angiogenesis. 
 
1.7 Organization of the Dissertation 
The goal of this work is to investigate the role of three-dimensional matrix stiffness in 
regulating the structure and integrity of angiogenic blood vessels.  We demonstrate 
that matrix stiffness influences the formation of angiogenic vasculature in vitro, ex 
ovo, and in histological sections from murine and human models.   
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In Chapter 2, we characterize the physical properties of collagen matrices that had 
been stiffened by non-enzymatic glycation cross-linking.  We demonstrate that 
glycating collagen gels with 0-100 mM ribose only minimally changes collagen fiber 
distributions while increasing the compressive moduli of the gels three-fold.  We 
embed endothelial cells within these glycated matrices and find that increased gel 
stiffness significantly alters angiogenic outgrowth from multi-cellular spheroids.  This 
work is the first demonstration that increasing three-dimensional stiffness 
independently of matrix density increases angiogenic outgrowth. 
 
In Chapter 3, we further investigate the role of extracellular matrix stiffness on 
angiogenic function.  We find that increasing collagen density decreases angiogenic 
outgrowth from endothelial spheroids.  We also determine that increasing matrix 
cross-linking increases angiogenic outgrowth both in vitro and in the ex ovo 
embryonic chick model.  We further investigate the role of three-dimensional stiffness 
in mediating endothelial cell-cell junctions.  We demonstrate that increasing matrix 
stiffness increases the widths of vascular endothelial cadherin “stalk” junctions.  We 
also show that localization of vascular endothelial cadherin and the permeability of 
endothelial monolayers are significantly altered by matrix stiffness.  This work is the 
first demonstration that three-dimensional matrix stiffness modulates vascular 
endothelial cadherin junction widths. 
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In Chapter 4, we use histology to investigate the role of tumor stiffness on the 
regulation of the vasculature in murine and human tumors.  We determine that altered 
matrix stiffness correlates with differences in vascular density and mural cell 
localization in murine mammary tumors.  Additionally, we find that the expression of 
a specific splice variant of fibronectin (EDB-FN) is expressed in the vasculature of 
human mammary tumors but not in patient-matched normal tissues.  
 
In Chapter 5, we developed a microfluidic device to investigate the combined roles of 
matrix stiffness and chemical cues on endothelial cell migratory behavior.  We also 
demonstrate that gradients of the phorbol ester PDBu stimulate podosomes in a 
directed manner in vascular smooth muscle cells. 
 
Chapter 6 overviews my experience as an NSF STEM Fellow in GK-12 Education, 
where we developed laboratory activities and taught a science curriculum to high 
school students that focused on nutrient transport from the vasculature.  In Chapter 7, 
conclusions and future directions are presented. 
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CHAPTER 2 
 
TUNING THREE-DIMENSIONAL COLLAGEN MATRIX STIFFNESS 
INDEPENDENTLY OF COLLAGEN CONCENTRATION MODULATES 
ENDOTHELIAL CELL BEHAVIOR 
 
Published in Acta Biomaterialia [1]. 
 
2.1 Abstract 
Numerous studies have described the effects of matrix stiffening on cell behavior 
using two-dimensional synthetic surfaces; however less is known about the effects of 
matrix stiffening on cells embedded in three-dimensional in vivo-like matrices.  A 
primary limitation in investigating the effects of matrix stiffness in three dimensions is 
the lack of materials that can be tuned to control stiffness independently of matrix 
density.  Here, we use collagen-based scaffolds where the mechanical properties are 
tuned using non-enzymatic glycation of the collagen in solution, prior to 
polymerization. Collagen solutions glycated prior to polymerization result in collagen 
gels with a three-fold increase in compressive modulus without significant changes to 
the collagen architecture.   Using these scaffolds, we show that endothelial cell 
spreading increases with matrix stiffness, as does the number and length of angiogenic
 sprouts and the overall spheroid outgrowth.  Differences in sprout length are 
maintained even when the receptor for advanced glycation endproducts is inhibited.  
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Our results demonstrate the ability to de-couple matrix stiffness from matrix density 
and structure in collagen gels, and that increased matrix stiffness results in increased 
sprouting and outgrowth.   
 
2.2 Introduction  
The importance of the mechanical properties of the extracellular matrix (ECM) in 
mediating cell health and behavior is now well accepted.  Changes in matrix stiffness 
have been shown to promote cardiovascular disease
1,2
 and cancer
3,4
 by altering cellular 
morphology
5
, differentiation
6
, traction force generation
7
, focal adhesion formation
8
, 
and cell migration dynamics
9
. Additionally, the mechanical properties of the ECM 
have been found to be crucial regulators of the formation and arrangement of multi-
cellular assemblies during tissue formation
10–13
.  However, most studies investigating 
the role of matrix stiffening on cell behavior have primarily used 2D synthetic 
surfaces.  As such, significantly less is known about the effects of matrix stiffening on 
cells embedded in three-dimensional (3D) in vivo-like matrices.  This gap in 
knowledge is largely due to the lack of materials with tunable mechanical properties 
that are amenable to 3D cell culture.  
 
Recent efforts to modulate 3D matrix stiffness have included modifying matrix density 
of natural proteins
14–17
 and alginate
18
, using synthetic polymers with tunable cross-
linking densities such as poly(ethylene) glycol (PEG) to create hydrogel scaffolds
19,20
, 
and creating mixed matrices of natural proteins and other hydrogels such as 
agarose
16,21,22
.  Although these modifications are capable of generating 3D scaffolds 
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with tunable mechanical properties, they also change the fundamental structural 
properties of the culture system.   For example, increasing the density of the matrix 
also causes changes in the porosity of the scaffold and the number of binding sites 
presented to the cells. Synthetic PEG-hydrogels offer the advantage of allowing for 
specific binding sequences to be incorporated at a specified density, independent of 
stiffness; however, PEG-hydrogels are amorphous and lack the native fiber structures 
found within most tissues. Alginate offers the ability to modulate stiffness in 3D, but it 
does not allow for cell migration because cells are unable to remodel it
18
.  Therefore, 
while a number of approaches have been developed to modulate the stiffness of 3D 
culture, they each face limitations. 
 
To develop and characterize 3D mechanically tunable scaffolds, we used non-
enzymatic glycation to stiffen naturally-derived collagen
23,24
.  Non-enzymatic 
glycation is a process whereby proteins are cross-linked by reducing sugars such as 
glucose or ribose through a sequence of chemical modifications known as the Maillard 
reaction
25,26
.  During non-enzymatic glycation, reducing sugars interact with amino 
groups on proteins to form Schiff bases that can rearrange into Amadori products
27
.  
These Amadori products subsequently form advanced glycation endproducts (AGE) 
that accumulate on proteins and cause cross-link formation.  A number of studies have 
utilized non-enzymatic glycation to create stiffer collagen scaffolds with increased 
mechanical integrity by incubating polymerized collagen gels with reducing sugar 
solutions
28,29
.  However, since an excess of sugars create a hyperosmotic extracellular 
environment, this technique has been limited to stiffening scaffolds prior to seeding 
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cells onto the surface of the gels and does not allow cells to be embedded within the 
ECM scaffold prior to gel polymerization.  Notably, others have used collagen gels 
glycated with glucose-6-phosphate post-polymerization to investigate endothelial cell 
response
30
.  However, the limitations of this system include the inability to examine 
sparse cellular cultures and unclear effects to the collagen architecture as a result of 
cell injection.  By glycating the collagen prior to polymerization, we are able to 
observe immediate spreading and migration effects or single cells or multi-cellular 
aggregates without disruption of the collagen architecture. 
 
In addition to the role of AGEs in modulating the mechanical properties of the 
extracellular environment, some cells possess receptors for advanced glycation 
endproducts (RAGE) that can influence intracellular signaling
31,32
.  Interestingly, the 
engagement of these receptors on cells is thought to be a factor in a number of disease 
states including diabetes, atherosclerosis, Alzheimer’s, cataracts, and cancer33–37 and 
RAGE signaling has been shown to affect endothelial cell responses
38
.  
 
Here, we glycate the collagen prior to polymerization, which allows for cell 
encapsulation at the time of gelation
23,24
. Using this technique, cells can be embedded 
within collagen gels and the collagen density can be kept constant while mechanical 
stiffness is varied. We characterized the fiber structure of glycated collagen gels and 
show that there exists a regime where stiffness can be increased three-fold with only 
minimal changes in fiber architecture and no change in collagen density.  
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To investigate the effects of changes in 3D matrix stiffness on cell behavior, we 
embedded individual bovine aortic endothelial cells (ECs) or cellular spheroids in 
collagen of varying stiffness. Our data indicate that both individual cell spreading and 
the growth of angiogenic sprouts increase with matrix stiffness.  We also found that 
even when the AGE/RAGE interaction is inhibited, spheroid outgrowth increases with 
the stiffness of the matrix.  Together, our study describes a tractable method for 
modulating 3D matrix stiffness independently of collagen structure, and using these 
materials, we demonstrate that matrix stiffness in 3D plays a critical role in 
modulating endothelial cell behavior.  
 
2.3 Materials and Methods  
Cell Culture 
EC Culture 
Bovine aortic endothelial cells (ECs) were purchased from VEC Technologies 
(Rensselaer, NY) and used until passage 12 as described previously
11
.  Briefly, cells 
were fed every other day and grown to confluence at 37°C and 5% CO2 in Medium 
199 (Invitrogen, Carlsbad, CA) supplemented with 10% Fetal Clone III (HyClone, 
Logan, UT) and 1% each of MEM Amino Acids (Invitrogen), MEM Vitamins 
(Medtech, Manassas, VA), and penicillin-streptomycin (Invitrogen).   
 
Spheroid Generation 
ECs were suspended in complete Medium 199 supplemented with 0.25% Methocult 
(StemCell Technologies, Vancouver, BC, Canada) and seeded at 10,000 cells/well in 
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non-adherent 96-well round bottom plates (Costar, Corning Incorporated, Corning, 
NY).  Plates were centrifuged to pellet the cells and placed on an orbital shaker at 
37°C and 5% CO2 for 2 hours to facilitate spheroid formation.  EC spheroids were 
cultured for 2 days in the plates prior to embedding within collagen gels to allow for 
spheroid compaction. 
 
Preparation of Collagen Gels 
Isolation and Non-enzymatic Glycation of Collagen 
Type I collagen was isolated from rat tail tendons (Pel-Freeze Biologicals, Rogers, 
AR) and extracted in 0.1% sterile acetic acid (JT Baker, Phillipsburg, NJ) at 4°C.  The 
resulting solution was centrifuged to remove solids and the supernatant was 
lyophilized and then solubilized in 0.1% sterile acetic acid to form 10 mg/mL stock 
solutions.  As described previously, collagen stock solutions were mixed with 0.5 M 
ribose to form glycated collagen solutions containing a final concentration of 0, 50, 
100, 150, 200, or 250 mM ribose in 0.1% sterile acetic acid and incubated at 4°C for 5 
days
23,24
.  Glycated collagen solutions were neutralized with 1 M sodium hydroxide in 
10X D-PBS buffer and mixed with HEPES (EMD Millipore, Billerica, MA) and 
sodium bicarbonate (JT Baker) in 10X D-PBS (Invitrogen) to form 1.5 mg/mL 
collagen gels with final concentrations of 1X D-PBS, 25 mM HEPES, and 44 mM 
sodium bicarbonate.   
 
Fluorescent Labeling of Collagen  
Collagen was labeled with tetramethylrhodamine isothicyanate (TRITC) (Invitrogen) 
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as described previously
39,40
.  Briefly, lyophilized collagen was mixed with 0.1 M, pH 9 
sodium bicarbonate (JT Baker) to achieve a final collagen concentration of 10 mg/ml.  
TRITC in DMSO was then added at a 1:30 dilution to the collagen and allowed to 
react in the dark for 24 hours at 4ᴼC.  The labeled collagen solution was then dialyzed 
extensively against 0.1% sterile acetic acid using dialysis tubing with a 20,000 MW 
cutoff (Spectrum Laboratories, Inc., Rancho Dominguez, CA).    
 
Cell and Spheroid Embedding 
Isolated cells or spheroids were mixed with neutralized collagen solutions.  Collagen 
gels were allowed to polymerize at 37°C and then overlaid with complete medium.  
Medium was changed at 1 hour and then every other day during experiments.  When 
investigating the effects of the receptors for advanced glycation endproducts (RAGE) 
on spheroid outgrowth, a polyclonal anti-RAGE antibody (N-16, Santa Cruz 
Biotechnology, Inc., Santa Cruz, CA) was added to spheroids to inhibit the interaction 
of RAGE with AGE.  The anti-RAGE antibody was at added at 10 ug/ml in complete 
medium to embedded spheroids after the spheroids had been incubated for a 1 hour 
with complete medium.  Spheroids treated with the anti-RAGE antibody were 
monitored over the course of for 2 days for extension outgrowth
41–45
.  In cases where 
isolated cells were not suspended within the gel, an equivalent volume of complete 
medium was added to the gel to maintain gel composition between experiments. 
 
Collagen Polymerization Assay 
The polymerization of collagen gels at 37°C was monitored by measuring the 
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absorbance of the collagen solutions every 3 minutes at 500 nm using a Synergy HT 
microplate reader (BioTek, Winooski, VT).  Polymerization curves were fit with a 
variable slope sigmoidal dose-response curve and the slope of linear portion of the 
curve was reported as the fibril formation rate (GraphPad Prism, GraphPad Software, 
Inc, La Jolla, CA). 
 
Mechanical Testing of Collagen Gels 
The equilibrium compressive modulus of collagen gels was quantified as described 
previously
24
.  Briefly, an Enduratec EL2100 frame (Bose, Eden Prairie, MN) with a 
250-g load cell was used to measure the resultant forces of 75 micron displacements 
on 6 mm x 1.5 mm collagen gels in a confined compression chamber.    A standard 
linear solid model of viscoelastic behavior was used to fit the stress relaxation data by 
using the equation, σeq = A (1 – e 
–t/τ
) + B, where B is the instantaneous stress and A + 
B is the equilibrium stress, t is time, and τ is the exponential time constant24,39.  The 
equilibrium modulus was calculated as the slope of the linear region of the stress-
strain curve.  Similarly to other studies of collagen gel mechanical properties, we 
assumed that the collagen gels were isotropic and elastic
39,46
.  
 
Cellular Proliferation Assay 
ECs were suspended at 250,000 cells/ml of collagen and cultured for up to 3 weeks.  
Collagen gels were collected at 0, 1, 2, 3 weeks and frozen at -20°C.  The gels were 
digested for 14 hours at 60°C with papain and the DNA content of the gels was 
quantified with a Quant-iT PicoGreen dsDNA Kit (Invitrogen) using a Synergy HT 
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microplate reader (BioTek).  Total DNA content per gel were normalized to DNA 
content at day 0 for each experiment and then experiments were averaged (N=3). 
 
Imaging 
Confocal Reflectance Collagen Imaging  
The internal structure of collagen gels was visualized with confocal reflectance 
microscopy using a Zeiss LSM700 inverted laser scanning confocal microscope (Carl 
Zeiss, Oberkochen, Germany).  Samples were illuminated with a 405 nm laser and  
optical slices 1 micron in depth were collected with a long working distance water-
immersion C-Apochromat 40×/1.1 NA objective (Carl Zeiss)
47
.  Image acquisition 
parameters were kept the same for all gels.   
 
Image Autocorrelation Analysis 
To compare the structural properties of the collagen gels, an autocorrelation analysis 
was performed on the confocal reflectance microscopy images
48,49
. Briefly, each 
image was translated with respect to itself in all directions (2D) and the average length 
of intensity correlation between the images was measured.  The decay in the 
correlation between the images was used to determine the mean characteristic length 
of features (collagen fibers) within the image.  The mean characteristic lengths were 
plotted for each image and coincide with the mean fibril length, the average fibril 
distribution and the extent of bundling within the collagen gel.  
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Single Cell and Spheroid Imaging and Analysis 
Isolated cells were imaged on a Zeiss CSU-X1 (Carl Zeiss) spinning disc confocal and 
each z-stack was projected onto a single plane using the ImageJ maximum intensity 
feature (ImageJ 1.44p, NIH).  The resulting 2D cellular images were used to quantify 
projected cell areas and perimeters (n = 138-148)
50–52
.  Multi-cellular spheroids were 
imaged with brightfield on a Zeiss Axio Observer Z1m (Carl Zeiss) and with 
fluorescence on a Zeiss LSM700 point scanning confocal. Brightfield images of 
spheroids after 1 day in culture were compared to images of the spheroids at the time 
of embedding and analyzed for the number and length of extensions emanating from 
the spheroids (n = 18-23).  Additionally, brightfield images were used to quantify the 
area of both control spheroids (n = 17-18) and spheroids treated with anti-RAGE 
antibody (n=16-23) over time.  Control data sets of spheroid outgrowth were collected 
independently.    
 
Staining  
Cells within collagen gels were fixed with 3.7% (v/v) formaldehyde in PBS, 
permeabilized with 1% (v/v) Triton (JT Baker) in PBS, and stained for actin with 
Alexa Fluor 488 phalloidin (Invitrogen) in PBS/1% (w/v) bovine serum albumin 
(BSA, Sigma-Aldrich, St. Louis, MO) and for DNA with DAPI (Sigma-Aldrich) in 
purified deionized water.   
 
Statistics 
Data were analyzed using a one-way analysis of variance (ANOVA) and Tukey’s 
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Honest Significant Difference test in JMP (SAS, v.8.0 and v.9.0) with statistical 
significance considered as p<0.05.  All values are expressed as the mean ± SEM.   
 
2.4 Results 
Non-enzymatic Glycation Affects Collagen Gel Mechanical and Structural Properties  
The mechanical properties of collagen gels were modulated by incubating un-
polymerized collagen solutions with 0 – 250 mM ribose for 5 days prior to collagen 
neutralization and polymerization.  The equilibrium compressive modulus was 
measured by applying a 5% stepwise strain to a confined collagen gel, measuring the 
resultant force, and fitting the data to a standard linear solid model of viscoelastic 
behavior.  Collagen gels polymerized after non-enzymatic glycation have an increased 
equilibrium compressive modulus that varies approximately linearly with ribose 
concentration (Figure 2.1). Over the range of ribose concentrations tested, the 
Figure 2.1.  Collagen gel mechanical properties. The equilibrium compressive 
moduli of 1.5 mg/mL collagen gels were measured by confined compression testing. 
Data presented as mean ± SEM 
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compressive modulus of the collagen gels increased approximately four-fold (from 
~175 Pa to ~730 Pa). 
 
To investigate the effects of non-enzymatic glycation on collagen gel fiber 
architecture, the gels were imaged with confocal reflectance and fluorescence 
microscopy.  Collagen solutions glycated with 0 – 100 mM ribose form gels that have 
qualitatively similar fiber distributions and arrangements; whereas collagen solutions 
treated with 150 – 250 mM ribose form gels with larger, more prominent collagen 
fibers when imaged either confocal reflectance (Figure 2.2a) or fluorescence 
microscopy (Figure 2.3).  To further characterize the fiber architecture of the glycated 
collagen gels, an image autocorrelation analysis was performed.  The autocorrelation 
mean radius is a measure of the size over which fibril structures persist in the image.  
The autocorrelation data indicated that collagen gels treated with 0 – 100 mM ribose 
have similar fibril sizes and arrangements, while higher ribose concentrations generate 
populations of larger fibrils in confocal reflectance images (Figure 2.2b).  
 
Because differences in fiber structure have been shown previously to be correlated 
with differences in polymerization dynamics
53,54
, the effects of non-enzymatic 
glycation on collagen gel polymerization dynamics were investigated with an 
absorbance assay.  During polymerization, collagen fibril formation causes an increase 
in opacity that can be directly measured by absorbance. Collagen polymerization 
dynamics can generally be described by three stages and correspond to a sigmoidal 
curve that are observed with the absorbance assay: the nucleation phase is denoted by 
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the toe region of the curve, the fibril formation phase is denoted by the linearly 
increasing portion of the curve, and the fibril stabilization phase is denoted by the 
plateau region of the curve.  Non-enzymatic glycation increased the nucleation time of 
Figure 2.2 The effects of non-enzymatic glycation of collagen fibril arrangement. 
(a) Confocal reflectance microscopy was used to image the collagen gels formed from 
solutions that had been incubated with 0, 50, 100, 150, 200, or 250 mM ribose. (b) 
Collagen fiber organizations were compared using the image autocorrelation mean 
radius. Scale is 20 μm. 
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collagen fibril formation (Figure 2.4a).  Notably, the rate of fibril formation showed a 
comparable trend to the autocorrelation data and was very similar for collagen 
incubated with 0 – 100 mM ribose and was significantly altered for collagen solutions 
that had been treated with 150 – 250 mM ribose (Figure 2.4b).  These results indicate 
that the extent of glycation can alter the polymerization dynamics of collagen gels. 
 
Endothelial Cell Viability and Proliferation in Glycated Collagen Gels  
To evaluate the effect of collagen glycation on cell proliferation, ECs were embedded 
within collagen gels, and DNA content was quantified at 0, 7, 14, and 21 days. ECs 
Figure 2.3. The effects of non-enzymatic glycation of fluorescently labeled 
collagen fibril arrangement.  TRITC-labeled collagen was incubated with 0, 50, 100, 
150, 200, or 250 mM ribose and imaged with fluorescence microscopy.  Scale is 20 
μm.  
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remained viable and proliferated at similar levels within glycated collagen gels and 
controls during the 3 week proliferation assay (Figure 2.5).  These results indicate that 
Figure 2.4.  The effects of non-enzymatic glycation on the polymerization 
dynamics of collagen.  (a) Collagen polymerization dynamics were measured as a 
function of ribose concentration based on absorbance readings at 500 nm during 
polymerization.  (b) The fibril formation rates of glycated collagen polymerization 
were found by fitting a sigmoidal curve to the polymerization data in (a) and reporting 
the slope of the linear section of the curve.  Data presented as mean ± SEM. 
 
Figure 2.5.  Endothelial cell proliferation within glycated collagen gels.  ECs were 
embedded within collagen gels that had been glycated with 0, 50, 100, 150, 200, or 
250 mM ribose.  Cellular viability and proliferation was assessed by measuring the 
DNA content of gels at 0, 7, or 21 days.  Data presented as mean ± SEM. 
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collagen glycation prior to gel polymerization does not alter EC proliferative potential 
and that the cells remain viable within the gel. 
 
Changes in 3D Matrix Stiffness Increase Cell Spreading 
Studies using 2D planar substrates have reported that increased matrix stiffness results 
in increased cell spreading
55
.  To assess whether modulating collagen stiffness 
independently of collagen organization caused cellular morphological changes in 3D 
matrices, ECs were embedded within collagen gels that had been glycated with 0 – 
100 mM ribose and imaged with confocal microscopy.  Ribose concentrations ranging 
from 0 – 100 mM were chosen because our data indicate that the structure of the 
Figure 2.6.  Single cell response to matrix stiffness.  Isolated ECs were embedded 
within collagen gels formed from solutions that had been incubated with 0, 50, or 100 
mM ribose.  Cells were allowed to spread for 24 h and then were fixed and stained for 
actin.  (a) ECs were imaged using confocal microscopy and the projected cell (b) area 
and (c) perimeter were determined.  Data presented as mean ± SEM, * indicates p < 
0.05, Scale is 20 μm. 
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collagen is only minimally altered (Figure 2.2 and Figure 2.3) while the compressive 
modulus increases from ~175 to ~515 Pa (Figure 2.1). ECs appeared well-spread with 
an elongated morphology and displayed defined actin fibrils in each stiffness condition 
studied (Figure 2.6a).  Interestingly, EC projected area and perimeter were both 
significantly increased as a function of matrix stiffness (Figure 2.6b-c), indicating that 
Figure 2.7.  Angiogenic outgrowth response to matrix stiffness.  Multicellular 
spheroids were embedded within collagen polymerized from solutions treated with 0, 
50, or 100 mM ribose.  (a) Spheroids were imaged using bright-field microscopy at 0, 
1, and 2 days after embedding.  (b)  The total length of extensions and (c) the average 
number of extensions per spheroid were measured at day 1.  (d)  The projected 
spheroid area, including the extensions, was measured over the course of 5 days.  Data 
presented as mean + SEM, * indicates p < 0.05, Scale is 200 μm. 
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stiffness is a mediator of cell spreading in 3D matrices.   
 
Increased Matrix Stiffness Enhances Spheroid Outgrowth  
Our lab has previously shown that endothelial cell network formation can be 
modulated by both matrix stiffness and ligand density in 2D
11
.  To investigate whether 
endothelial sprouting is altered by collagen stiffness in 3D, EC spheroids were 
embedded within glycated collagen and the formation of sprouts from the spheroids 
was monitored over several days.  Notably, increasing the stiffness of the collagen 
visibly altered the morphology of the outgrowths emanating from the spheroids 
(Figure 2.7a).  While spheroids in all gels displayed a robust sprouting response, those 
cultured within the softer gels had fewer extensions that appeared to be less branched 
than the spheroids cultured within the stiffer, glycated gels.  After only one day, 
spheroids within the stiffest collagen gels (100 mM ribose), had a two-fold increase in 
the total extension length per spheroid and a 1.5-fold increase in the average number 
of extensions per spheroids when compared to spheroids cultured within the soft 
Figure 2.8.  Long-term angiogenic outgrowth response to matrix stiffness.  
Multicellular spheroids were grown in collagen gels polymerized from solutions 
treated with 0, 50, or 100 mM ribose for 8 days.  Spheroids were fixed and stained for 
actin and DAPI and imaged using confocal microscopy.  Scale is 200μm. 
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collagen gels (0 mM ribose) (Figure 2.7b-c).   Additionally, spheroids in the stiffest 
collagen gels (100 mM ribose) had a significantly larger projected area during the 
entire 5 day analysis period than those in soft gels (0 mM ribose) (Figure 2.7d).  These 
data indicate that 3D matrix stiffness altered endothelial sprouting dynamics. To 
determine if the differences in extension morphology persisted in long-term spheroid 
culture, EC spheroids were embedded and grown for 8 days.  The resulting sprouts 
were stained for actin and DAPI and imaged using confocal microscopy (Figure 2.8).  
The morphology of spheroid outgrowth remained altered dependent upon collagen 
stiffness.  To investigate the effects of AGE/RAGE signaling relative to stiffness on 
spheroid outgrowth, RAGE were inhibited with an anti-RAGE blocking antibody
41
.  
Notably, although the overall spheroid outgrowth was decreased with anti-RAGE 
treatment when compared to controls, the EC spheroid outgrowth remained 
significantly increased in the stiffer collagen gels at day 2 (Figure 2.9).     
Figure 2.9.  The effects of RAGE inhibition on spheroid outgrowth.  Multicellular 
spheroids were embedded within collagen polymerized from solutions treated with 0 
or 100 mM ribose and fed at 1 h with either complete media with or without 10 ug ml
-1
 
anti-RAGE blocking antibody.  (a) The projected spheroid areas were measured at 
days 0, 1 and 2 after embedding.  Data presented as mean + SEM, * indicates p < 0.05. 
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2.5 Discussion 
While numerous studies have investigated the role of matrix stiffness in mediating cell 
behavior on 2D substrates, much less is known about cell response to matrix stiffness 
in 3D matrices. Here, we describe and characterize a method to modulate the 3D 
stiffness of native, fibrillar collagen matrices while only minimally altering the 
inherent fiber structure, without the addition of synthetic materials.  Using non-
enzymatic glycation, collagen gel stiffness can be increased three-fold while only 
minimally changing the fiber architecture.  Further, the method described permits 
isolated cells or multi-cellular spheroids to be embedded within the glycated collagen 
gels during polymerization so that the resulting cellular response to 3D stiffness can be 
studied.  Our data indicate that increasing the collagen gel modulus from ~175 Pa to 
~515 Pa caused changes in cell spreading and dramatic differences in the morphology 
of endothelial sprouts from spheroids. These results demonstrate the utility non-
enzymatic glycation to alter 3D matrix mechanics with minimal changes in collagen 
fibril organization so that cell response to 3D changes in matrix stiffness can be 
studied. 
 
Methods to glycate collagen have been explored previously in the literature.  Several 
reports have described methods to glycate collagen gels once they have been 
polymerized
28,29
 or to adsorb glycated collagen to glass or plastic
56
.  However, neither 
of these methods allow for cells to be embedded within the collagen.  Other studies 
have reported glycating collagen gels prior to polymerization
23,24,57
, however it was 
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not clear what effect the process of glycation was having on the fiber architecture. 
Because fiber architecture is known to alter cell behavior
58
, it is important to develop 
scaffolds where it is possible to control stiffness without altering fiber diameter or 
distribution. Here, we identify a range of ribose concentrations where stiffness can be 
increased with minimal changes to fiber architecture.  Our data show that collagen 
glycated with 0 – 100 mM ribose exhibits a compressive modulus that varies over 
three fold (~175 Pa to ~515 Pa) (Figure 2.1) without significant changes to the fibril 
formation rates or fiber arrangements.  At higher concentrations of ribose (150 – 250 
mM), the compressive modulus of the gels increases, but a change in the fibril length 
scale (Figure 2.2 and Figure 2.3) and a decrease in the rate of gel polymerization 
(Figure 2.4) also occur.  Therefore, while glycation can tune the moduli of collagen by 
four-fold, the changes in modulus that can be controlled while not producing 
statistically significant changes in fiber architecture fall within a narrower range.  It is 
important to note that ligand availability and pore size can also affect cell behavior, 
although we did not directly test for these parameters.   
 
Notably, the changes in fiber architecture due to glycation (Figure 2.2 and Figure 2.3) 
coincide with changes in the polymerization dynamics (Figure 2.4) of collagen treated 
with varying concentrations of ribose. Polymerization rate has been shown to be 
affected by a number of other parameters as well, including pH
59
, temperature
60,61
, and 
the presence of ions
62
, where pore structure and fiber length and diameter are also 
altered.  These results suggest that the polymerization rate of the collagen gels may be 
responsible for the changes in the fiber architecture we observe for collagen incubated 
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with high concentrations of ribose. Further modulation of the polymerization kinetics 
using temperature or pH may allow for the formation of highly glycated collagen gels 
that resemble the architecture of gels glycated with 0 – 100 mM ribose. 
 
While stiffness has been shown to modulate numerous cellular behaviors, these reports 
are largely based on studies using 2D substrates.  It is not clear how results based on 
the use of 2D substrates translate into behaviors in three dimensions.  In previous 
work, we showed that changes in substrate stiffness resulted in changes in cell 
spreading
55
.  Our data using 3D glycated gels indicate that, similar to our results 
obtained in 2D cultures, endothelial cells increase their spreading due to increased 
matrix stiffness.   Unlike many studies using 2D substrates, we find no change in 
endothelial cell proliferation rates in 3D due to stiffness (Figure 2.5).  These results 
may be attributed to the complex relationship of cell division with spreading and 
matrix deposition, degradation, and remodeling in 3D matrices
63,64
.  However, just as 
cell response to matrix stiffness on 2D substrates has been found to be cell-type 
specific
5
, it is likely that cell response in 3D matrices is also cell-type specific and 
should be further investigated.   
 
In our study, we observed a significant increase in cellular spreading and extension 
formation with increasing matrix stiffness almost immediately (within 24 hours) after 
the individual cells and multi-cellular spheroids were embedded (Figure 2.6 and 
Figure 2.7) and these effects persisted throughout the entire course of our culture (8 
days) (Figure 2.8).  Interestingly, work by Francis-Sedlak et al. reported a transient 
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and opposite response to matrix stiffness when human umbilical vein endothelial cell 
aggregates were injected into gels glycated with glucose-6-phospate post-
polymerization
30
.  A number of differences in experimental design could attribute for 
these discrepancies including the density of the collagen matrices, cell type, or 
methods of glycation and cellular embedding.  Additionally, collagen glycation has 
been shown to decrease adherent cell adhesion and mechanotransduction by 
modifying integrin binding sites
56,65–67
.  Interestingly, we found that spheroids and 
isolated cells within the stiffer, glycated matrices have increased extension outgrowth 
and spreading when compared to those in non-glycated matrices (Figures 2.6 and 2.8).  
While we did not directly investigate cell adhesion in our study, our findings suggest 
that endothelial cells within glycated matrices integrate mechanical cues and increase 
their spreading, even if cell adhesion is disrupted when compared to the non-glycated 
matrices. Others have also shown that increasing the amount of non-enzymatic 
glycation cross-linking decreases the degradability of matrices
30,68,69
.  It is notable that 
we saw the most spheroid outgrowth in the stiffest, least degradable and least adhesive 
collagen matrices (Figure 2.7).  Future studies should elucidate whether our results are 
universal responses for all endothelial cell sources or specific to bovine aortic 
endothelial cells and further experiments should be performed to determine the 
relative effects of matrix density, glycation, and matrix degradation on cell outgrowth 
and function in collagen matrices.   
 
In vivo, the cross-linking of matrix proteins via non-enzymatic glycation is a slow 
process that occurs naturally, resulting in AGE cross-links that cause tissue stiffening 
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with age. Cross-link accumulation is accelerated in diseases where blood sugar levels 
are not well-regulated such as diabetes
68–70
.  Glycation has the most profound effect on 
components within the body that have a low turnover rate, including collagen
70
.  
Tissues including the vasculature
71
, bone
72
, cornea
73
, and skin
73
 and diseases such as 
Alzheimer’s74, rheumatoid arthritis75, and end stage renal disease76 have all been 
associated with the formation of glycation cross-links.  In this study we have shown 
that collagen gel stiffness alters spheroid outgrowth when the AGE/RAGE interaction 
is inhibited (Figure 2.9).  Notably, spheroid outgrowth decreased in RAGE inhibited 
spheroids when compared to control spheroids in matrices of the same stiffness, 
suggesting that the presence of the AGE/RAGE interaction may play a role in 
promoting extension formation and outgrowth.  The concentrations and experimental 
time points we chose were similar to other studies using anti-RAGE antibodies for 
blocking
41–45
; however, it is not clear if the antibody completely blocks the interaction 
between AGE/RAGE at the concentrations used.  To determine the relative roles of 
chemical vs. mechanical changes due to glycation, additional experiments are required 
and are an interesting area of future work given the effects of glycation on many major 
tissues in the body.  Better models using collagen glycation may not only enable a 
greater understanding of how matrix stiffness affects cells in three dimensions but also 
how glycation can promote disease.    
 
In both solid tumor growth and diabetes, tissues tend to stiffen
72,77
 and, in both disease 
states, angiogenesis is perturbed and vessels tend to be malformed and present 
abnormally
78,79
.  Our results suggest that the stiffening of the matrix may be one 
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mechanism which causes changes in the quantity and organization of blood vessels.  
In our study, differences in the number of extensions per spheroids were measurable 
as early as one day after embedding (Figure 2.7) indicating that the cells were 
integrating the stiffness cues into their behavior in the early stages of extension 
formation.  Notably, the morphological differences in the extensions with stiffness 
were maintained throughout the entire length of culture, indicating that matrix 
stiffness likely plays a key role in angiogenesis.   
 
2.6 Conclusions 
The study describes a tractable technique for modifying collagen stiffness 
independently of gel density and fiber structure.  By glycating the collagen while in 
solution, we were able to embed cells within collagen matrices to examine the effects 
of 3D stiffness on individual- and multi-cellular behaviors.  These changes in stiffness 
significantly altered endothelial cell morphology and 3D sprouting from spheroids, 
indicating that the 3D mechanical environment is an essential mediator of cellular 
response.  In the future, non-enzymatic glycation could be used to study the effects of 
extracellular matrix stiffness on a range of cell types that have previously been shown 
to be influenced by changes in matrix stiffness in 2D systems such as neurons
4
, stem 
cells
6
, and vascular smooth muscle cells
2
. 
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CHAPTER 3 
 
COLLAGEN CROSS-LINKING INCREASES ANGIOGENESIS AND DISRUPTS 
BARRIER INTEGRITY 
 
Portions of this chapter are in preparation for submission. 
 
3.1 Abstract 
Tumor microvasculature tends to be malformed, more permeable and more tortuous 
than vessels in healthy tissue, effects that have been largely attributed to up-regulated 
VEGF expression. However, during solid tumor progression, tumor tissue tends to 
stiffen and tissue stiffness is known to alter cell behavior including the formation and 
stabilization of cell-cell contacts which are requisite for angiogenesis.  Using cross-
linked collagen gels, we investigated the effects of matrix stiffness on vessel growth 
and integrity during angiogenesis. Using in vitro and ex ovo models, our data indicate 
that angiogenic outrgrowth increases with matrix cross-linking but decreases with 
matrix density. Cross-linking also results in increased vessel branching, another 
hallmark of tumor vasculature. In addition to promoting increased outgrowth and 
branching, stiffness also disrupts endothelial barrier function.  Importantly, we show 
that inhibiting matrix metalloproteinases with GM6001 significantly reduces 
angiogenic outgrowth in stiffer cross-linked gels and modifies sprout morphology. 
These results demonstrate that matrix stiffness, independently of exogenous growth 
factor cues and separately from matrix density, can alter vascular growth and integrity.  
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These data suggest that therapeutically targeting stiffness or endothelial cell response 
to stiffening in the tumor microenvironment may help maintain and restore vessel 
structure and function to minimize metastasis and aid in drug delivery.   
 
3.2 Introduction 
Tumor tissues generally have altered mechanical properties as compared to native, 
healthy tissue and solid tumors are associated with an increase in local extracellular 
matrix (ECM) stiffness and angiogenesis
1,2
. The in-growth of newly sprouted blood 
vessels is necessary for tumor growth and the tumor vasculature is typically 
malformed, leakier, and more tortuous than the vasculature of normal tissues
2,3
.  
Generally, the aberrant vasculature is viewed to be the result of up-regulated vascular 
endothelial growth factor (VEGF) expression resulting in chaotic vascular growth and 
failure to establish mature well-regulated networks.  In fact, many studies have been 
focused on the role of increased VEGF expression in tumor angiogenesis
4–6
.  Here, we 
propose a novel hypothesis, namely that ECM mechanical properties contribute to the 
aberrant vascular phenotype seen in tumors.  
 
The increase in ECM stiffness of tumors is primarily due to both increased collagen 
deposition and increased cross-linking within the tumor stroma
7
.  Increased ECM 
density and cross-linking are both known to be poor prognostic markers in a number 
of cancers
8–13
.  Many studies have investigated the role of matrix density on 
angiogenesis and, in both collagen and fibrin matrices, have shown that angiogenesis 
decreases with increasing matrix concentration
14–18
.     However, less is known about 
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how stiffening due to matrix cross-linking affects angiogenesis.   In this study, we 
examine the effects of altering ECM stiffness through non-enzymatic glycation cross-
linking to further understand the effects on the angiogenic response.      
 
Non-enzymatic glycation is a process that occurs in vivo whereby proteins are cross-
linked by reducing sugars such as glucose or ribose through a sequence of chemical 
modifications known as the Maillard reaction
19
.   The process of non-enzymatic 
glycation forms cross-links termed advanced glycation endproducts (AGE).  
Importantly, AGEs have been found to be present in a number of different cancers and 
have been implicated in increased malignancy
20,21
.   
 
Here, we show that increasing the extent of collagen cross-linking leads to 
significantly more outgrowth and branching both in vitro and in an ex ovo embryonic 
chick model.  We further show that the stiffness of the matrix plays an important role 
in endothelial cell-cell junctional integrity and endothelial monolayer permeability.  
Together, our study demonstrates matrix cross-linking plays a critical role in 
modulating the angiogenic potential and cell-cell associations of endothelial cells.  
 
3.3 Materials and Methods 
Cell Culture 
EC culture 
Human umbilical vein endothelial cells (HUVEC) were purchased from Invitrogen 
and used until passage 8.  HUVECs were grown in M200 (Invitrogen) supplemented 
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with low-serum growth supplement (Invitrogen) and 5% fetal bovine serum 
(Invitrogen).  Cells were fed every other day and grown to confluence in a 37ᴼC and 
5% C02 incubator. Bovine aortic endothelial cells (BAEC) were purchased from VEC 
Technologies (Rensselaer, NY) and used until passage 12.  BAECs were grown in 
M199 (Invitrogen, Carlsbad, CA) supplemented with 1% each of MEM amino acids 
(Invitrogen), MEM vitamins (Mediatech, Manassas VA), and penicillin-streptomycin 
(Invitrogen) and 10% fetal clone III (Hyclone, Logan, UT).  For studies with GM6001 
(EMD Millipore, Billerica, MA), GM6001 was diluted to 5 mM in dimethyl sulfoxide 
(DMSO; Sigma-Aldrich, St. Louis, MO) and then mixed with complete M199 to form 
a 5 μM solution.  
 
Spheroid generation 
Multicellular spheroids were prepared through forced aggregation as described 
previously
22
.  Briefly, BAECs were suspended in complete M199 supplemented with 
0.25% Methocult (Stem Cell Technologies, Vancouver, BC, Canada) and seeded into 
non-adherent 96-well round bottom plates (Corning Inc., Corning, NY) at 10,000 cells 
per well.  Cells were pelleted by centrifugation and spheroids were formed by placing 
the plate on an orbital shaker for 2 hours and subsequently incubating the spheroids 
for 2 days prior to embedding within collagen gels.   
 
Preparation of collagen gels 
Isolation and non-enzymatic glycation of collagen 
Type I collagen was isolated from rat tail tendons (Rockland Immunochemicals, 
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Gilbertsville, PA) as described previously
22
.  Briefly, type I collagen was extracted in 
0.1% acetic acid (JT Baker, Phillipsburg, NJ) at 4ᴼC, lyophilized, and solubilized in 
0.1% sterile acetic acid to form 10 or 20 mg ml
-1
 stock solutions.  Glycated collagen 
solutions were prepared by mixing collagen stock solutions with 0.5 M ribose to form 
solutions containing 0, 50, or 100 mM ribose in 0.1% sterile acetic acid on ice.  
Solutions were incubated for 5 days at 4ᴼC and then neutralized with 1N sodium 
hydroxide in 10x Dulbecco’s Phosphate Buffered Saline (D-PBS; Invitrogen), mixed 
with HEPES (EMD Millipore) and sodium bicarbonate (JT Baker) in 10x D-PBS to 
form 1.5, 5, or 10 mg ml
-1
 collagen gels with final concentrations of 1x D-PBS, 25 
mM HEPES and 44 mM sodium bicarbonate. 
 
Cell and spheroid embedding 
Spheroids or isolated cells were embedded within neutralized collagen solutions and 
allowed to polymerize at 37ᴼC and 5% CO2 and then overlaid with complete medium.  
The medium was exchanged after 1 hour and then every other day during experiments.  
In cases were isolated cells were not suspended within the collagen gels, an equivalent 
volume of complete medium was added to the gel solutions prior to polymerization to 
maintain gel composition between experiments. 
 
Vasculogenesis Assays 
Vasculogenesis assays were seeded with HUVECs and fed every other day with 
CM200 supplemented with 40 ng ml
-1
 vascular endothelial growth factor (VEGF; 
R&D Systems, Minneapolis, MN), 40 ng ml
-1 
basic fibroblast growth factor (bFGF; 
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EMD Millipore), 50 ng ml
-1 
phorbol-12-myristate-13-acetate (TPA; EMD Millipore), 
and 50 μg ml-1 ascorbic acid (JT Baker)17.   
 
Mechanical testing of collagen gels 
The equilibrium compressive moduli of collagen gels were quantified on an Enduratec 
EL2100 frame (Bose, Eden Prarie, MN) with at 250 g load cell measuring the resultant 
forces of 5% stepwise displacements on collagen gels in confined compression
22,23
.  
Briefly, a standard linear solid model of viscoelastic behavior was used to fit the 
relaxation data from 1.5, 5, or 10 mg ml
-1
 collagen gels and the equilibrium modulus 
was calculated as the slope of the stress-strain curve
17,23
.  We assumed that the 
collagen gels were isotropic and elastic similarly to other studies of collagen gel 
mechanical properties
17,24
. 
 
Chicken embryo culture 
Ex ovo chicken embryo culture was performed as previously described
25
.  Briefly, 
fertilized white Leghorn chicken eggs were cultured for 72 hours at 37.5ᴼC and 60% 
humidity in a rocking incubator. The chicken embryos were then cracked into 
humidified hammocks and cultured ex ovo in a static incubator. At embryonic day 10, 
constructs consisting of two 5 mm x 5 mm squares of nylon mesh (Amazon Supply, 
Seattle, WA) sandwiched around 30 μl of 1.5 mg ml-1 collagen with that had been 
glycated with 0 or 100 mM ribose and containing 5 μg ml-1 VEGF (R&D Systems) 
were polymerized
26
.  Constructs were placed onto the distal region of the 
chorioallantoic membrane (CAM) and returned to the incubator. At embryonic day 15, 
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the embryos were injected with 0.25% (w/v) fixable 70 kDa Texas Red-dextran 
(Invitrogen) in D-PBS into the vitelline veins and the dye was allowed to perfuse for 
45 minutes.  The collagen constructs were fixed for 1 hour in 3.7 vol% formaldehyde 
in PBS, removed from the CAM and washed with PBS.  The vasculature within the 
collagen constructs was imaged using a Zeiss LSM700 (Carl Zeiss) confocal.  
Vascular density was scored by counting the number of mesh squares within a 6x6 
region that had angiogenic vessels within the collagen
26
 (n=40).     
 
Release of VEGF from glycated collagen gels 
Implants consisting of two 5 mm x 5 mm squares of nylon mesh and 30 μl of 1.5 mg 
ml
-1 
collagen that had been glycated with 0 or 100 mM ribose and containing 5 μg ml-1 
VEGF (R&D Systems) were polymerized as described for chicken embryo culture.  
Individual constructs were placed in a 100 mm petri dish (VWR, Radnor, PA) 
containing 10 ml TBS with 0.05% Tween (JT Baker) and 0.1% BSA.  Petri dishes 
were placed in an incubator at 37ᴼC and 5% CO2 and 100 μl samples of the solution 
were obtained at 0, 1, 2, 4, 8, and 24 hours.  Samples were frozen at -20ᴼC until 
quantification of VEGF release was performed using an ELISA according to the 
manufacturer’s instructions (R&D Systems).   
 
Polyacrylamide gel synthesis 
Polyacrylamide (PA) hydrogels were synthesized as described previously
27–29
.  
Briefly, the ratio of acrylamide (40% w/v solution, Bio-Rad, Hercules, CA) and N,N’-
methylene-bis-acrylamide (2% w/v solution, Bio-Rad) were varied to tune the 
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Young’s moduli of the gels from 0.2 to 10 kPa.  Substrates were functionalized with 
N-6-((acryloyl)amido)hexanoic acid, succinimidyl ester that was synthesized in our 
lab and covalently bound to 0.1 mg ml
-1 
type I rat tail collagen (Becton Dickinson, 
Franklin Lakes, NJ) or 0.1 mg ml
-1 
glycated collagen that had been prepared as 
described above
30,31
.   
 
Western Blot  
Subconfluent BAECs on PA substrates ranging from 0.2-10 kPa or polystyrene were 
lysed with buffers to fractionate the Triton-soluble and Triton-insoluble proteins
32
.  
Triton-soluble fractions were extracted with 1% (w/v) NP-40 and 1 vol.% Triton in 
Tris-buffered saline (TBS; 10 mM Tris-HCl, 150 mM NaCl) with 2 mM CaCl2 (JT 
Baker) pH 7.5, and protease inhibitor cocktail (1:500, Sigma-Aldrich). The Triton-
insoluble fractions were extracted with 0.5% (w/v) sodium dodecyl sulfate and 1% 
(w/v) NP-40 (JT Baker) in TBS.  The supernatants were analyzed with a protein assay 
(Bio-Rad, Hercules, CA) and subjected to gel electrophoresis (15 μg per sample; 8% 
acrylamide gel) and Western blot. Antibodies to VE-cadherin (C-19, Santa Cruz 
Biotechnology, Santa Cruz, CA), and to β-actin (AC-15, Sigma-Aldrich) were 
detected by chemiluminescence on a Bio-Rad ChemiDoc imaging system. 
Densitometry of VE-cadherin was performed with Quantity One (v. 4.6.5; Bio-Rad) 
and expressed as a ratio to β-actin. Total cell VE-cadherin was calculated by adding 
the VE-cadherin/ β-Actin ratios for Triton-soluble and Triton-insoluble fractions and 
the VE-cadherin in each fraction was determined as a percent of the total VE-cadherin 
(N=3). 
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Permeability 
BAECs on polyacrylamide substrates with Young’s moduli from 0.2 to 10 kPa were 
used to measure endothelial cell permeability as described previously
33
.  Briefly, 2-day 
post-confluent BAEC monolayers were immersed in a 10 μM solution of 40 kDa 
FITC-dextran (Sigma-Aldrich) for 5 minutes.  Confocal z-slices were acquired using a 
Zeiss LSM700 microscope with a long working distance water-immersion C-
Apochromat 40x/1.1 NA objective (Carl Zeiss).  To calculate relative permeability, 
the intensity of the dextran accumulation within the gel was divided by the fluorescent 
intensity of the solution above the gel.  These values were then normalized by the 
relative accumulation of dextran within gels without cells (n=21-56).   
 
Immunocytochemistry 
Cells and spheroids were fixed in 3.7 vol.% formaldehyde in 1x D-PBS, permeabilized 
with 1 vol.% Triton (JT Baker) in 1x D-PBS and blocked with 3% w/v bovine serum 
albumin (BSA, Sigma-Aldrich).  Cells were stained for actin using Alexa Fluor 488 or 
Alexa Fluor 568 phalloidin (Invitrogen) and for nuclei with 4’,6-diamidino-2-
phenylindole (DAPI) (Sigma-Aldrich).  BAECs were immunostained for VE-cadherin 
with a goat polyclonal VE-cadherin primary antibody (C-19, Santa Cruz 
Biotechnology) and Alexa Fluor 568 donkey anti-goat secondary antibody 
(Invitrogen).   
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Imaging 
Confocal reflectance imaging 
As described previously, the internal structure of collagen gels were visualized using 
confocal reflectance microscopy
22,34
.  A Zeiss LSM 700 inverted laser scanning 
microscope (Carl Zeiss, Oberkochen, Germany) equipped with a 405 nm laser and a 
long working distance water-immersion C-Apochromat 40x/1.1 NA objective (Carl 
Zeiss) were used to acquire 1 μm optical slices of the collagen structure. Image 
acquisition parameters were the same for all gels. 
 
Spheroid Outgrowth 
BAEC multicellular spheroids were imaged with bright-field on a Zeiss Axio Observer 
Z1.m (Carl Zeiss) and with fluorescence on a Zeiss LSM700 point scanning confocal.  
Bright-field images of spheroids in culture were acquired daily for outgrowth studies.  
Spheroid outgrowth was compared across conditions by measuring the area of the 
spheroids with the resultant extensions over 5 days and normalizing to the area of the 
spheroid immediately after embedding within the collagen gel (n=7-14).  For the 
GM6001 data, spheroid outgrowth was measured at day 3 and normalized to the area 
of the spheroid immediately after embedding in the collagen gel (n=19-28).  
 
Spheroid Branching 
Spheroids embedded in 1.5 mg ml
-1
 collagen for 5 days were stained for actin and 
nuclei.  Images of the spheroids were acquired as z-stacks with 5 μm spacing using a 
EC Plan-Neofluar 10x/0.30 NA objective (Carl Zeiss).  Maximum intensity 
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projections of the confocal z-stacks were analyzed for branching density by counting 
the number of branches per sprout length for five randomly chosen extensions per 
spheroid (n=35-55).  Data were normalized to the 0 mM ribose condition. 
 
Spheroid Sprout Width 
Spheroids embedded in 1.5 mg ml
-1
 collagen for 3 days with and without GM6001 
treatment were stained for actin and nuclei.  Images of the spheroids were acquired as 
z-stacks with 5 μm spacing using a EC Plan-Neofluar 10x/0.30 NA objective (Carl 
Zeiss).  Maximum intensity projections of the confocal z-stacks were analyzed for 
sprout width by drawing a line perpendicular to the sprout and fitting the intensity 
profile to with a two-Gaussian curve in MATLAB.  The tip width was defined as the 
width of the two-Gaussian fit 20% above the background intensity (n=61-85). 
 
VE-cadherin  
BAEC spheroids embedded for 24 hours in 1.5 mg ml
-1
 collagen gels were stained for 
VE-cadherin and nuclei.  Images of the sprouts emanating from the spheroids were 
acquired as z-stacks with 1 μm spacing using a long working distance water-
immersion C-Apochromat 40x/1.1 NA objective (Carl Zeiss).  The widths of 
endothelial cell junctions were analyzed as described previously using a custom-
written MATLAB algorithm
33
.  Briefly, z-stacks of were used to visually determine 
the focal plane for a given junction in ImageJ.  A line was drawn perpendicular to the 
junction and the intensity profile was recorded and then fit with a two-Gaussian curve 
in MATLAB.  The junctional width was defined as the width of the two-Gaussian fit 
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20% above the background intensity. Tip cell junctions were defined as the junction of 
the terminal cell with the rest of the sprout (n=80-105).  Stalk cell junctions were 
defined as those between adjacent cells within the sprout (n=118-130).   
 
Timelapse microscopy and single cell migration  
Individual BAEC migration was monitored beginning 24 hours after embedding 
within collagen gels using a Zeiss Axio Observer Z1.m (Carl Zeiss) microscope 
equipped with motorized stage and an environmental chamber maintained at 37ᴼC and 
5% CO2.  Images were acquired every 10 minutes for 15 hours.  Cells were traced in 
ImageJ and centroid positions were used to calculate the mean-square displacement 
(  ) to find cell migration speed ( ) using the persistent random walk equation:  
       [   (    (   ))], where ( ) is time interval, and ( ) is the persistence 
time using a nonlinear least squares regression analysis as previously described
35–37
 
(n=46-68).  
 
Vasculogenesis imaging and analysis 
HUVECs were imaged using a Zeiss LSM700 (Carl Zeiss) after being embedded 
within 1.5 mg ml
-1
 gels for 7 days and stained for actin and nuclei.  Images of cells 
were acquired as z-stacks with 5 μm spacing using an EC Plan-Neofluar 10x/0.30 NA 
objective (Carl Zeiss).  Cellular structures were analyzed using a custom-written 
MATLAB algorithm for volume and tortuosity based on previously published 
methods
38,39
.  Volume measurements were extracted as three-dimensional connected 
components from binary images processed with an adaptive thresholding method. 
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Tortuosity was defined as ratio of path length of lumen center divided by the 
Euclidean distance between the two distal tips of the lumen (n=51-70). 
 
Statistics 
Data were analyzed using a one-way analysis of variance (ANOVA) followed by a 
post-hoc Tukey’s Honest Significant Difference test in JMP (SAS, v.10.0).  To 
normalize the data distributions, spheroid branch density, VE-cadherin junction width, 
and permeability data were transformed by natural logarithm prior to running a 
Tukey’s test.  Statistical significance was considered as p < 0.05.  All values are 
expressed as the mean ± standard error of the mean (SEM). 
 
3.4 Results 
Non-enzymatic collagen glycation and collagen density modulate the mechanical 
properties and fiber arrangements of collagen gels. 
The individual and combined effects of non-enzymatic collagen glycation and 
collagen density on the mechanical and structural properties of collagen gels were 
studied.  Non-enzymatic collagen glycation occurs when a non-reducing sugar such as 
ribose reacts with a free amino group on the collagen molecule to form a Schiff base 
(Figure 3.1A).  The Schiff base can then undergo rearrangement to form an Amadori 
product and interact with a free amino group on an adjacent collagen fiber to create an 
advanced glycation endproduct (AGE) cross-link between the fibers.  Accumulation of 
these AGE cross-links increases the stiffness of the collagen gels. 
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We have previously shown that 1.5 mg ml
-1 
collagen gels glycated with 0-100 mM 
ribose have similar fiber arrangements while those glycated with 150-250 mM ribose 
have larger and more prominent collagen fibers
22
.  Thus, we chose to use glycation 
concentrations of 0-100 mM ribose in this study.  The process of non-enzymatic 
glycation was used to stiffen 1.5, 5, and 10 mg ml
-1
 collagen in vitro by incubating un-
polymerized collagen solutions with 0, 50, or 100 mM ribose for 5 days at 4ᴼC prior to 
neutralization and polymerization.  This incubation period allowed AGE precursors to 
form within the solubilized collagen so that cross-links could form upon 
polymerization of the gels
22,23
.  
 
To investigate the effects of collagen density and cross-linking on collagen gel fiber 
Figure 3.1.  Matrix density and cross-linking alter collagen gel mechanical 
properties and fiber arrangements. (A) Schematic of the chemistry of collagen 
glycation.  (B)  Confocal reflectance microscopy images of 1.5, 5, and 10 mg ml-1 
collagen gels glycated with 0, 50, or 100 mM ribose.  (C) The equilibrium 
compressive moduli of the gels were measured by confined compression testing. Data 
presented as mean ± SEM, Scale is 50 μm. 
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architecture, gels were polymerized and the internal collagen fiber distributions were 
visualized with confocal reflectance microscopy.  Increasing the density of the 
collagen visibly decreases the porosity and alters the size and distribution of fibers 
within the collagen gels (Figure 3.1B).  However, collagen gels within a given density 
and glycated with 0-100 mM ribose form gels with qualitatively similar fiber 
architectures. 
 
Confined compression testing was performed to investigate the mechanical properties 
of collagen gels by applying a 5% stepwise strain to a confined gel and measuring the 
resultant force.  The equilibrium compressive modulus was calculated as the slope of 
the stress-strain curve by fitting the data to a standard linear solid model of 
viscoelastic behavior.  Increasing the density of the collagen gels from 1.5 to 10 mg 
ml
-1
, increases the equilibrium compressive modulus approximately 6-fold from ~180 
Pa to ~ 1200 Pa (Figure 3.1C).  Within a given density, increasing the extent of 
glycation from 0 to 100 mM also increases the modulus of the gels from ~180-500 Pa, 
~600-715 Pa, and ~1200-1400 Pa, for 1.5, 5, and 10 mg ml
-1
 collagen gels, 
respectively. 
 
Taken together, these results indicate that non-enzymatic glycation can modulate the 
mechanical properties of collagen gels within a defined range while only minimally 
altering the collagen fiber architecture.  Altering the density of collagen modulates the 
stiffness of the gels to a greater extent, but also changes the collagen fiber distributions 
and arrangements within the gels.  We used these two competing mechanisms of 
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stiffening collagen to investigate the relative roles of collagen stiffness and density on 
the outgrowth of angiogenic sprouts from multicellular spheroids into collagen gels.    
 
Spheroid outgrowth is modulated by matrix density and collagen glycation 
We have previously shown that increasing the stiffness of collagen matrices via non-
enzymatic collagen glycation increases the angiogenic outgrowth of multicellular 
endothelial cell spheroids into 1.5 mg ml
-1
 collagen gels
22
.  To investigate the 
individual and combined roles of stiffening gels via collagen glycation and density on 
endothelial cell (EC) outgrowth, EC spheroids were embedded within 1.5, 5, and 10 
mg ml
-1
 gels glycated with 0, 50, or 100 mM ribose and imaged every 24 hours over 5 
days.  Increasing the density of the collagen matrix decreased the overall outgrowth of 
angiogenic sprouts from the spheroids (Figure 3.2A,B).  However, at all densities, 
increasing the stiffness of the collagen via glycation increased the outgrowth response 
from the spheroids.  EC spheroids invaded significantly further in collagen gels 
glycated with 100 mM ribose than with 0 mM ribose beginning at days 1 and 3 for 1.5 
and 5 mg ml
-1
 collagen densities, respectively (Figure 3.2B).   This trend is observed 
across all collagen densities, although it is not statistically significant at 10mg/ml. 
These data suggest that both the stiffness of the collagen matrix and the density can 
influence EC sprouting. 
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Spheroid branching is modulated by collagen glycation 
To further analyze the effects of matrix stiffness on spheroid outgrowth, the density of 
branching along angiogenic sprouts in spheroids embedded for 5 days in 1.5 mg ml
-1 
collagen gels glycated with 0, 50, or 100 mM ribose was analyzed.   Spheroids stained 
for actin and nuclei were imaged using confocal microscopy and the number of 
branches per sprout length was measured.  Increasing the stiffness of the gels via non-
Figure 3.2.  Collagen cross-linking and density alter the angiogenic sprouting 
response from multicellular spheroids.  EC spheroids were embedded within (A) 
1.5, (B) 5,or (C) 10 mg/ml collagen gels glycated with 0, 50, or 100 mM ribose and 
the angiogenic sprouting response (arrowheads) was monitored.  (D) The projected 
spheroid area, including the extensions, was measured over the course of 5 days.  Data 
presented as mean + SEM, * indicates p<0.05, Scale is 200 μm. 
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enzymatic glycation increased the density of branching in angiogenic outgrowths from 
spheroids (Figure 3.3A).  Spheroids in stiffer gels (100 mM ribose) had an 
approximately 1.5-fold increase in branching when compared to those within softer (0 
mM ribose) gels (Figure 3.3B).  These data indicate that increasing matrix stiffness via 
non-enzymatic collagen glycation not only causes increased outgrowth from spheroids 
(Figure 3.2B) but also changes the morphology of the angiogenic sprouts that have 
formed.   
 
Spheroid outgrowth requires matrix metalloproteinase activity 
To understand the role of matrix metalloproteinase (MMP) activity on spheroid 
outgrowth, the broad spectrum MMP inhibitor, GM6001, was used.  EC spheroids 
were embedded within 1.5 mg ml
-1
 collagen gels that had been glycated with 0 or 100 
mM ribose and fed with either control media or media containing 5 μM GM6001.  The 
Figure 3.3.  Matrix cross-linking alters angiogenic branching.  EC multicellular 
spheroids were embedded within 1.5 mg/ml collagen gels glycated with 0, 50, or 100 
mM ribose.  (A) Spheroids were fixed, stained for actin (green) and nuclei (blue), and 
imaged using confocal microscopy after 5 days.  (B) The number of branches per 
sprout length were counted and data were normalized to the 0 mM condition.  Data 
presented as mean + SEM, * indicates p<0.05, Scale is 100 μm. 
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extent of spheroid outgrowth after 3 days of culture was quantified.  Spheroids 
cultured with GM6001 in stiffer gels (100 mM ribose) had significantly less 
angiogenic outgrowth than spheroids in stiff controls (Figure 3.4A,B).  Interestingly, 
spheroid outgrowth in stiffer gels (100 mM ribose) with GM6001 treatment was not 
significantly different than outgrowth within the softer gels (0 mM ribose) with or 
without GM6001 treatment.  We observed that the morphologies of the angiogenic 
sprouts appeared to be altered with the GM6001 treatment.  To investigate the role of 
Figure 3.4.  Spheroid outgrowth requires MMP activity.  (A)  EC multicellular 
spheroids were embedded within 1.5 mg ml
-1
 collagen gels glycated with 0 or 100 mM 
ribose and fed with complete medium with or without 5 μM GM6001. Scale is 200 
μm.  (B) Spheroid outgrowth was quantified after 3 days of culture and normalized to 
the Day 0 condition.  (C)  Spheroids were stained for actin (green) and nuclei (blue) 
and imaged with confocal microscopy.  Scale is 100 μm. (D) The width of the 
angiogenic sprouts was measured by fitting the intensity profile of a line drawn 
perpendicular to the sprout with a two-Guassian curve.  Data are presented as mean + 
SEM. 
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GM6001 on sprout morphology, spheroids were fixed and stained for actin and 
nuclear proteins and imaged using confocal microscopy (Figure 3.4C). Angiogenic 
sprout widths were measured by fitting the intensity profile to a two Gaussian curve.  
Sprouts in soft and stiff control gels (0 and 100 mM ribose) had similar morphologies 
while sprouts from spheroids cultured with GM6001 were much thinner than controls 
(Figure 3.4D).  These data suggest that MMPs may be critical for the establishment of 
the wider, multicellular angiogenic sprouts seen in controls.  Taken together, these 
data indicate that MMP activity is essential for the increased outgrowth that is seen in 
stiffer matrices.   
 
Increased matrix stiffness increases angiogenesis in ex ovo chicken embryos 
To investigate the role of matrix stiffness in mediating angiogenesis in a more 
physiologically-relevant model, we studied the formation of blood vessels in 1.5 mg 
ml
-1 
collagen gels glycated with 0 and 100 mM ribose using an ex ovo embryonic 
chicken model. Collagen implants were made by sandwiching 30 μl of collagen 
containing 5 μg ml-1 VEGF between two 5 mm x 5 mm pieces of nylon mesh and were 
placed onto the distal region of the chorioallantoic membrane (CAM) at embryonic 
day 10 (Figure 3.5A-C).  To ensure that the elution of VEGF was not influenced by 
the stiffness of the gel, a VEGF ELISA was used to determine the release profile of 
VEGF.   The ELISA analysis indicates that the release of VEGF from the collagen 
constructs was not affected by the stiffness of the gels (Figure 3.5D).  On embryonic 
day 15, embryos were perfused with a 0.25% (w/v) solution of fixable 70 kDa Texas 
Red-dextran in D-PBS such that any open and patent angiogenic vessels in the
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Figure 3.5. Matrix cross-linking alters angiogenic sprouting into collagen gels in 
the chick CAM model. (A) Collagen gels were placed on the chick CAM at day 10.  
Schematic views of the (B) top and (C) side of the collagen and nylon meshes depict 
angiogenic ingrowth into the collagen gels from the vasculature underlying the CAM. 
(D) VEGF release profiles over 24 hours from collagen glycated with 0 or 100 mM 
ribose were quantified by ELISA. (E) Angiogenic sprouting (arrowheads) into 1.5 
mg/ml collagen gels glycated with 0 or 100 mM ribose were imaged with confocal 
microscopy and (F) the vessel density per gel was quantified. Data presented as mean 
+ SEM, * indicates p<0.05, Scale is 200 μm.     
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collagen gels could be imaged via fluorescence.  Collagen constructs were fixed with 
3.7 vol.% formaldehyde in D-PBS and imaged using confocal microscopy.  Vessels 
within the collagen gels appear as thin fluorescent sprouts (Figure 3.5E, arrowheads). 
Stiffer collagen gels (100 mM ribose) had significantly more angiogenic ingrowth than 
the more compliant (0 mM ribose) gels (Figure 3.5F).  Importantly, these data indicate 
that angiogenesis in the CAM model is also modulated by the stiffness of the matrix.   
 
Collagen stiffness influences single cell migration and persistence 
To determine whether we could attribute the increased extent of angiogenic outgrowth 
with stiffness in vitro and ex ovo to the migration speed of ECs, we embedded ECs 
within 1.5 mg ml
-1 
collagen gels that had been glycated with 0, 50, or 100 mM ribose.  
The migration of the cells was monitored using timelapse microscopy, the cell 
centroid was tracked using ImageJ, and individual cell trajectories were plotted 
(Figure 3.6A).  Centroid positions were used to quantify the mean-square 
displacement and cell speed and persistence were calculated by fitting the data to a 
persistent random walk model
35–37
.  Surprisingly, as the stiffness of the gels increased, 
the speed of migration decreased (Figure 3.6B).  However, the persistence time 
increased with increasing gel stiffness (Figure 3.6C).  These data indicate that 
individual endothelial cells migrate slower within stiffer matrices and suggest that the 
increased extent of angiogenic outgrowth observed in stiffer collagen gels may be due 
to the increased persistence of cell migration. 
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Vasculogenesis formation is not altered with matrix stiffness 
Since matrix stiffness results in differences in angiogenic outgrowth and branching, 
and single ECs have altered migration in response to matrix mechanical properties, we 
decided to study whether matrix stiffness influences the process of vasculogenesis.  
During vasculogenesis, single cells within a matrix migrate and proliferate to form 
Figure 3.6.  Endothelial cell migration is altered by matrix cross-linking.   (A) 
Rose plots of individual EC migration within the 1.5 mg/ml collagen gels glycated 
with 0, 50, or 100 mM ribose. Scales of axes are μm. Migration (B) speed and (C) 
persistence were quantified. Data presented as mean + SEM. 
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vascular structures.  HUVECs were seeded within 1.5 mg ml
-1
 collagen gels that had 
been glycated with 0, 50, or 100 mM ribose and fed with CM200 supplemented with 
40 ng ml
-1
 VEGF, 40 ng ml
-1 
bFGF, 50 ng ml
-1 TPA and 50 μg ml-1 ascorbic acid17.  
After 7 days of culture, gels were fixed and stained for actin and nuclei and imaged 
using confocal microscopy.  HUVECs formed qualitatively similar vasculogenic 
structures containing enclosed lumens in all conditions studied (Figure 3.7A,B).  A 
custom MATLAB algorithm was used to quantify the volume and tortuosity of the 
HUVEC structures.  Interestingly, there were not quantifiable differences in either the 
Figure 3.7.  Vasculogenesis is not altered with matrix cross-linking in glycated 
collagen gels.   (A) Maximum intensity projections of ECs stained for actin (green) 
within 1.5 mg/ml collagen gels glycated with 0, 50, or 100 mM ribose. Scale is 200 
μm. (B) Orthogonal projection showing fully-enclosed lumens (arrowheads) formed 
by endothelial cells stained for actin (green) and DAPI (blue) with confocal 
reflectance of the collagen fibers. Scale is 50 μm. The (C) volume and (D) tortuosity 
of the vessel structures were measured using a customized Matlab code.  Data 
presented as mean + SEM. 
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volume or tortuosity of the resultant structures (Figure 3.7C,D).  These results suggest 
that matrix stiffness does not significantly change the process of vasculogenesis. 
 
Matrix stiffness influences VE-cadherin localization and endothelial monolayer 
permeability 
Previous studies have shown that the barrier function within the tumor vasculature is 
impaired when compared to the vasculature in healthy tissue
3,40
. To understand the 
role of matrix stiffness on mediating endothelial junctional integrity, BAEC spheroids 
were embedded in 1.5 mg ml
-1
 collagen that had been glycated with 0, 50, or 100 mM 
ribose, fixed after 24 hours of outgrowth, and stained for vascular endothelial cadherin 
(VE-cadherin) and nuclei.  Confocal images of the angiogenic outgrowth were 
acquired and VE-cadherin widths were measured by drawing a line perpendicular to 
the junction (Figure 3.8A).  Interestingly, the VE-cadherin junctions of the tip cells 
were significantly wider than the junctions within the stalks (Figure 3.8B).  
Additionally, we found that the VE-cadherin junctions within the stiff (100 mM 
ribose) collagen were significantly wider than those within the softer (0 or 50 mM 
ribose) collagen gels.   
 
To further study the role of matrix stiffness on mediating VE-cadherin junctional 
properties, BAECs were seeded onto soft (0.2 kPa) or stiff (10 kPa) polyacrylamide 
(PA) substrates.  As we have shown previously, endothelial cell networks 
spontaneously assemble on soft PA substrates but not on stiff PA substrates (Figure 
3.8C,D)
28
.  Cells on soft substrates formed VE-cadherin junctions that were
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Figure 3.8.  Matrix stiffness alters VE-cadherin expression and junction width. 
(A) EC spheroids were fixed 24 hours after embedding within 1.5 mg/ml collagen gels 
glycated with 0, 50, or 100 mM ribose and imaged with confocal microscopy to 
visualize VE-cadherin (red) and nuclei (blue) with confocal reflectance of the collagen 
fibers.  The profile of VE-cadherin junctions were acquired by drawing a line 
perpendicular to the junction (dotted line) and (B) widths were quantified at the tip or 
within the stalk of the sprouts. Scale is 50 μm. ECs were seeded on (C) compliant (0.2 
kPa) or (D) stiff (10 kPa) PA substrates. Scale is 100 μm. (E) On compliant substrates, 
VE-cadherin localization was continuous at cell-cell junctions (arrowheads). (F) On 
stiff substrates, VE-cadherin localization was punctate at cell-cell junctions. Scale is 
50 μm. (G) Western blot and (H) quantification of VE-cadherin fractionated to 
localize association with the cytoskeleton (Ctsk +/-; E, Young’s Modulus; TCP, tissue 
culture plastic). Insets are magnifications of boxed regions, Data presented as mean + 
SEM, * indicates p<0.05. 
Figure 3.7C-F contributed by Dr. Joseph Califano 
Figure 3.7G-H contributed by Dr. Christine Montague 
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continuous between cells while those on stiff substrates were punctate (Figure 3.8E,F; 
inset is a magnification of boxed region).  To quantify the effect of matrix stiffness on 
VE-cadherin localization, BAECs plated on PA substrates ranging from 0.2 kPa to 
tissue culture plastic (TCP; polystyrene, E=3GPa
41
) were analyzed by Western blot.  
Triton was used to fractionate insoluble and soluble VE-cadherin fractions, where the 
cytoskeleton-associated (Ctsk) insoluble fraction corresponds to mature endothelial 
cell junctions
32
.  The percentage of total VE-cadherin associated with the cytoskeleton 
was quantified and plotted (Figure 3.8H).  A significantly greater proportion of total 
VE-cadherin was associated with the cytoskeleton (Ctsk[+]) in soft, 0.2 kPa gels and 
decreased with increasing substrate stiffness (black bars) while the soluble fraction 
(Ctsk[-]) increased proportionally with increasing substrate stiffness (white bars).   
 
To further investigate how matrix stiffness and collagen glycation modulates VE-
Figure 3.9. Endothelial cell permeability is modulated by collagen stiffness but 
not by collagen glycation.   (A) Schematic of setup showing ECs grown to 
confluence on polyacrylamide hydrogels with elastic moduli ranging from 0.2-10 kPa 
and coated with 0.1 mg ml-1 of collagen glycated with 0, 50, or 100 mM ribose.  The 
permeability of the ECs to 40kDa FITC-dextran was measured by monitoring the flux 
of fluorescence into the hydrogels in response to (B) stiffness and (C) collagen 
glycation.  Data presented as mean + SEM, * indicates p<0.05. 
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cadherin integrity, the permeability of BAEC monolayers on PA gels ranging from 0.2 
kPa to 10 kPa were measured as described  previously
33
.   BAEC monolayers were 
immersed in a 10 μM solution of 40 kDa FITC-dextran and the accumulation of 
dextran was measured relative to the fluorescent intensity above the gels (Figure 
3.9A).  We found that increasing the substrate stiffness significantly increases the 
permeability of endothelial cell monolayers (Figure 3.9B).  Interestingly, we found no 
association between the extent of collagen glycation and endothelial permeability at a 
given stiffness (Figure 3.9C) suggesting that endothelial cells may be more responsive 
to the stiffness of their matrix than to the extent of collagen glycation.  Together, these 
data indicate that the stiffness of the substrate modulates the integrity of VE-cadherin 
junctions, with compliant substrates encouraging the formation of tight and mature 
cell-cell interactions. 
 
3.5 Discussion 
While several studies have investigated the role of increasing three-dimensional 
matrix stiffness via matrix density on angiogenesis, much less is known about role of 
cross-linking on the formation of vascular structures.  Here, we modulate matrix 
stiffness by increasing the amount of non-enzymatic glycation cross-linking.  We 
show that increasing the extent of glycation increases the stiffness of the resultant 
collagen gels but only minimally changes the collagen fiber structure (Figure 3.1B,C).  
Additionally, we found that increasing the density of the matrices resulted in reduced 
angiogenic outgrowth from endothelial spheroids (Figure 3.2B) while increasing the 
cross-linking increased the extent of outgrowth and branching in endothelial spheroids 
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and in the ex ovo embryonic chick model (Figures 3.2B, 3.3B, and 3.5F).  We also 
show that inhibiting MMP activity with GM6001 prevents the increased outgrowth 
from spheroids in cross-linked matrices and alters the resultant angiogenic sprout 
morphology (Figure 3.4).  Interestingly, we demonstrate that endothelial cell-cell 
junctional properties are modulated by the stiffness of the matrix and that the 
localization of VE-cadherin and the permeability of endothelial monolayers are 
significantly altered by matrix stiffness (Figures 3.8A-H, 3.9B).  Together, these 
results show that three-dimensional matrix stiffness plays an important role in 
regulating angiogenesis and vascular stability. 
 
The Warburg effect, whereby cells produce energy through glycolysis instead of 
through oxidative phosphorylation, has been generally acknowledged to be a 
metabolic hallmark of cancer
42,43
.  During glycolysis, glucose is converted into 
pyruvate to create adenosine triphosphate (ATP).  Importantly, intermediates in the 
glycolytic pathway have been shown to be precursors of AGE cross-link 
formation
44,45
.  Indeed, AGEs have been found in a number of different tumors types 
but the relationship between these cross-links and the integrity of the tumor 
vasculature has not been well-studied
20
.  Our data suggest that increasing matrix 
stiffness through non-enzymatic glycation alters angiogenesis and endothelial cell-cell 
junctional integrity (Figures 3.2B, 3.8B).  Future work should focus on understanding 
how processes such as the Warburg effect influence tumor vascular function in vivo.    
 
In addition to the changes in ECM mechanics, the vasculature within tumors is known 
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to be more permeable than in normal tissues
3
.  Our data demonstrate that increasing 
matrix stiffness increases endothelial cell-cell junction widths (Figure 3.8B) and 
modifies the localization of VE-cadherin from Ctsk[+] (mature, cell-cell junctions) to 
Ctsk[-] (soluble, cytoplasm) (Figure 3.8G,H).  Further, we show that increasing the 
stiffness of the matrix also increases the permeability of endothelial monolayers 
(Figure 3.9B).  Others have shown that increasing the amount of soluble VE-cadherin 
can induce endothelial membrane protrusions
46
.  Recent work from the Gerhardt lab 
suggests that increased VE-cadherin dynamics lead to active endothelial cell 
movements within the sprout and branching morphogenesis
47
.  Taken together, these 
observations provide a possible link between VE-cadherin localization and sprouting 
dynamics.  
 
Methods to study the role of stiffness on angiogenesis in naturally-derived hydrogels 
have primarily focused on altering matrix density and have typically found that 
increased density decreases angiogenesis
15,17,18,48
.  We also observed that increasing 
collagen density decreases angiogenic outgrowth from endothelial cells spheroids 
(Figure 3.2) but visibly altered the collagen fiber architecture (Figure 3.1B).  
However, glycation of 1.5, 5, or 10 mg ml
-1
 collagen with 0-100 mM ribose only 
minimally altered the resultant fiber arrangements in collagen gels (Figure 3.1B) while 
modulating the stiffness of the matrix (Figure 3.1C).  Interestingly, when the stiffness 
of the matrix is increased through glycation, we observed increased angiogenic 
sprouting both in vitro ex ovo (Figures 3.2, 3.5F).  Notably, work by Francis-Sedlak et 
al., showed a transient, decreased angiogenic sprouting in matrices that had been 
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stiffened by glycation with glucose-6-phospate
49
.  However, prior work by Francis-
Sedlak et al., showed that, collagen gels glycated with glucose-6-phosphate have a 2-
fold increase in the volume fraction of insoluble materials when compared to collagen 
gels that were not glycated
50
.  They attributed the increase in insoluble materials to 
increased fiber size or swelling of collagen fibers.  In our previously published work, 
we quantified that autocorrelation mean radius to compare the fiber structural 
properties between glycated collagen gels and showed that 1.5 mg ml
-1
 gels that had 
been glycated with 0-100 mM ribose had only minimal differences in fiber structural 
properties;  suggesting that large differences in fiber size or swelling do not exist in 
our system
22
.  These differences in gel structural properties could account for the 
discrepancies in our experimental results.  Additionally, recently published work 
investigating the effects of stiffening collagen matrices by using microbial 
transglutaminase or by varying the ratio of collagen monomers to oligomers supports 
our findings of increased angiogenic outgrowth in stiffer matrices
51,52
. 
 
Previously published work has shown that MMP activity is an important regulator of 
angiogenesis
15,53–55
.  GM6001 is a broad-spectrum MMP inhibitor that is known to 
inhibit degradation of collagen by MMPs and, interestingly, has been shown to reduce 
the formation of angiogenic structures in response to  matrix density of fibrin gels
15
.  
Here, we demonstrate that MMP activity is essential for the increased angiogenic 
response we observed within the stiffer, cross-linked, 1.5 mg ml
-1
 collagen gels 
(Figure 3.4).  Surprisingly, we only observed a small decrease in angiogenic sprouting 
after 3 days of culture in the softer collagen gels with GM6001 treatment (Figure 
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3.4B).  However, we did see a dramatic change in the sprout morphology from 
spheroids embedded within both the soft and stiff collagen gels and treated with 
GM6001 (Figure 3.4A,C,D).  Prior studies have seen differences in the angiogenic 
sprouting response when using extended time periods (3-21 days)
15,54
, different 
GM6001 concentrations (0.1-5 μM)15,54,55, or increased collagen matrix density (2.5-
3.75 mg ml
-1
)
54,55
.  It is possible that culturing the spheroids for an increased time 
period or in higher density collagen gels with the GM6001 treatment would further 
demonstrate a decreased angiogenic response in gels that are less cross-linked.  Taken 
together, these data show that MMPs are integral to the formation angiogenic sprouts 
from spheroids.     
 
3.6 Conclusions 
This chapter describes the effects of modulating matrix stiffness via AGE cross-
linking on vessel architecture and integrity.  Increasing collagen stiffness by 
increasing cross-linking at a given collagen density significantly increased the in vitro 
outgrowth from spheroids and ex ovo angiogenesis in the embryonic chick model 
while MMP inhibition prevented this response.  Additionally, collagen stiffness 
modulated the extent of angiogenic branching, endothelial cell-cell junctional 
integrity, and permeability.  These results indicate that three-dimensional matrix 
stiffness is an important regulator of angiogenesis and vascular integrity.  While this 
study focuses on the biophysical mechanisms of angiogenesis, future work should 
further investigate the role of matrix stiffness on mediating the molecular mechanisms 
of angiogenic outgrowth. 
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CHAPTER 4 
 
HISTOLOGICAL ANALYSIS OF THE TUMOR VASCULATURE IN HUMANS 
AND MICE 
 
Portions of this chapter are in preparation for submission.  Murine and human tumors 
were analyzed as part of collaborative projects with Dr. Valerie M. Weaver and Dr. 
Sandra Shin, respectively.   
 
4.1 Abstract 
The tumor vasculature is known to be more dense, disordered, and permeable than the 
vasculature in normal tissue.  Additionally, cells within the tumor deposit and cross-
link matrix proteins during the process of tumorigenesis, thereby creating a stiffer 
extracellular environment with altered protein expression.  The objectives of the work 
presented in this chapter are two-fold.  First, we sought to understand how the 
extracellular stiffness of murine mammary tumors influences vascular density and the 
association of mural cells with the vasculature.  Secondly, based on previous data from 
our lab indicating that fibronectin expression is modulated by extracellular matrix 
stiffness
1
, we investigated the expression an alternatively-spliced isoform of 
fibronectin in human mammary tissue and tumors.  We show that vascular density and 
the localization of mural cells are altered within murine mammary tumors where 
collagen cross-linking has been disrupted.  We further demonstrate that a specific 
splice variant of fibronectin (EDB-FN) typically associated with angiogenic blood 
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vessels is also found within the vasculature of human breast tumors but not in patient-
matched normal tissue.  Together, these data show that the tumor vasculature is 
inherently different than that of normal tissue and suggests that matrix stiffness may 
play a role in these alterations.   
 
4.2 Introduction 
During the process of the solid tumor formation, multiple changes occur to the 
physical and chemical environment of the extracellular matrix (ECM).  Indeed, tumors 
are known to be stiffer than normal tissue and importantly, these mechanical changes 
have been correlated with altered cellular function and ECM deposition
2–4
.  The ECM 
protein fibronectin (FN) has been suggested to be correlated with cancer severity
5,6
.  
However, it is unclear how tumor formation is related to the deposition and alternative 
splicing of new matrix proteins such as “extra domain B”-fibronectin (EDB-FN) by 
endothelial cells (EC).  Additionally, blood vessels within solid tumors are known to 
be more dense, tortuous, and leaky when compared to those in normal, healthy 
tissues
7,8
.  The presence of mural cells (MCs; pericytes and vascular smooth muscle 
cells) that stabilize and support the vasculature has been shown to be altered in solid 
tumors
9–11
.  However, the role of matrix stiffness on MC-coverage of the tumor 
vasculature has not been studied.  This chapter discusses the histological analysis of 
human and murine mammary tumors to investigate MC localization, vessel density, 
and fibronectin expression in the vasculature.    
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Staining of the vasculature in murine mammary tumors 
The vascular density and MC localization of murine mammary tumors were studied as 
part of a collaborative project with Prof. Valerie M. Weaver at The University of 
California, San Francisco.  Current work in the Weaver lab suggests that tumor 
stiffness influences the permeability of the vasculature in a number of murine models 
(unpublished).  MCs are supporting cells that directly contact ECs and provide both 
physical and chemical cues to stabilize the vasculature.  In the tumor vasculature, 
these cues are known to be dis-regulated and MC-coverage of vessels is altered
9,10,12
.  
In fact, decreases in MC-coverage have been implicated in increased vascular 
permeability and intravasation of tumor cells
10,11,13
.  Here, we show that vascular 
density and MC-coverage were altered in mice that had been treated to inhibit lysyl 
oxidase activity or induce β1 integrin clustering.   
 
Fibronectin staining in human breast tumors 
In order for angiogenesis to occur, the polymerization of the dimeric glycoprotein 
fibronectin by endothelial cells is required
14
.  Notably, increased extracellular matrix 
stiffness, vascularity, and fibronectin expression are all correlated with increased 
breast cancer aggressiveness
3,15,16
.  We have previously shown that matrix stiffening 
regulates the rate of angiogenesis as well as the resultant blood vessel architecture and 
integrity in vitro
17–19
.  Previous work in the Reinhart-King lab has also shown that the 
synthesis and deposition of fibronectin is influenced by the stiffness of the ECM
20
.  In 
recent work, we found that the expression of a specific splice variant of fibronectin 
(termed “extra domain B” fibronectin (EDB-FN)) that is normally only present during 
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embryonic development and with angiogenic blood vessels is regulated by ECM 
stiffness
21
.  Here, we stained for the presence of EDB-FN in invasive ductal 
carcinomas and patient-matched normal mammary tissues.  We found that EDB-FN is 
present in the vasculature of tumor tissue but is absent in normal mammary tissue.  
Since EDB-FN is generally undetectable within normal adult tissues, its presence in 
the in vivo breast tumor vasculature could lead to new clinical therapeutics.   
 
4.3 Materials and Methods 
CD31 and aSMA staining of Mouse Tumors  
Mouse mammary tumor slides were provided by Dr. Valerie Weaver from The 
University of California, San Francisco.  Immunohistochemistry slides were 
deparaffinized in xylene (VWR, Radnor, PA), rehydrated in graded ethanol (VWR), 
and washed in water.  Heat activated antigen retrieval was performed in a pH 6, 0.01 
M sodium citrate buffer (Sigma-Aldrich, St. Louis, MO) and slides were washed with 
0.05% tween (JT Baker, Phillipsburg, NJ) in D-PBS (Invitrogen, Carlsbad, CA).  
Blocking was performed using a mouse-on-mouse kit (Vector Laboratories, 
Burlingame, CA) at the recommended concentrations.   Endothelial cells and smooth 
muscle cells were stained with a rabbit polyclonal CD31 antibody (1:100; Santa Cruz 
Biotechnology, Dallas, TX) and a mouse monoclonal αSMA antibody (1:50; Dako, 
Carpinteria, CA), respectively, and for 1 hour at room temperature.  The secondary 
antibodies were Alexa Fluor 568 donkey anti-rabbit (Invitrogen) and Alexa Fluor 488 
goat anti-mouse (Invitrogen) and were incubated for 30 minutes at room temperature.  
All antibodies were applied using the diluent from the mouse-on-mouse kit.  Nuclei 
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were counterstained with 4’,6-diamidino-2-phenylindole (DAPI) (Sigma-Aldrich).  
Slides were mounted in Vectashield (Vector Laboratories) and imaged using a Zeiss 
LSM 700 with a water-immersion C-Apochromat 40x/1.1 NA objective (Carl Zeiss, 
Oberkochen, Germany). 
 
Analysis of vessel density and αSMA+ vessels in mouse tumors 
CD31 positive vessels with open lumens were scored as being αSMA positive 
(αSMA+) or αSMA negative (αSMA-).  A vessel was identified as αSMA+ if any 
portion of the vessel was visibly in contact with αSMA staining.   Vessel density was 
calculated by dividing the number of vessels scored for the αSMA+ by the sum of the 
area of DAPI staining in each image in ImageJ.  Images were acquired using similar 
parameters. 
 
EDB-FN staining of Human Tumors 
Formalin-fixed, paraffin-embedded, invasive ductal carcinoma and patient-matched 
normal human breast tissue were provided by Dr. Sandra Shin from New York 
Presbyterian Hospital-Weill Cornell Medical College.  For each tumor case, 4-μm-
thick sections were deparaffinized in xylene, rehydrated in graded alcohols, and 
antigen retrieval was performed in a pH 6, 0.1 M citrate buffer.  Envision+System-
HRP (DAB) (Dako) was used for immunostaining according to the manufacturer’s 
protocol.  The sections were incubated overnight at 4ᴼC with a mouse anti-human 
EDB-FN antibody (1:200, BC1; Abcam, MA).  Primary antibody was omitted for 
negative controls.  Slides were counterstained with Harris hematoxylin (VWR) and 
 97 
 
mounted with permount (Thermo Fisher Scientific, Waltham, MA).  Slides were 
imaged on an A1 Axio Scope with an Axio Cam MRc5 color camera (Carl Zeiss).   
 
4.4 Results 
Modulating LOX activity changes MC-coverage and vessel density in murine tumors 
To investigate the role of in vivo tumor stiffness on MC-coverage of the vasculature, 
sections of mammary tumors from FVB/N-Tg(MMTV-PyVT)634Mul/J mice (herein 
described as PyMT mice) that had been treated to inhibit lysyl oxidase (LOX), were 
used.  Lysly oxidase (LOX), a collagen cross-linker, is frequently elevated in tumors 
and has been shown to cause matrix stiffening
22,23
.   Previous studies have shown that 
lysyl oxidase activity is inhibited in mice that have been treated with beta-
aminopropionitrile (BAPN) or an anti-LOX inhibitory antibody (α-LOXab)2,24.   
Figure 4.1. Immunohistochemical staining of murine breast tissue for αSMA 
(green), CD31 (red), and nuclei (blue). (A) PyMT tumor section with outlined 
region (B) showing an αSMA- vessel.  (C) PyMT tumor treated with BAPN with (D) 
showing an αSMA+ vessel. Scale in A,C is 50 μm, Scale in B,D is 25 μm. 
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Tumor sections from PyMT mice treated with BAPN or α-LOXab were stained for 
CD31, αSMA, or nuclei and vessels were identified as being αSMA-negative   
(αSMA-) (Figure 4.1A,B) or αSMA-positive (αSMA+) (Figure 4.1C,D).  Interestingly, 
BAPN-treated PyMT mice had a significantly greater proportion of αSMA+ vessels 
and an increased vessel density compared to PyMT control mice (Figure 4.2).  
Surprisingly, PyMT mice treated with α-LOXab had a decreased proportion of 
αSMA+ vessels (Figure 4.3B).  While the number of vessels was slightly increased in 
vessels treated with the α-LOXab, the trend was not significant (Figure 4.3A,C).  
These data indicate that modulating the activity of LOX in the tumor was capable of 
altering the density of the vasculature and its association with MCs.   
 
 
Figure 4.2. Vessel density and α-SMA expression are increased in BAPN-treated 
PyMT mice.  (A) Immunohistochemical staining of murine breast tissue for α-SMA 
(green), CD31 (red), and nuclei (blue) with arrowheads denoting vessels.  
Quantification of the percentage of (B) α-SMA(+) vessels and (C) vessel density.  
Data presented as mean + SEM, * indicates p<0.05, Scale is 50 μm. 
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Figure 4.3. α-SMA expression is decreased in PyMT mice treated with α-LOX 
antibody.  (A) Immunohistochemical staining of murine breast tissue for α-SMA 
(green), CD31 (red), and nuclei (blue) with arrowheads denoting vessels.  
Quantification of the percentage of (B) α-SMA(+) vessels and (C) vessel density. Data 
presented as mean + SEM, * indicates p<0.05, Scale is 50 μm. 
Figure 4.4. Vessel density is increased in V737N mice compared to FVB mice. (A) 
Immunohistochemical staining of murine breast tissue for α-SMA (green), CD31 
(red), and nuclei (blue) with arrowheads denoting vessels. (B) Quantification of the 
vessel density. Data presented as mean + SEM, * indicates p<0.05, Scale is 50 μm. 
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Increased integrin clustering increases MC-coverage and vessel density in murine 
tumors 
To study the role of β1 integrin clustering on MC localization within the 
microvasculature, FVB/N-Tg(MMTVneu)202Mul/J mice, also known as MMTV-Her-
2/neu mice (herein described as Neu mice), with or without a mutation for V737N β1 
integrin clustering were used.  Previous studies have shown that the V737N mutant 
induces focal adhesion formation and increased tumor size but the effects of the 
mutation on MC localization are unknown
3
.  Normal tissue sections from FVB control 
or V737N mice or tumor sections from Neu or Neu/V737N mice were stained for 
CD31, αSMA, or nuclei and vascular density was quantified.  Additionally, the 
proportion of αSMA+ vessels was quantified for Neu or Neu/V737N tumors.  We 
found that V737N mice had significantly increased vascular density when compared to 
Figure 4.5. Vessel density and α-SMA expression are increased in Neu/V737N 
mice.  (A) Immunohistochemical staining of murine breast tissue for α-SMA (green), 
CD31 (red), and nuclei (blue) with arrowheads denoting vessels.  Quantification of the 
percentage of (B) α-SMA(+) vessels and (C) vessel density. Data presented as mean + 
SEM, * indicates p<0.05, Scale is 50 μm. 
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FVB controls (Figure 4.4).  Interestingly, increasing β1 integrin clustering in Neu mice 
increased the extent of αSMA+ vessels and vascular density within the tumors 
compared to Neu tumors alone (Figure 4.5).    These data show that V737N tumors 
exhibited increased vascular density compared to FVB controls and suggest that 
increasing β1 integrin clustering alters the association of MCs with the vasculature.   
 
EDB-FN is expressed in the human tumor vasculature 
To determine if human breast tumors express EDB-FN, sections of invasive ductal 
carcinomas and patient-matched normal breast tissue were stained for EDB-FN.  Our 
results show strong EDB-FN staining in the vessel wall within the tumor vasculature 
and no EDB-FN staining in normal breast tissue (Figure 4.6).  These observations 
indicate that FN in the tumor vasculature has been alternatively spliced to contain the 
EDB-region and suggest that targeting EDB-FN may be one way to localize 
therapeutics to the tumor vasculature.    
 
Figure 4.6. EDB-FN is expressed in human breast tumor vasculature.  
Immunohistochemical staining of human breast tissue for EDB-FN showing (A) 
negative control of the tumor vasculature, (B) strong EDB-FN staining in the tumor 
vasculature, and (C) no immunoreactivity for EDB-FN in the normal tissue 
vasculature.  Images were acquired at same exposure settings, Scale is 50 μm. 
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4.5 Discussion 
While several studies have shown a decrease in MC coverage of the vasculature in 
tumors, much less is known about how the extracellular matrix mechanical properties 
of the tumor regulate MC localization of matrix deposition of FN splice variants.  
Here, we have used histological staining and analysis to study the localization of MCs 
and vascular density in mouse tumors and the localization of EDB-FN human tissue.  
We show that modulating LOX activity or β1 integrin clustering altered the vascular 
density and localization of MCs.  We also show that EDB-FN is localized to the tumor 
vasculature but was not seen in the vasculature of normal tissues.   
 
LOX-mediated cross-linking is known to play a role in tumor matrix stiffening and has 
been implicated in the promotion of breast cancer metastasis
22,23,25
.  The inhibition of 
LOX through treatment with BAPN or α-LOXab has been previously shown to 
decrease collagen cross-linking, focal adhesion, and tumor incidence
3,26
.  However, 
our results unexpectedly indicated that the localization of MCs with the tumor 
vasculature was increased in PyMT tumors treated with BAPN and decreased in those 
treated with α-LOXab (Figures 4.2,4.3).  We speculate that the differences in MC 
localization in the BAPN and the α-LOXab are due to tumor stage and progression.  In 
fact, the tissue sections we analyzed for mice treated with α-LOXab were later stage 
than those from BAPN-treated mice (15 weeks vs. 10 weeks).  Our collaborators have 
confirmed that while inhibiting stiffness with either BAPN or α-LOXab reduced 
vascular permeability in 9-12 week old animals, there ceases to be differential effects 
of matrix stiffness on vascular permeability in late stage, 15 week, tumors. 
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The V737N mutation replaces a hydrophobic valine with asparagine in the β1 integrin 
to promote clustering through increased hydrogen bonding
27
. Interestingly, increased 
spreading, integrin clustering, and force generation are observed when the V737N 
mutation is expressed in mammary epithelial cells plated on soft substrates in vitro
27
.  
The β1 integrin has been implicated as a key regulator in the regulation of EC tube 
formation, basement membrane matrix deposition, and EC-MC interactions
28
.  Our 
data indicate that increasing β1 integrin clustering with the V737N mutation in Neu 
tumors increases vascular density and the localization of MCs with the vasculature 
(Figure 4.5).  These results suggest that enhancing integrin clustering may be one way 
to enhance MC-EC association.   
 
EDB-FN is often referred to as oncofetal-fibronectin because of its expression in fetal 
development and cancer.  Importantly, we have recently found that expression of 
EDB-FN is regulated by matrix stiffness
21
.  Here, we found that EDB-FN was 
expressed in the vasculature of human invasive ductal carcinomas while it is absent in 
patient-matched normal tissue Figure 4.6).  These results suggest that EDB-FN could 
be utilized as a specific marker to target tumor vasculature.    
 
4.6 Conclusions 
This chapter describes the histological staining of mammary tumors to study protein 
composition, MC localization, and vascular density.  We found that murine mammary 
tumors modulate the extent of MC-coverage and density of the vasculature when LOX 
 104 
 
activity is inhibited or β1 integrin clustering is induced.  Additionally we found that 
EDB-FN is expressed in human mammary tumors but not in patient-matched controls.  
Together, these data indicate that the process of tumorigenesis drastically changes the 
composition and density of the vasculature. 
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CHAPTER 5 
 
DEVELOPMENT OF A MICROFLUIDIC DEVICE TO STUDY CHEMOTACTIC 
AND DUROTACTIC CUES ON CELLULAR MIGRATION 
 
Portions of this chapter are in preparation for submission
1
. 
 
5.1 Abstract 
Cell behavior is influenced by both the local mechanical and chemical 
microenvironment. To study the interplay and balance between chemical and 
mechanical cues, we developed a microfluidic device to expose cells cultured on 
substrates of well-characterized, tunable stiffness to well-defined, stable chemical 
gradients. The device utilizes source, culture, and sink channels to regulate the cellular 
chemical environment while simultaneously permitting control of the mechanical 
environment using polyacrylamide (PA) substrates of known stiffness. This device 
was used to study two distinct phenomena: the formation of podosomes in vascular 
smooth muscle cells (VSMCs), and the combined roles of chemotaxis and durotaxis in 
endothelial cells (ECs).   Herein, we describe the device design and gradient 
generation characterization.  While we found that the microfluidic device was not 
well-suited to experiments involving the chemotaxis of ECs to vascular endothelial 
growth factor, we did demonstrate that gradients of the phorbol ester PDBu stimulated 
podosomes in a directed manner in VSMCs.  Together, these data demonstrate that the 
described microfluidic platform could be amenable to the study of chemotaxis, 
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durotaxis, or molecular activation in a number of cellular systems.   
 
5.2 Introduction 
Cells within the vasculature are continuously exposed to different chemical and 
mechanical stimuli.  The effects of chemical factors such as vascular endothelial 
growth factor (VEGF) on endothelial cell (EC) behavior have been extensively studied 
and it is well established that ECs migrate up a gradient to higher concentrations of 
VEGF.  The stiffness of the extracellular matrix (ECM) has also been shown to play 
an important role on EC and vascular smooth muscle cell (VSMC) function
2–4
.  
However, the combined effects of ECM stiffness and chemotactic factors have not 
been well-studied.  Here, we develop a microfluidic device to test the additive and 
potentially synergistic effects of combining chemical gradients and mechanical cues.  
Because there is no suitable tool currently available to study chemical gradients and 
matrix mechanics simultaneously, we developed a microfluidic device that maintains a 
stable concentration gradient and simultaneously allows cells to be seeded on matrices 
of tunable compliance. We utilized this device to study the migratory response of ECs 
to matrix stiffness and VEGF and also investigated the formation of podosomes in 
VSMCs stimulated with gradients of the phorbol ester PDBu.   
 
EC Migration 
Angiogenesis is important to many biological processes including wound healing and 
cancer progression.  During angiogenesis, ECs migrate from a pre-existing vessel into 
the surrounding tissue to form new vessels.  A better understanding of EC migration 
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can lead to therapeutics to regulate angiogenesis and promote better wound healing or 
inhibit tumor vascularization.   
 
VEGF is an important protein involved in EC migration, proliferation, and 
angiogenesis and it is well known that ECs tend to migrate towards increasing 
concentrations.  In addition, it has become apparent that matrix mechanics play an 
important role in dictating cell behavior
5,6
.  Indeed, there is an important balance 
between the extracellular matrix compliance and chemistry in EC function
3,7
.  
However, the extent to which matrix mechanics influence EC migration during 
chemotaxis has not been explored, as most chemotaxis studies have been done on 
polystyrene or glass.   
 
To study the interplay and balance between chemical and mechanical cues, we have 
developed a microfluidic device to expose cells cultured on substrates of well-
characterized, tunable stiffness to well-defined, stable chemical gradients. The device 
utilizes source, culture, and sink channels to regulate the cellular chemical 
environment while simultaneously permitting control of the mechanical environment 
using polymer substrates of known stiffness. We have used this device to investigate 
the combined roles of chemotaxis and durotaxis on EC migration.   
 
Using this novel device, the migration of EC was measured in response to linear 
gradients of vascular endothelial growth factor (VEGF) on collagen-functionalized 
substrates.  ECs adhere, migrate, and proliferate within the microfluidic culture 
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channel.  Unfortunately, ECs did not undergo chemotaxis within the device for 
reasons we discuss.  Although we found that this device is not amenable to EC 
migration with VEGF, it could be used to study the combined roles of chemotaxis and 
durotaxis in response to other chemotactic molecules.  
 
Podosome Formation 
Podosomes are dynamic actin-rich cellular structures capable of adhering to and 
degrading extracellular matrix (ECM)
8–10
. As such, podosomes are largely found in 
invasive cell types, including macrophages, osteoclasts, and dendritic cells
11,12
.  More 
recently, vascular smooth muscle cells (VSMCs) have also been shown to form 
podosomes when induced by phorbol esters or growth factors
13,14
. Podosomes are 
thought to mediate VSMC migration and may contribute to intimal hyperplasia in 
response to vascular injury or atherosclerosis
8,14,15
. However, very little is known 
about the chemical and physical cues in the microenvironment that induce and mediate 
podosome formation.  Here, we show that chemical gradients of phorbol esters can 
trigger directed podosome formation.   
 
5.3 Materials and Methods 
Cell culture 
A7R5 rat aortic smooth muscle cells were maintained in DMEM (Invitrogen, 
Carlsbad, CA) supplemented with 10% fetal bovine serum (Invitrogen) and 1% of 
penicillin-streptomycin (Invitrogen) at 37°C in a 5% CO2 incubator.  Cells were 
transfected with 1 μg ml-1 actin-eGFP (a gift from David Holowka, Department of 
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Chemistry and Chemical Biology, Cornell University, Ithaca, NY) in 3 μg ml-1 
Lipofectamine 2000 (Invitrogen). Media was replenished after 4 hours of lipofection. 
 
Bovine aortic endothelial cells (Vec Technologies, Rensselaer, NY) were used until 
passage 12.  Cells were fed every other day with M199 (Invitrogen) supplemented 
with 10% Fetal Clone III (HyClone, Logan, UT) and 1% each of MEM amino acids 
(Invitrogen), MEM vitamins (Mediatech, Manassas, VA), and penicillin-streptomycin 
at kept in a 37°C in a 5% CO2 incubator. 
 
Polyacrylamide gel synthesis 
Polyacrylamide (PA) hydrogels were synthesized as described previously by varying 
the ratio of acrylamide (40% w/v solution, Bio-Rad, Hercules, CA) and N,N’-
methylene-bis-acrylamide (2% w/v solution, Bio-Rad) to tune the Young’s moduli of 
the gels
3,16,17
.  The PA gels were made on a 3 x 1 in. glass slide so they could be 
incorporated into the microfluidic device manifold.  PA substrates were functionalized 
with N-6-((acryloyl)amido)hexanoic acid, succinimidyl ester (N-6) that was 
synthesized in our lab and bound to 0.1 mg ml
-1
 type I rat tail collagen (Becton 
Dickinson, Franklin Lakes, NJ)
4,18
.   
 
Microfluidic device  
Fabrication and assembly 
Microfluidic channels were cast by pouring an agarose solution over a silicon master 
mold as described previously
19
. Briefly, an etched silicon wafer patterned with 
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positive reliefs was used to create a mold of the channel features. A 
polydimethlysiloxane (PDMS) (Dow Corning, Midland, MI) rectangular spacer was 
placed around the section of the silicon mold that was to be casted so the height of the 
resulting agarose mold could be precisely controlled. A heated, 3% (w/v) solution of 
agarose (Fisher Scientific, Pittsburg, PA) in PBS was poured into the center of the 
spacer. The agarose was allowed to gel over the positive reliefs of the channels while 
being compressed by a glass slide. Once the agarose gelled, the glass slide was 
removed and a punch was used to create holes over the port areas of the channels. 
 
To construct the microfluidic device, the agarose mold containing the channels was 
inserted between a plexiglass manifold and a glass slide or polyacrylamide gel.  A 
multichannel precision peristaltic pump (Mettler Toledo, Columbus, OH) was used to 
generate a stable flow of the chemotactic agent through the source chamber. The 
chemotactic agent was cleared from the device via media flowing in the sink channel 
at an identical rate, thereby creating a linear gradient of the chemical through the 
agarose gel and over the cells in the culture channel. 
 
Validation of linear gradient 
To validate the generation of a linear gradient, 0.1 mM of 10kDA FITC-dextran 
(Sigma-Aldrich) was flowed through the source channel, and the resultant fluorescent 
gradient was imaged. The pixel intensities of the images were measured in ImageJ and 
graphed as a function of distance away from the source channel (Figure 5.3). 
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Stimulation of EC migration with VEGF 
To investigate the effect of substrate stiffness on EC response to a VEGF gradient, we 
utilized the microfluidic device to generate stable gradients of VEGF.  A 5 kPa PA 
hydrogel was seeded with ECs, cells were allowed to spread overnight, and a 
microfluidic device was assembled with the cell-seeded PA slide.  A multichannel 
precision peristaltic pump was used to generate a stable flow of 32ng ml
-1
 of VEGF in 
complete media through the source chamber of the microfluidic device.  The VEGF 
was cleared from the device via complete media flowing in the sink channel at an 
identical rate, thereby creating a linear gradient of VEGF through the agarose gel. As a 
control, measurements were made using an identical chamber with complete media 
flowing through both the source and sink channels of the device. Cell migration was 
monitored with time-lapse microscopy beginning 1 hour after the beginning of VEGF 
or complete media flow for a period of 6 hours.  Cell trajectories were tracked using 
ImageJ.   
 
Stimulation of podosomes in A7R5 cells with PDBU 
A glass slide was seeded with transfected VSMCs expressing actin-eGFP.  Cells were 
allowed to spread overnight and a microfluidic device was assembled with the cell-
seeded slide.  All channels of the microfluidic device were primed with complete 
media. The peristaltic pump was used to generate a stable flow of 2 μM phorbol 12,13 
dibutyrate (PDBu) (Sigma-Aldrich) through the source chamber and cleared from the 
device via media flowing in the sink channel at an identical rate.   
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Timelapse microscopy was used to monitor the formation of podosomes in real-time.  
To quantify the location of podosomes within individual cells, cells were segmented 
into two halves, and the number of podosomes was counted within each half. Cells 
with a majority of podosomes located closer to the PDBu source were labeled 
“proximal,” those with podosomes located closer to the sink were labeled “distal,” and 
those with equal number of podosomes throughout were labeled “equal.” 
 
5.4 Results and Discussion 
Microfluidic device fabrication and characterization 
To create a device that was capable of modulating both the mechanical and chemical 
Figure 5.1.  Schematic of microfluidic device assembly.  Microfluidic channels 
were cast in agarose and assembled over polyacrylamide hydrogels within a manifold. 
Figure 5.2.  Microfluidic channels seal tightly with PA 
gels.  (A)  Phase contrast image of microfluidic channel 
and (B) fluorescence image of the same channel showing 
that 0.5 μm beads are completely contained within the 
channel.  Scale is 50 μm. 
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environment of cells in culture, we modified an agarose-based, three-channel 
microfluidic device that has been previously used to study bacterial and mammalian 
cell chemotaxis
20,21
.   A PA hydrogel substrate functionalized with N-6 and bound to 
0.1 mg ml
-1
 collagen was incorporated into the device to control the stiffness of the 
substrate cells were seeded upon (Figure 5.1).   
 
To determine whether the microfluidic device was operating as intended and created a 
stable, linear chemical gradient, a series of characterization tests were performed.  To 
ensure that the agarose-molded channels sealed tightly to the PA substrate, a 
microfluidic device was assembled and 0.5 μm fluorescent beads were injected into 
the channels.  Phase images were taken to localize the channels and fluorescence 
images were acquired to determine if there was any flow between the PA hydrogel and 
agarose (Figure 5.2).  We found that the agarose sealed well to the PA substrate and 
beads were completely contained within the channels.  Concentration gradients were 
quantified within the culture channel by using a 10kDa FITC-dextran fluorescent 
biomarker with a similar mobility as VEGF
22
. Phase images of the channels were 
acquired and matched to fluorescence images of the resultant gradient (Figure 
5.3A,B).  The intensity profiles of the fluorescence images were measured using 
ImageJ.  We found that the device creates a nearly linear gradient from the source to 
the sink channel.  The gradient was established within 30 minutes and was stable over 
the 16 hour experiment (Figure 5.3C).  To ensure that the microfluidic device was 
suitable for long-term cell culture, microfluidic devices were assembled with PA gels 
seeded with ECs.  ECs remained viable and proliferated within the channels 
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throughout the course of the 3-day experiment (data not shown).  These data 
demonstrate that we were able to incorporate PA gels to control the stiffness of the 
substrate and that the resultant microfluidic device was amenable to cell culture and 
capable of generating and maintaining a linear chemical gradient.   
 
Figure 5.3.  Example of gradient generation in the microfluidic device.  
Chemotactic agents in complete medium were flowed through the source channel and 
complete medium was flowed through the sink at an identical rate, creating a linear 
gradient of the chemotactic agent through the agarose. (A) Phase images showing the 
channels within the microfluidic device and (B) fluorescence images showing an 
established gradient.  (C) Monitoring the fluorescence intensity through the source, 
culture, and sink channels over time indicated that gradients are established within 30 
minutes and remained stable over the 16 hour study.  Scale is 50 μm. 
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EC chemotactic response to VEGF is limited in the microfluidic device 
To investigate the combined chemotactic and durotactic response of ECs, ECs were 
seeded on a 5 kPa PA substrate, allowed to attach overnight, and assembled into a 
microfluidic device.  A VEGF gradient was created by flowing 32 ng ml
-1
 VEGF into 
the source channel while complete medium was flowed into the sink channel.  Cell 
migration in response to VEGF or control (no chemical) gradients were imaged using 
timelapse microscopy (Figure 5.4).  Cells were traced using ImageJ and the 
trajectories were plotted (Figure 5.5).  Surprisingly, the presence of VEGF did not 
elicit a chemotactic response from ECs.  Similar results were obtained when 
chemotactic experiments were extensively repeated with glass and 0.5 kPa – 30 kPa 
substrates, with different concentrations of VEGF, or when human umbilical vein 
endothelial cells were used.   
Figure 5.4.  Timelapse images of ECs within the microfluidic device.  Images 
show endothelial cells migrating within the channel over time.  Scale is 50 μm. 
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VEGF has been repeatedly and consistently shown to have a chemotactic effect on 
ECs and adaptations of this device have been successfully used for a number of 
studies to generate chemical gradients across cells
20,21,23–26
.  In combination with the 
lack of chemotaxis we have reported, these observations suggest that the formation 
and establishment of the VEGF chemotactic gradient was somehow prevented within 
our device.  We hypothesize that VEGF was being sequestered within the agarose, 
thus precluding gradient formation.  While we were able to demonstrate the 
establishment of a gradient using a 10 kDa FITC-dextran molecule with similar 
mobility to VEGF (Figure 5.3), experiments using a fluorescently-tagged VEGF were 
cost-prohibitive.  However, investigating and validating gradient generation with 
fluorescently-tagged VEGF could help explain why these experiments were 
unsuccessful.   
Figure 5.5.  Cell trajectories of ECs within a microfluidic device demonstrate no 
preferential migration of ECs to VEGF.  ECs were tracked for 6 hours in 
microfluidic devices with either (A) complete medium in both the source and sink 
channel (as a control) or (B) 32 ng/ml VEGF flowing through the source channel 
(location of VEGF channel marked).   
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Importantly, even though we found that this device was not well-suited to the 
investigation of EC chemotaxis to VEGF, it could be used for other studies.  For 
example, other studies have demonstrated the compatibility of agarose-based devices 
with epidermal growth factor (EGF) but these studies have not investigated the effects 
of mechanical stiffness on cellular function
26
.  EGF is known to be a key factor in 
tumor growth and cancer cell invasion.  During tumor metastasis, cancer cells migrate 
from the primary tumor and through a mechanically heterogeneous stromal 
environment to secondary metastatic sites.  Since cancer cells are exposed to gradients 
of EGF and diverse mechanical environments during metastasis, it would be 
interesting to investigate the combined role of matrix mechanics and chemical 
gradients using the described microfluidic device.     
Figure 5.6.  VSMCs form podosomes locally at the leading edge in response to a 
chemical gradient. (A) Representative images of VSMCs exhibiting podosomes after 
stimulation with a PDBu gradient. (B) Cartoon schematic of methods to quantify 
podosome location within the cell. Cells with a majority of podosomes located closer 
to the PDBu source were labeled “proximal,” those with podosomes located closer to 
the sink were labeled “distal,” and those with equal number of podosomes throughout 
were labeled “equal.” (C) Quantification of the percentage of cells exhibiting 
podosomes proximal, central or distal to the PDBu source before and after PDBu 
gradient generation. 
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Podosomes are directionally formed towards increasing PDBu concentrations 
To investigate the formation and localization of podosomes in VSMCs in respect to 
chemical cues, we used the microfluidic device to create linear chemical gradients of 
PDBu.  Using this device, we stimulated actin-eGFP transfected VSMCs with a 
gradient of PDBu which resulted in robust podosome formation (Figure 5.6A). To 
characterize the location of podosome formation relative to the gradient, we quantified 
the percentage of cells that exhibited podosomes in response to the chemical gradient 
as a function of their position relative to the nucleus and the source channel of the 
gradient (Figure 5.6B). When stimulated uniformly by flowing PDBu through both the 
source and sink channels, the majority of cells formed podosomes with no preferential 
distribution (Figure 5.6C, dark bars).  Interestingly, when stimulated with a linear 
gradient of PDBu, approximately 70% of cells formed podosomes proximal to the 
source channel. These data indicate that VSMC can respond to gradients by locally 
forming podosomes in the direction of the gradient.   
 
Podosomes are thought to be important for cellular adhesion, matrix degradation, and 
migration
9,12,27
.  While chemical cues are known to trigger the formation of 
podosomes, the formation of podosomes in response to chemical gradients has not 
been well studied.  Our results show that VSMCs exposed to gradients of PDBu form 
podosomes that are localized proximally to increased concentrations (Figure 5.6).  
Interestingly, VSMC podosome formation has been suggested to contribute to the 
migration of VSMCs during atherosclerosis.  These results suggest that chemical 
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gradients may have the ability to assist in mediating this response.   
 
5.5 Conclusions 
Cells within our body exist within a complex and dynamic environment filled with 
chemical and mechanical stimuli.  This chapter describes the development and 
characterization of a microfluidic device to simultaneously investigate the effects of 
well-defined mechanical and chemical cues on cells.  Chemical gradients within the 
device are established within 30 minutes of initiating flow of the chemotactic 
molecule and are maintained long-term allowing for observation of cell responses such 
as migration or cell activation.  Interestingly, we found that PDBu gradients generated 
the directional formation of podosomes in VSMCs.  Together, these results 
demonstrate that the described microfluidic device can be used to study cellular 
response to chemical and mechanical stimuli in different cell models.   
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CHAPTER 6 
 
EXPLORING TISSUE PERFUSION AND NUTRIENT DELIVERY IN THE 
CLASSROOM 
 
6.1 Abstract 
In June 2012, I was selected to be a fellow in Cornell’s National Science Foundation 
Graduate STEM Fellows in K-12 Education (NSF GK-12) program.  As part of this 
year-long fellowship, I had the privilege of working with Ms. Laura Austen, a high 
school biology teacher at Elmira Southside High School.  During this time, I became 
the “scientist in residence” in Ms. Austen’s classes and developed a number of 
lectures and inquiry-based laboratories to engage the students in experiential learning.  
This chapter will discuss my experiences with the program and detail the laboratories I 
developed to introduce the students blood vessel transport and tissue perfusion.     
 
6.2 Introduction 
Connections between the science curriculum that is taught in schools and real-world 
problems are not obvious to middle and high school students although such 
connections have been shown to be critical for student performance in STEM fields. 
The NSF funded Cornell Learning Initiative in Medicine and Bioengineering 
(CLIMB) GK-12 program pairs biomedical engineering (BME) graduate students 
(fellows) with local high school science teachers to provide opportunities for students 
to experience science and integrate knowledge across disciplines. The goals of the 
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NSF GK-12 program are to enhance the content of the science curriculum in a local 
classroom by interacting extensively with the teacher to introduce them to a research 
environment, developing new inquiry-based activities, and becoming a resident 
scientist in the classroom.  GK-12 fellows, work with teachers both in the research lab 
on an original research project as well as in the classroom where new science 
experiments and activities are implemented based on the fellow’s BME research.  This 
program has allowed collaborations with high school teachers to develop and utilize 
simple, yet highly effective approaches to engage high school students in inquiry-
based approaches to science to promote learning and retention. The GK12 fellow 
becomes a resident scientist, utilizing biomedical engineering as an integrative glue to 
connect the separate science disciplines (biology, chemistry, and physics) to relevant 
health issues. 
 
I was paired with Laura Austen, a teacher from Elmira Southside High School who 
teaches the New York State Regents Living Environment course and an Advanced 
College Education General Biology course.  During the summer of 2012, Laura 
familiarized herself with a number of techniques in the Reinhart-King lab including 
cell culture, hydrogel synthesis, microscopy, and immunofluorescence to complete a 
novel research project.  During the academic year, I became a scientist in residence in 
Laura’s classroom.  Together, we developed a curriculum designed around the theme 
of blood vessel mechanics from my graduate research and incorporating the concept of 
diffusion to reinforce information learned in one of the New York State mandated 
laboratories for the Living Environments class.  In addition, we created a number of 
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other modules and revised experimental protocols to promote inquiry-based learning, 
organized a “lunch with scientists” for junior and senior students, and held a field trip 
where the students toured the science facilities in the Biomedical Engineering 
Department, Veterinary School, and Nanofab Facilities at Cornell University.  
Working with Laura at Elmira Southside was an eye-opening experience that allowed 
me to learn how to translate and communicate complex scientific information into 
material that is relevant to high school students.   
 
6.3 Results from Laura’s summer research 
Laura worked with me in the Reinhart-King lab during the summer of 2012 to 
experience how research is conducted in an academic setting.  Her project was to 
determine the role of collagen glycation on endothelial cell proliferation.  I taught 
Laura how to make polyacrylamide hydrogel substrates that were coated with collagen 
that had been glycated with 0 – 100 mM ribose.  She also learned how to culture 
Figure 6.1. Proliferation on polyacrylamide hydrogels.  (A) ECs on PA gels imaged 
imaged showing a phase image, DAPI staining, or merged image.  (B) DAPI images 
of ECs on PA substrates coated with glycated or non-glycated collagen.  Scale is 200 
μm. 
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endothelial cells, seed them on the polyacrylamide hydrogels, and then fix, stain, and 
image the cells after 0, 2, 4, or 7 days in culture (Figure 6.1).  I wrote a custom 
algorithm in ImageJ to count the number of cells per field of view and Laura used this 
to process the image and analyzed the amount of endothelial cell proliferation on 
glycated or non-glycated substrates (Figure 6.2A).  Laura determined that the 
endothelial cell proliferation was not a function of collagen glycation (Figure 6.2B).  
Laura created a poster that highlighted the work she completed over the summer and 
displayed it in her classroom as an example of how scientists communicate data to one 
another.  Our experiences together in the research lab were instrumental in forming the 
basis for our curriculum materials. 
 
Figure 6.2.  Proliferation on PA gels coated with glycated or non-glycated 
collagen.  (A)  Cells were stained with DAPI and counted using a custom ImageJ 
algorithm.  (B) The average cell number per image was plotted against time.  The 
number of cells increases on both glycated and non-glycated gels with time.  Data 
were normalized to the Day 0 cell number.  Scale is 200 μm. 
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6.4 Curriculum Development 
The curriculum Laura and I developed includes two separate modules to investigate 
how the density of our tissues can influence nutrient transport and to relate how the 
foods and drinks we consume relate to our blood sugar levels.  The transport module 
here utilizes gelatin-coated petri dishes that can be used to model the diffusion of 
molecules from the vasculature into the surrounding tissue.  The blood sugar module 
utilizes dialysis tubing, glucose meters, and a variety of drinks (such as water, milk, 
soda, juice, or sport drinks) to help students understand how the foods we eat 
influence the blood sugar levels in our bodies.  This inexpensive, inquiry-based 
experiment can be easily integrated into a high school biology classroom to reinforce 
the fundamentals of diffusion by connecting it to the core concepts of the circulatory 
and transport system within our bodies.  Students who complete this module 
significantly increase their knowledge about the circulatory system and the factors that 
regulate tissue perfusion and become more proficient at using the scientific method to 
design experiments and collect data.   
 
6.5 Materials and Methods 
The transport of molecules and perfusion of tissues via the circulatory system 
Introduction 
This experimental module utilizes gelatin-coated petri dishes to simulate “tissues” of 
different densities.  “Blood vessels” are created within the ‘tissues’ by using a biopsy 
punch to remove circular areas of the gelatin.  Tissue perfusion is simulated by adding 
a small amount of red food coloring to the ‘blood vessels’ and measuring the extent of
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diffusion over the course of 2 days.   
 
Materials and Methods 
The following materials are needed for each group: One each of a 35 mm petri dish 
coated with 2%, 5% and 15% gelatin solution (5 ml/dish), 6 mm biopsy punch or 
straw, red food coloring, liquid droppers or pipettes, paper towels.   
 
Classroom Procedure 
The entire exercise was performed in three New York State High School Regents 
Living Environments classes.  Students were provided with background information 
about the circulatory system and basic tissue composition after which they were asked 
to complete a pre-test to gauge their knowledge of the topic before the experimental 
module was begun.  At the beginning of the experiment, the students were allowed to 
choose the density of their tissue samples and asked to hypothesize about the optimal 
vascular distribution (number and arrangement of punches) and tissue density that 
Figure 6.3.  The transport of 
molecules and perfusion of tissues via 
the circulatory system.  Gelatin density 
modulates the diffusion of food coloring 
from the “blood vessels.” 
 132 
 
would be needed to achieve diffusion throughout the entire tissue construct.  Figure 
6.3 shows an example of diffusion within gelatin of different densities.  Throughout 
the experiment, students collected both qualitative and quantitative data and were 
asked to use all the steps of the scientific method. At the completion of the 
experiment, students were given a post-test to assess the effectiveness of the module.   
 
The relationship of the food we eat to blood sugar levels 
Introduction 
In this laboratory, students investigated how different drinks can influence blood sugar 
levels.  Students will simulated the absorbance of nutrients into the blood stream from 
different liquids using dialysis tubing filled with fluid to model the blood vessel.   
They tested the amount of glucose that has entered the blood vessel using a glucose 
meter and compare between the conditions they chose. 
 
Materials and Methods 
The following materials are needed for each group: Dialysis tubing, drinks (water, 
milk, soda, juice, and sports drink), beakers, glucose meter, glucose meter test strips, 
red food coloring, pipettes or droppers, toothpicks. 
 
Classroom Procedure 
The entire exercise was performed in three New York State High School Regents 
Living Environments classes.  Students were provided with background information 
about the circulatory and digestive systems and were asked to complete a pre-test to 
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gauge their knowledge of the topic before the experimental module was begun.  At the 
beginning of the experiment, the students were allowed to choose which drink 
conditions they wanted to test and asked to hypothesize about how the drinks would 
influence the sugar levels of the vessels made out of dialysis tubing.  Throughout the 
experiment, students collected both qualitative and quantitative data and were asked to 
use all the steps of the scientific method. At the completion of the experiment, 
students were given a post-test to assess the effectiveness of the module.   
 
6.6 Results from the lab exercises 
Overall, this experimental module was very effective at helping the students develop 
mental connections about diffusion, the circulatory system, and the digestive system.  
An anonymous survey indicated that the students were excited about the experiment 
and particularly enjoyed creating their own experimental protocol to do hypothesis 
testing.  Data from the post-test indicates that the students incorporated their 
experiences from the laboratory into their knowledge base (Figure 6.4).  
 
Figure 6.4.  Pre-test and post-test results from the 
curriculum module.  Students performed 
significantly better on the post-tests. 
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6.7 Conclusions 
Creating collaborations between researchers and high school classrooms can prove to 
be beneficial for everyone involved.  Being the resident scientist in a high school 
classroom allows graduate students to work with educators to create useful and 
meaningful science curriculum materials related to BME research and has directly 
impacted the students, some of whom have now decided to pursue a career in a 
science-related field.  It also allows high school students to interact with and “real-life 
scientists” and helps them to understand that we are not so different from them.  Prior 
to my first day in the classroom and again at the end of the school year, Laura had her 
students draw a scientist.  Importantly, at the end of the school year, students drew 
scientists that were qualitatively more like themselves.  In fact, significantly more of 
the scientists that were drawn were female and there were also slight increases in the 
Figure 6.5.  Quantification of the scientist drawings.  (A)  Students drew 
significantly more female scientists at the end of the school year.  The same number of 
scientists were wearing (B) safety goggles or (C) a smile in drawings completed at the 
beginning and end of the school year. 
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number of scientists wearing goggles or with smiles (Figure 6.5).  Being a GK-12 
fellow was highly rewarding experience that taught me how to communicate complex 
concepts in an interesting and engaging way to non-scientists.  These skills will 
continue to be important during the rest of my career. 
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CHAPTER 7 
 
CONCLUSIONS AND FUTURE DIRECTIONS 
 
7.1 Conclusions 
As our knowledge of the mechanical and chemical regulation of angiogenesis 
continues to expand, so will our ability to develop therapeutics to influence the 
process of angiogenesis.  This thesis contributes to the knowledge of angiogenesis by 
identifying three-dimensional matrix stiffness as a regulator of the formation and 
function of the angiogenic vasculature.  It also describes a tractable method to 
modulate the stiffness of the matrix without changing collagen density.  We utilized 
non-enzymatic collagen glycation to cross-link and stiffen three-dimensional collagen 
gels with only minimal changes to the collagen fiber arrangements.  Using these 
matrices, we demonstrate that angiogenic outgrowth, branching, and cell-cell 
junctional integrity are altered by increases in matrix stiffness.   Together, these data 
suggest that therapeutically targeting stiffness or endothelial cell response to stiffening 
may help maintain and restore vessel structure and function in cases where it is 
disrupted, such as in the tumor vasculature.   
 
In Chapter 2, we characterized the physical properties of collagen matrices that had 
been stiffened by non-enzymatic glycation cross-linking.  We were motivated by work 
done by Roy et al. that demonstrated the mechanical properties of collagen gels can be 
modulated by pre-glycating collagen solutions prior to collagen polymerization; 
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allowing for cells to be completely embedded within the cross-linked gel upon 
polymerization
1,2
.  By using confocal reflectance microscopy and TRITC-labeled 
collagen, we showed that while increasing the concentration of ribose from 0-250 mM 
increases collagen gel stiffness, the collagen fiber architecture is modified in gels 
glycated with 150 mM ribose or greater.  We demonstrated that glycating collagen 
gels with 0-100 mM ribose only minimally altered collagen fiber distributions while 
increasing the equilibrium compressive moduli three-fold.   
 
A number of methods have been utilized to modulate the mechanical stiffness of three-
dimensional matrices.  Among the methods used to create naturally derived hydrogels, 
altering the density of extracellular matrix components such as collagen, fibrin, or 
hyaluronic acid is the most basic and commonly utilized
3–5
.   However, in addition to 
changing the stiffness of the matrix, altering the density can also modulate the 
porosity, fiber structure and binding site frequency
3,4,6
.   Importantly, when we cross-
linked collagen gels by glycating with 0-100 mM ribose, there were significant 
increases in gel stiffness but there was not a significant difference in the collagen fiber 
structure within gels.  
 
Previous work in our lab has shown that the stiffness of two-dimensional matrices 
regulates the formation of vascular networks
7
.  Additionally, tissue stiffness is known 
to be altered in a number of disease states that are also known to have aberrant 
vasculature such as diabetes and cancer.  Thus, we hypothesized that three-
dimensional matrix stiffness would modulate the angiogenic response of endothelial 
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cells.  We found that increased gel stiffness significantly altered the morphology of 
spreading or angiogenic outgrowth in single cells or spheroids, respectively.  The 
work presented in Chapter 2 was the first to show that increasing three-dimensional 
stiffness independently of matrix density increases angiogenic outgrowth.  Recently, 
others have confirmed our findings by utilizing collagen matrices that are cross-linked 
with microbial transglutaminase or by varying the ratio of collagen monomers to 
oligomers
8,9
.   
 
We further investigated the role of extracellular matrix stiffness on angiogenic 
function in Chapter 3 where we modulated matrix stiffness by glycating collagen gels 
of different densities.  As expected, increasing the density or the extent of glycation 
cross-links increased the equilibrium compressive moduli of the collagen gels.  
Methods to study the role of stiffness on angiogenesis in naturally-derived hydrogels 
have primarily focused on altering matrix density and have typically found that 
increased density decreases angiogenesis
3,4,10,11
.  We also observed that increasing 
collagen density decreases angiogenic outgrowth from endothelial cell spheroids.  
Importantly, we found that increasing matrix cross-linking increased angiogenic 
outgrowth both in vitro and in the ex ovo embryonic chick model.  Additionally, we 
demonstrated that the increased outgrowth in the stiffer collagen matrices was 
prevented by inhibition of matrix metalloproteinase activity with GM6001.  Together, 
these results demonstrate that matrix stiffness, and specifically matrix cross-linking, 
plays an important role in regulating angiogenesis in three-dimensional matrices.   
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Inspired by work in our lab that showed that endothelial cell-cell connectivity is 
altered by matrix stiffness on two-dimensional substrates
7,12
, we chose to investigate 
the role of stiffness on cell-cell junctional properties in angiogenic outgrowths.  
Interestingly, we demonstrate that endothelial cell-cell junctional widths are 
modulated by the stiffness of the matrix.  Angiogenic “stalk” cell junction widths 
increase with increasing three-dimensional matrix stiffness.  Additionally, we found 
that “tip” junctions are significantly wider than “stalk” junctions in all conditions 
studied.  Recently published work has also shown that VE-cadherin junctions are 
qualitatively different in tip and stalk cells
13
.  However, our data is the first to 
demonstrate that three-dimensional matrix stiffness modulates VE-cadherin junction 
widths.  We further show that the localization of VE-cadherin and the permeability of 
endothelial monolayers are significantly altered by matrix stiffness.  These results 
show that the stiffness of the matrix modulates endothelial cell-cell junctions and 
alters vascular integrity.  
 
In Chapter 4, we investigated how tumor stiffness regulates the vasculature by 
performing histological staining of murine and human mammary tumors.  It is well 
known that the tumor vasculature is more dense, disordered, and permeable than the 
vasculature in normal tissue.  Additionally, cells within the tumor deposit and cross-
link matrix proteins during the process of tumorigenesis, thereby creating a stiffer 
extracellular environment with altered protein expression.  We collaborated with Prof. 
Valerie Weaver’s lab to study how tumor stiffness and integrin clustering influences 
vascular density and the presence of vessel-associated mural cells in murine mammary 
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tumors.  When tumor stiffness was modulated by inhibiting collagen cross-linking, we 
found that the vascular density and mural cell localization were altered.  Additionally, 
in both normal and mammary tumors tissues where the clustering of β1 integrins had 
been increased with the V737N mutation, we observed increased vessel density.  
Interestingly, we found that a specific splice variant of fibronectin (EDB-FN) that is 
known to be associated with angiogenesis was expressed within the human tumor 
vasculature but not in patient-matched normal mammary tissue.  Together, these data 
show that the tumor vasculature is inherently different in composition and density than 
that of normal tissue and suggests that matrix stiffness may play a role in these 
alterations.   
 
Finally, in Chapter 5, we hypothesized that the stiffness of the matrix would modulate 
endothelial cell response to chemical cues such as VEGF.  To test this hypothesis, we 
developed a novel microfluidic device to expose cells cultured on substrates of well-
characterized, tunable stiffness to well-defined, stable chemical gradients.  While the 
microfluidic device was not well-suited to experiments involving the chemotaxis of 
endothelial cells to VEGF, we did demonstrate that gradients of the phorbol ester 
PDBu stimulated podosomes in a directed manner in vascular smooth muscle cells.   
 
The findings presented in this dissertation aid in our understanding of how the 
extracellular matrix mechanical environment regulates the formation and stabilization 
of angiogenic vessels.  Importantly, we show that matrix stiffness influences the 
formation of angiogenic vasculature in vitro, ex ovo, and in histological sections from 
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murine and human models.  We were the first to show that increasing three-
dimensional stiffness independently of matrix density increases angiogenic outgrowth 
and modulates VE-cadherin junction widths.  We also demonstrate that endothelial 
monolayer barrier function, mural cell localization, and vascular density are 
modulated by the stiffness of the matrix.  Together, these results demonstrate that 
matrix stiffness, and specifically matrix cross-linking, plays an important role in 
regulating angiogenesis, endothelial cell-cell junctions, and vascular integrity in three-
dimensional matrices.   
 
Perhaps most importantly, this dissertation extends work done by Roy et al. to 
describe a tractable platform for tuning collagen gel stiffness independently of 
collagen fiber structure and matrix density
1,2
.  By utilizing non-enzymatic glycation 
while collagen is in solution, cells can be embedded at the time of polymerization 
which allows for complete cell encapsulation and excellent cell viability.  These gels 
could be used to study the effects of mechanical stiffness on a multitude of cellular 
behaviors including migration, cellular signaling, and tissue formation.  Additionally, 
since collagen is the most abundant protein within the body and non-enzymatic 
glycation is a naturally occurring process in vivo, this method of matrix stiffening is 
physiologically relevant.  
 
A number of studies have investigated the effects of stiffness on endothelial cell 
behavior and function (Table 7.1).  Previous work from the Reinhart-King lab has 
demonstrated that two-dimensional matrix stiffness influences endothelial cell 
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network formation, force generation, and monolayer permeability
7,12,14
.  Increasing the 
density of the matrix has traditionally been the most commonly used method to 
investigate the effects of three-dimensional matrix stiffness on cellular behavior and, 
generally, increased collagen or fibrin matrix density results in decreased vessel 
formation
3,4,9,10,15
.  Here, we have also reported that increased collagen density 
resulted in decreased angiogenesis from multicellular endothelial cell spheroids 
(Figure 3.2).  Interestingly, recent studies have confirmed our findings showing that 
increasing matrix stiffness via cross-linking and independently of matrix density 
increases angiogenesis
8,9
. 
 
These findings are important and relevant to aging, diabetes, and cancer because these 
conditions are correlated with increased matrix stiffness and angiogenesis and vascular 
integrity are known to be disrupted
16–18
.  Increased matrix stiffness in tumors is 
correlated with increased vessel density, tortuosity, and permeability.  Traditionally, 
the changes to the tumor vasculature have been thought to be associated with altered 
vascular endothelial growth factor signaling within the tumor microenvironment.  
Interestingly, increases in tissue stiffness in diabetic and elderly patients are also 
correlated with increased vessel permeability as well as delayed and disrupted 
angiogenesis resulting in a decreased wound healing ability.  Importantly, our data 
suggest that the decreased vascular integrity observed in these conditions is caused by 
increased tissue stiffness.  Further, if our findings are integrated with data previously 
collected in our lab, the results suggest that decreasing cellular contractility on
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Table 7.1. Increased matrix stiffness influences endothelial cell behavior.
  Method 
Stiffness, 
Density, or 
Concentration Cell Type Response 
     
Findings from our lab and others: 
2D Polyacrylamide 
Hydrogels 
0.2-10 kPa 
Bovine aortic 
endothelial cells Decreased network formation
7
 
  1-10 kPa 
Bovine aortic 
endothelial cells 
Increased traction force 
generation
14
 
  
 
2.5-10 kPa 
Bovine aortic 
endothelial cells 
Increased endothelial monolayer 
permeability
12
 
  
   
  
  
Polyacrylamide 
Hydrogels 1.2-11 kPa 
Human umbilical vein 
endothelial cells 
Increased cell-cell and cell-
substrate forces
19
 
  
   
  
3D Collagen Density 3-20 mg/ml 
Human umbilical vein 
endothelial cells 
Decreased lumen density, lumen 
area, and cell invasion
3
 
  0.5-3.5 mg/ml 
Human umbilical cord 
blood endothelial 
colony forming cells 
Decreased vessel formation and 
increased vessel cross-sectional 
area
15
 
  
 
0.3-2.7 mg/ml 
Human dermal 
microvascular 
endothelial cells 
Intermediate density promoted 
the most angiogenesis
20
 
  
 
2-4 mg/ml 
Rat microvessel 
fragments Decreased vessel formation
10
 
  
 
0.5-3 mg/ml 
Endothelial colony 
forming cells Decreased vessel formation
9
 
  
   
  
3D Collagen Cross-linking    
  
Glucose-6-
phosphate 0-375 mM 
Human umbilical vein 
endothelial cells Decreased vessel formation
21
 
  Transglutaminase 0-500 μg/ml 
Human umbilical vein 
endothelial cells Increased angiogenic sprouting 
  
Oligomer: 
Monomer 
 
Endothelial colony 
forming cells 
Increased total vessel length and 
vessel volume
8
 
  
   
  
3D Fibrin Density 2.5-10 mg/ml 
Human umbilical vein 
endothelial cells Decreased vessel formation
22
 
  
   
  
3D Collagen: Fibrin 2.5 mg/ml 
Human umbilical vein 
endothelial cells Decreased vessel formation
23
 
    
Findings reported in this dissertation: 
3D 
Collagen Cross-
linking (Ribose) 0-100 mM 
Bovine aortic 
endothelial cells Increased vessel formation
24
 
3D Collagen Density 1.5-10 mg/ml 
Bovine aortic 
endothelial cells Decreased vessel formation 
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matrices of increased stiffness could provide a mechanism to stabilize the 
vasculature
12
.    
 
The knowledge gained through these experiments could also be used to assist in the 
development of vascularized tissue-engineered organs.  One of the greatest challenges 
in the field of tissue engineering is to create matrices that are capable of being 
vascularized so that nutrients can be delivered and waste products can be removed 
from the encapsulated cells.  Without the formation of a functional vascular network, 
tissue-engineered therapies are limited to a thickness of less than 200 μm25.  
Importantly, the impact of creating vascularized tissue-engineered organs is enormous.  
According to Donate Life America, an average of 18 people die each day due to the 
lack of organs available for transplantation.  Our results demonstrate that matrix cross-
linking and density are critically important to the resultant angiogenic potential of the 
matrices used in tissue engineering therapies.  Integrating our findings into current 
tissue engineering research could help fill the gap between the availability and need 
for organs.  
 
7.2 Future Directions 
 
Although the work described in this dissertation contributed significantly to our 
knowledge about the mechanical regulation of angiogenic vessel formation and 
vascular integrity, additional work is required to fully understand how mechanical 
stimuli regulate angiogenesis.  Future directions of this work will provide additional 
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insights into how matrix stiffness mediates angiogenesis and facilitates vascular 
branching and integrity and may inform the development of therapeutics to regulate 
angiogenesis.  There are several avenues of approach which should be completed. 
 
1. What are the molecular signaling pathways involved in the increased 
angiogenic outgrowth that is observed in stiffer matrices? 
While the work described in this dissertation focuses primarily on the biophysical 
mechanisms of angiogenesis, future work should further investigate the roles of 
cellular contractility and matrix degradation on angiogenic outgrowth in response to 
matrix stiffness in our system.  Matrix degradation by matrix metalloproteinases 
(MMPs) has been shown to be crucial to the formation and stabilization of angiogenic 
structures
4,11,26–28
.  In Chapter 3 we show that inhibiting MMP activity with GM6001 
decreases angiogenic outgrowth from spheroids embedded within stiffer, cross-linked 
matrices.  Additionally, previously published work from our lab has shown that 
endothelial cells sense and respond to increased matrix stiffness by increasing cell 
traction force generation and Rho GTPase activity
12,14
.  Cellular contractility has also 
been implicated in mediating a number of angiogenic responses including endothelial 
cell survival, proliferation, migration, stress fiber formation, sprouting, cord 
formation, and permeability
11,29–32
.  Based on these studies, we hypothesize increased 
matrix metalloproteinase activity, possibly coupled with increased cellular 
contractility, in the stiffer, glycated matrices is triggering the increased angiogenic 
response.   
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To test this hypothesis, the effects of cell contractility could be investigated by using 
the small molecule inhibitors Y27632 or ML7.  Y27632 is an inhibitor of Rho-
associated protein kinase (ROCK) which is known to be an important regulator of 
cellular contractility, motility, and polarity.  Inhibiting ROCK with Y27632 has been 
shown to inhibit the formation of vascular networks
11,30
.  ML7 is a selective inhibitor 
of myosin light chain kinase and has been shown to decrease angiogenic sprouting and 
vessel formation
11
.  To investigate the role of Y27632 or ML7 on mediating 
angiogenic outgrowth in response to increased collagen stiffness in our system, the 
branching and extent of outgrowth of spheroids could be quantified.  Spheroids 
embedded within 1.5 mg ml
-1
 collagen gels that had been glycated with 0 or 100 mM 
ribose could be treated with Y27632, ML7, or vehicle-controls.  The qualitative and 
quantitative outgrowth of spheroids would be studied by imaging spheroids with phase 
microscopy and measuring the total projected area, respectively.  After five days of 
outgrowth, the density of branching would be studied in response to the inhibitor 
molecule.   
 
As a preliminary study, we inhibited cellular contractility with the small molecule 
Y27632.  Bovine aortic endothelial cell (BAEC) spheroids were embedded within 1.5 
mg ml
-1
 collagen gels that had been glycated with 0 or 100 mM ribose.  Collagen gels 
were allowed to polymerize for 45 minutes and then overlaid with complete medium 
which was exchanged after 1 hour.  After an additional 3 hours, medium was 
exchanged with complete medium with or without 10 μM Y27632.  Spheroids were 
fed every other day with the respective medium.  Spheroid outgrowth was monitored 
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by imaging the spheroids using brightfield microscopy on a Zeiss Z1 microscope 
daily.  
 
We found that spheroids treated with Y27632 exhibited increased outgrowth in 
collagen gels glycated with 0 or 100 mM ribose when compared to controls (Figure 
7.1).  While most studies have shown that decreasing ROCK activity decreases 
angiogenic potential, inhibition of ROCK with Y27632 has also been shown to 
enhance endothelial cell sprouting and angiogenesis both in vitro and in vivo
33,34
.  Our 
preliminary data show that decreasing cellular contractility with Y27632 leads to 
increased angiogenic sprouting and outgrowth.   
 
Based on the data discussed in Chapter 3 and the preliminary data discussed here, I 
expect that matrix degradation will play a larger role in mediating angiogenic 
Figure 7.1. Endothelial cell spheroid outgrowth increases with Y27632 treatment.  
Endothelial cell spheroids were embedded within 1.5 mg/ml collagen that had been 
glycated with 0 or 100 mM ribose and were fed with complete media with or without 
10 μM of Y27632.  Y27632 treatment increases spheroid outgrowth in spheroids 
within 0 and 100 mM glycated collagen gels. 
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outgrowth than cellular contractility in response to matrix stiffness in our system.  
However, more work needs to be done to determine how MMP activity is altered by 
glycated collagen matrices and with GM6001 inhibition in our system.  
 
2. How does matrix stiffness mediate tip cell formation and branching? 
More work is needed to fully understand how matrix stiffness is mediating the 
formation of angiogenic outgrowths.  Because we have shown an increase in sprouting 
and branching from endothelial cell spheroids in stiffer three-dimensional matrices, it 
would be interesting to study whether matrix stiffness is mediating the formation of tip 
cells.  The Notch inhibitor, delta-like ligand 4 (Dll4) has been shown be expressed in 
the tip cells of angiogenic vasculature in response to VEGF stimulation
35
.  The up-
regulation of Dll4 causes adjacent cells to down-regulate VEGFR-2 and up-regulate 
VEGFR-1 and consequently specifies their fate as “stalk” cells36.  Dll4 up-regulation 
is correlated with a decrease in sprouting and Dll4 expression has been, surprisingly, 
shown to be elevated in the vessels of a number of tumors
37–39
.  Interestingly, 
inhibiting Dll4 leads to an increase in sprouting but has also been correlated with a 
decrease in tumor volume because the resultant vessels are non-functional
40–42
.  Since 
tumors are known to have altered matrix mechanical properties and vascular densities, 
we hypothesize that Dll4 is mediated by matrix stiffness in addition to VEGF 
stimulation. 
 
To investigate whether Dll4 expression is altered in response to matrix stiffness, 
endothelial spheroids could be embedded in 1.5 mg ml
-1
 collagen gels that had been 
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glycated with 0, 50, or 100 mM ribose.  After 6, 24 or 48 hours of outgrowth, 
spheroids could be fixed and Dll4 localization would be studied with 
immunocytochemistry and confocal imaging.  Since we observe an increase in 
angiogenic sprouting and branching in stiffer matrices, I would expect that increasing 
matrix stiffness will decrease Dll4 staining in spheroids (and thus decrease the 
proportion of cells that are specified as stalk cells).  To further interrogate the system 
and ensure altered Notch activity is regulating angiogenic sprouting in response to 
matrix stiffness, inhibition of Notch signaling could be studied using N-[N-(3,5-
difluorophenacetyl)-L-ananyl]-S-phenylglycine t-butyl ester (DAPT) in glycated and 
non-glycated collagen gels.  If stiffness is indeed mediating Notch activity, I would 
expect that the inhibition of Notch with DAPT would increase the extent of angiogenic 
sprouting in softer matrices to a greater extent than it would in stiffer matrices.   
 
As a preliminary experiment, we embedded BAEC endothelial cell spheroids within 
1.5 mg ml
-1
 collagen gels and fixed the gels after 6, 24, or 48 hours.  Spheroids were 
Figure 7.2. Spheroids stained for delta-like ligand 4 (DLL4). Endothelial cell 
spheroids were embedded within collagen gels and stained for DLL4 (red) and DAPI 
(blue).  Extensive background staining was observed.  Scale is 200 μm. 
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stained for Dll4 using a monoclonal rat IgG (R&D Systems, Clone#207822) and 
DAPI.  Unfortunately, since the collagen we use is derived from rat tail tendons, there 
was significant background staining within the gel (Figure 7.2).  This experiment 
should be repeated using a different antibody that is specific to bovine Dll4 but not of 
rat origin.  
 
3. How does matrix stiffness influence the perfusion of tumors in vivo? 
The work we have presented indicates that inhibiting collagen cross-linking in vivo 
modulates vascular density and mural cell localization in the tumor vasculature.  We 
have also shown that the matrix stiffness mediates endothelial cell-cell junctional 
integrity in vitro.  Future work should focus on understanding how matrix stiffness 
alters the perfusion of tumors and the permeability of the vasculature.    
 
We have already received approval from the Cornell Institutional Animal Care and 
Use Committee to study the role of matrix stiffness on angiogenesis in a murine 
model.  We hypothesize that matrix stiffness will influence angiogenesis and vascular 
integrity in vivo. To test this hypothesis, we have proposed two different approaches.  
We propose to study the angiogenic response to matrix stiffness by using multiphoton 
microscopy to monitor angiogenesis into glycated and non-glycated collagen gels that 
have been implanted intra-dermally.   We also propose to modify the inherent cross-
linking of mouse tissues in the MMTV-PyMT mouse model.  PyMT mice 
spontaneously form palpable mammary tumors at as early as 5 weeks of age.  In some 
animals, tissue cross-linking will be inhibited by beta-aminopropionitrile (BAPN).  
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Previous work has demonstrated that inhibiting lysyl oxidase-mediated collagen cross-
linking with BAPN significantly alters the resultant mechanical properties of 
mammary tumors
43,44
.  We have proposed to investigate a number of metrics including 
the extent of angiogenesis, extracellular matrix and vessel architecture, permeability 
and blood flow.  Patent, angiogenic vessels will be visualized by injecting fluorescent 
contrast agents into the vasculature either retro-orbitally (for single injections) or using 
a tail-vein implanted catheter (for repeated injections).  While we had initially 
envisioned determining the extent of angiogenic sprouting and tissue perfusion using 
multiphoton imaging, I anticipate that this type of study could be approached using a 
number of other methodologies currently available at Cornell including optical 
coherence tomography or ultrasound.  End-point histological analysis of tissues should 
also be completed to determine the morphology, density, and organization of the 
vasculature. 
 
4. How can endothelial cell response to stiffness be regulated in vivo? 
Our in vitro, ex ovo, and histology results demonstrate that matrix stiffness is a key 
regulator of angiogenesis.  In order for this observation to have impactful, clinical 
significance, matrix stiffness or cellular response to matrix stiffness needs to be 
specifically controlled in vivo.  Since collagen cross-linking is needed to maintain 
tissue integrity, the systemic approaches to ubiquitously to regulate matrix stiffness by 
inhibiting collagen cross-linking in murine models are inappropriate for use in 
humans.  We have also proposed the use of molecules such as Y27632 and GM6001 
to interrogate endothelial cells response to matrix stiffness in controlled, in vitro 
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environments.  However, since these molecules are not specific to endothelial cells 
and cellular contractility and matrix degradation mediate a multitude of normal and 
essential processes in vivo, broad-spectrum inhibitors are poor choices for clinical use.  
Additionally, prolonged exposure to small molecules inhibitors such as Y27632 has 
been shown to induce apoptosis in endothelial cells
30
.   
 
Ultimately, being able to specifically stimulate angiogenesis in wound healing and 
inhibit angiogenesis in cancer, would allow clinicians to better- manage patient care.  
Additionally, since many current tissue-engineered approaches are limited due to the 
inability to selectively and specifically control the angiogenesis, understating how to 
regulate angiogenesis as a function of matrix stiffness could allow for the development 
of tissue-engineered organs.  Thus, future work should focus on elucidating 
therapeutics to control matrix stiffness or endothelial cell response in a localized 
manner.    
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APPENDIX A 
 
OTHER RESULTS 
 
This appendix details other work that has been completed but is not included in the 
chapters of the dissertation. 
 
A.1 Endothelial cell invasion is modulated by collagen glycation 
These experiments were completed in collaboration with Sahana Somasegar and 
Michael Mazzola, undergraduate researchers in the Reinhart-King Lab.   
In Chapters 2 and 3 we primarily use an in vitro multicellular endothelial cell spheroid 
model to determine the effects of three-dimensional matrix stiffening on angiogenic 
sprouting.  Another commonly used technique to assess the angiogenic potential of 
Figure A.1.1.  Endothelial cell invasion is altered with matrix stiffness in glycated 
collagen gels.   (A) Confocal imaging of the invasion of bovine aortic endothelial cells 
stained for actin (red) and DAPI (blue) into 1.5 mg/ml collagen gels glycated with 0, 
50, or 100 mM ribose at day 5. (B) The distance of invasion was measured over 5 
days. Data presented as mean ± SEM. 
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endothelial cells is an invasion assay where cells are seeded atop of a biomaterial and 
their sprouting is monitored
9
.    
 
To better understand how matrix stiffness influences endothelial cell sprouting and 
angiogenesis, we performed invasion assays with BAECs seeded on 1.5, 5, or 10 mg 
ml
-1 
collagen gels that had been glycated with 0, 50, or 100 mM ribose.  Endothelial 
cell invasion into the collagen gels was monitored using phase microscopy over 5 
days.  Surprisingly, BAECs seeded on the softer (0 mM ribose) gels invaded further 
Figure A.1.2.  Endothelial cell invasion is independent of RAGE activity.  (A) 
Western blot demonstrating knockdown of RAGE at 24 and partial recovery beginning 
at 48 hours after transfection. 20 pmol control FITC siRNA (FITC); 20 pmol RAGE 
siRNA (RAGE); Opti-MEM control (Ctrl) (B) Quantification of endothelial cell 
migration fed with control media or media containing 20 pmol RAGE siRNA or FITC 
control siRNA. Data presented as mean + SEM. 
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than those seeded on the stiffer (100 mM ribose) gels (Figure A.1.1).  Interestingly, 
BAEC invasion was relatively individualized and the resultant sprouts did not 
resemble the long, continuous angiogenic cords we had previously seen with BAECS 
in the spheroid model.  These observations suggest that there may be differences in 
endothelial cell migration and sprouting behaviors between the cells embedded as 
spheroids within the collagen gels or seeded as monolayers atop of a collagen gels. 
 
Glycating the collagen gels creates cross-links termed advanced glycation endproducts 
(AGE) and endothelial cells are known to have receptors for advanced glycation 
endproducts (RAGE).   Since it is possible that the increased concentration of AGE 
cross-links in the stiffer (100 mM ribose) gels was mediating the endothelial cell 
invasion, we blocked the AGE/RAGE interaction using siRNA against RAGE.  
BAECs were transfected with 20 pmol of RAGE siRNA (Santa Cruz, sc-270508) or a 
control FITC siRNA (Invitrogen, #2013) using lipofectamine.  An Opti-MEM control 
was also used and the knockdown of RAGE was quantified with a Western Blot 
(Figure A.1.2A).  We found that RAGE siRNA knocks down RAGE in BAECs for at 
least 24 hours and partial recovery begins at 48 hours.  We quantified the invasion of 
BAECs that had been transfected with either the RAGE or control FITC siRNAs and 
found that while both the control and RAGE siRNA treatment decreased overall 
invasion in 1.5, 5, or 10 mg ml
-1
 gels when compared to Opti-MEM controls, there 
were no significant differences between the invasion in response to the control or 
RAGE siRNAs (Figure A.1.2B).  These results suggest that the AGE/RAGE 
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interaction is not playing a significant role in the invasion of endothelial cells into the 
collagen matrices.  
 
We repeated the invasion assay with human umbilical vein endothelial cells (HUVEC) 
seeded on 1.5 mg ml
-1 
collagen gels that had been glycated with 0, 50, or 100 mM 
ribose.  Cells were fed with either complete M200 (CM200) or angiogenic medium 
(AM200; CM200 supplemented with 40 ng ml
-1
 vascular endotheial growth factor, 40 
ng ml
-1
 basic fibroblast growth factor, 50 ng ml
-1
 phorbol-12-myristate-13-acetate, and 
50 μg ml-1 ascorbic acid).  Interestingly, HUVECs invade into the gels collectively and 
form open, lumen-like structures (Figure A.1.3).  Quantification of the HUVEC 
invasion shows that HUVECs atop of the stiffer gels invade slightly more than those 
on the softer gels when cells are fed either with CM200 or AM200 (Figure A.1.4).  
These results show that HUVECs only slightly modulate the distance of invasion in 
response to matrix stiffness and suggest that other metrics that measure the number of 
lumens or lumen size may be potentially useful.  
  
A.2 Endothelial cell migration is modulated by matrix stiffness 
These experiments were completed in collaboration with Michael Mazzola and Lulu 
Bai, undergraduate students in the Reinhart-King Lab.   
Since we have found differences in BAEC migration in glycated collagen gels of 
different stiffness (Chapter 3), we decided to investigate the migration response 
BAECs in response to 2D stiffness and ligand density using polyacrylamide 
hydrogels. Previous studies have shown that ligand density influences the migration of 
 162 
 
cells in a biphasic manner
10
.  Additionally, because we had seen differences in the 
invasion of BAECs and HUVECs, we quantified the migration speed of HUVECs in 
glycated collagen gels.   
 
The stiffness of polyacrylamide hydrogels can be tuned by varying the ratio of 
acrylamide to bis-acrylamide.  BAECs were seeded on 1, 5, 10, or 20 kPA 
Figure A.1.3.  Endothelial cell invasion of human umbilical vein endothelial cells 
into glycated collagen matrices.  Orthogonal projection of confocal z-stack of human 
umbilical vein endothelial cell invasion into collagen gels demonstrates collective 
invasion and lumen formation.  Cells were stained for actin (green) and DAPI (blue) 
and confocal reflectance of the collagen fibers is also shown. 
Figure A.1.4.  Endothelial cell invasion is altered with matrix stiffness in glycated 
collagen gels. The distance of human umbilical vein endothelial cell invasion was 
measured over 5 days for cells seeded with (A) angiogenic medium (AM) or (B) 
complete medium (CM). Data presented as mean ± SEM. 
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polyacrylamide gels that had been functionalized with 0.001, 0.01, 0.1, or 0.5 mg ml
-1
 
collagen and their migration speed was quantified.  We found that the BAECs altered 
their migration speed in a biphasic manner when seeded on gels functionalized with 
different amounts of collagen (Figure A.2.1).  Interestingly, cells on stiff (5, 10, or 20 
kPa) gels had a peak migration speed on gels functionalized with 0.01 mg ml
-1 
collagen while the migration speed of cells on the softest matrices (1 kPa) peaked at 
0.1 mg ml
-1
 collagen.  We hypothesize that this is due to a balance between substrate 
mechanics and cellular adhesion as demonstrated previously in our lab by Califano et 
al.
11
. 
 
Because the migration and invasion of BAECs is significantly altered in three-
dimensional glycated collagen matrices (Chapter 3 and Figure A.1.1) and because we 
did not observe differences in HUVEC invasion (Figure A.1.4), we were interested in 
Figure A.2.1.  Endothelial cell migration is altered by 2D matrix stiffness and 
collagen concentration. Endothelial cells were seeded on 1-20 kPa polyacrylamide 
hydrogels functionalized with 0.001-1 mg/ml collagen and the cell migration speeds 
were quantified.  Data presented as mean ± SEM. 
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determining whether collagen stiffness mediates individual HUVEC migration.  
HUVECs were embedded within 1.5 mg ml
-1
 collagen gels that were glycated with 0, 
50, or 100 mM ribose.  Cells were fed with either CM200 or AM200 and their 
migration was monitored using timelapse microscopy. The cell centroid was tracked 
using Image J and the cell speed was calculated.  HUVEC cell migration was only 
minimally modulated by three-dimensional matrix stiffness in both cells fed with 
AM200 or CM200 (Figure A.2.2).    
 
A.3 Human umbilical vein endothelial cell spheroids in glycated collagen 
Since we had seen differences in BAEC spheroid outgrowth with three-dimensional 
matrix stiffness and because BAEC spheroid extensions do not form lumens (Chapters 
2,3), we decided to investigate HUVEC spheroid outgrowth.  We had previously 
found that HUVECs form lumens in the glycated collagen gels during vasculogenesis 
(Chapter 3).   
Figure A.2.2.  Endothelial cell migration is not altered with matrix stiffness in 
glycated collagen gels. Human umbilical vein endothelial cells were seeded within 
1.5 mg/ml collagen gels and their migration speed in response to angiogenic medium 
(AM) or complete medium (CM) was quantified. Data presented as mean ± SEM. 
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HUVEC multicellular spheroids with 100, 500, 5000, 10000 cells were embedded 
within 1.5 mg ml
-1 
collagen gels that had been glycated with 0, 50, or 100 mM ribose.  
HUVECs embedded within the collagen gels did not have consistent outgrowth and 
spheroids tended to appear as though they fell apart and did not form continuous 
angiogenic extensions (Figure A.3.1).  Additionally, in some spheroids, a dense region 
towards the center of the spheroids was observed that appeared to be a cluster of 
Figure A.3.1. Human umbilical vein endothelial cell spheroids.  (A) HUVEC 
spheroids do not form continuous cord-like sprouts into collagen gels. (B) In some 
spheroids a dense region towards the center of the spheroid is observed. 
 
Figure A.3.2. Confocal imaging of human umbilical vein endothelial cell 
spheroids.  (A) Confocal image showing what appears to be nuclear fragmentation at 
the center of a HUVEC spheroid.  (B) Orthogonal projection of a confocal stack 
showing a fully-enclosed, lumen-like structure at the center of a HUVEC spheroids.  
(C) Orthogonal projection of bovine aortic endothelial cell spheroids shows sprouting 
at the spheroid center with no lumen-like structures. 
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apoptotic cells (Figure A.3.1B).  HUVEC spheroids were fixed and stained for actin 
and DAPI and imaged using confocal microscopy.  We found that the dense region in 
the center of the spheroids did indeed appear to be apoptotic cells with fragmented 
nuclei (Figure A.3.2A).  Interestingly, when took a confocal z-stack of the HUVEC 
spheroids, we noticed that some of the spheroids had formed fully enclosed lumens 
(Figure A.3.2B) whereas individual sprouts were seen within the interior of BAEC 
spheroids (Figure A.3.2C).    Our results indicate that HUVEC spheroids do not form 
the classical angiogenic sprouts when embedded within our glycated collagen gels.  
 
A.4 Microcarrier bead culture of endothelial cells 
Several labs have utilized microcarrier beads to culture endothelial cells and 
embedded them within fibrin gels as an in vitro model of angiogenesis
4,12,13
.  Since we 
were unable to produce HUVEC spheroids that with consistent sprouting behaviors, 
we attempted to use microcarrier beads to model angiogenic sprouting within our 
system.   
 
Figure A.4.1. Microcarrier beads seeded with endothelial cells. (A,B)  Endothelial 
cells were allowed to attach to microcarrier beads in a 35 mm dish.  Microcarrier 
beads coated with (C) human umbilical vein or (D) bovine aortic endothelial cells 
were embedded within collagen gels.  Endothelial cells remained adherent to the 
microcarrier bead. 
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HUVECs and BAECs were successfully seeded onto Cytodex3 microcarrier beads 
(Sigma) using an orbital shaker (Figure A.4.1A,B).  Cell-seeded microcarrier beads 
were embedded within collagen gels and monitored for outgrowth.  Unfortunately, 
HUVEC and BAECs did not migrate off of the microcarrier bead and into the collagen 
(Figure A.4.1C,D).  Even when we attempted to use AM200 with the HUVECs to 
stimulate angiogenesis, the endothelial cells did not consistently migrate into the 
collagen solutions (not shown).  Our unsuccessful attempts taken together with 
successfully reported microcarrier experiments in collagen gels
14
 suggest that we may 
need to dope the collagen gels with  fibronectin to encourage endothelial cells invasion 
and sprouting. 
 
A.5 Microchannel culture of endothelial cells 
These experiments were completed in collaboration with Joseph Miller, a PhD student 
in the Reinhart-King Lab.   
In Chapter 3, we utilize a method previously developed in our lab to investigate 
endothelial cell permeability in response to two-dimensional matrix stiffness using 
polyacrylamide hydrogels
2
.  However, since this two-dimensional system more closely 
models large vessels and because it is difficult to form good monolayers on soft 
substrates (<1 kPa), we attempted to create a device that would allow us to quantify 
the permeability of microvessels within our glycated collagen gels.  Our device was 
modeled from a number of other devices that have successfully created three-
dimensional microvessels within collagen gels
15–18
. 
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Joseph Miller and I created a manifold design that contained a central “culture” 
chamber with two external chambers to hold media (Figure A.5.1A).  Manifolds were 
activated using polyethylenemine and glutaraldehyde as described in Appendix F and 
were dried using a lyophilizer (the 3D-printed ABS plastic is slightly porous).  
Vacuum grease was used to seal a 22x22 mm coverslip into the central culture channel 
and devices were UV sterilized in the biosafety cabinet.  Microchannels within the 
collagen gels were created by threading acupuncture needles (0.3 x 75 mm) were 
threaded through holes in walls of the device and polymerizing 1.5 mg/ml collagen 
around them for 1 hour.  The needles were carefully removed and a dense cell 
suspension (1,000,000 cells/ml) was injected into the channels.  Manifolds were 
Figure A.5.1. Microchannels seeded with endothelial cells in collagen gels. (A) 
Microchannels were created by polymerizing collagen around an acupuncture needle.  
(B) Endothelial cells were injected into the channels and allowed to adhere to the 
collagen.  Some endothelial cells form (C) tube-like structures in the microchannels 
while other areas (D) have a high degree of branching.   
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placed upside-down in a 37ᴼC, 5% CO2 incubator for 30 minutes to allow cells to 
attach to the top surface of the collagen microchannel (Figure A.5.1B).  CM200 
supplemented with 1% v/v penicillin-streptomycin was added to the collagen gels and 
outer wells.  Endothelial cell outgrowth was monitored for up to a week.  
Unfortunately, HUVEC behavior within the microchannels was inconsistent with 
some areas forming tube-like structures while other areas were highly-branched 
(Figure A.5.1).  Further optimization and experimentation may allow the experiments 
to be more consistent and feasible for 3D permeability measurements.  If so, I would 
recommend using a fixable Texas Red dextran molecule to assess permeability as 
done previously by the Putnam lab
19
.  
 
A.6 Young investigator trans-network project with Moffitt Cancer Center:  
Investigating in vivo angiogenesis in response to matrix stiffness 
These experiments were completed in collaboration with Mark Lloyd and Veronica 
Estrella at the Moffitt Cancer Center. 
I was awarded a Young Investigator Trans-Network Project Grant from the National 
Cancer Institute, Physical Sciences Oncology Center for work entitled “The Role of 
the 3-D mechanical Environment in Regulating Angiogenesis” with Mark Lloyd at the 
Moffitt Cancer Center.  In this PS-OC young investigator trans-network project, we 
explored the effects of 3D matrix stiffness on the organization and quantity of 
angiogenesis both in vitro and in vivo.  We utilized collagen gels stiffened via non-
enzymatic glycation implanted within a murine dorsal window chamber model. 
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Figure A.6.1.  Collagen fiber arrangements in vitro and in vivo.  Collagen gels 
were polymerized and imaged with reflectance using multiphoton microscopy in 
vitro in Mattek dishes and in vivo in a dorsal window chamber.   The arrangement of 
collagen fibrils was similar in both cases.   
Figure A.6.2.  Blood vessel growth visualized in murine dorsal window 
chambers. Murine dorsal window chambers were inoculated with collagen gels 
containing HCT116/RFP colon cancer cell tumors (red).  After 3, 5, 10, 14, or 17 
days of culture, the vasculature (green) and tumor tissues were imaged. 
Figure A.6.3.  A magnified view of the implants shows the vasculature (green) 
growing into the HCT116/RFP tumor tissue (red) at days 5, 14, and 17. 
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During solid tumor progression, tumor tissue tends to stiffen. Notably, angiogenesis in 
tumor tissue is perturbed. Compared to capillaries in healthy tissue, vessels in tumor 
tissue tend to be malformed, more permeable and more tortuous.  In Chapters 2 and 3, 
we show that matrix stiffening via non-enzymatic collagen glycation alters the 
spreading, angiogenic sprouting, and spheroid outgrowth of bovine aortic endothelial 
cells in vitro
1
.  Based on our in vitro results, we hypothesized that 3D mechanical 
stiffness will also regulate the dynamics of angiogenesis in vivo.   
 
In this project, we utilized the glycated collagen matrices coupled with a murine dorsal 
window chamber model to monitor angiogenesis in vivo as a function of matrix 
stiffness.  Since we have previously shown that different collagen fiber arrangements 
can influence cellular behavior
24
, we confirmed that the glycated collagen matrices 
have similar fiber arrangements in vitro and in vivo (Figure A.6.1).   
 
Initial in vitro experiments were performed to determine the optimal cell and glycated 
collagen mixtures to use within the dorsal window chambers.  Murine dorsal window 
chambers were inoculated with collagen constructs and allowed to heal for 2 days.  
Subsequently, the vasculature was visualized by perfusing the mouse with 2000 kDA 
FITC-dextran and imaged using multiphoton microscopy.  Constructs were imaged 
over the course at least 2 weeks and the development of the vasculature network was 
monitored.  During this time, angiogenic blood vessels invade the glycated collagen 
gels in vivo and perfuse the tumor structure (Figures A.6.2, A.6.3).  Our data have 
validated the feasibility of monitoring the response of vascular structures to matrix 
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stiffness with the glycated collagen gels.  Future work should expand the number of 
experiments completed to determine the role of matrix stiffness on the formation of 
angiogenic vessels within the glycated collagen gels. 
 
A.7 Collaboration with the Bonassar lab:  Printed collagen interfaces and riboflavin 
cross-linking of collagen 
These experiments were completed in collaboration with Stephanie Rhee, Nithin 
Reddy, and Timur Ozekcin from Lawerence J. Bonassar’s laboratory at Cornell 
University. 
To investigate whether collagen interfaces could be created to expose cells to a 
boundary between two distinct collagen domains, I worked with Stephanie Rhee in the 
Bonassar lab to utilize 3D printing technology.  Neutralized 10 mg ml
-1 
collagen gel 
solutions that had been glycated with 0 or 100 mM ribose mixed with red and green 
beads, respectively and printed onto a heated plate.  After printing, gels were 
Figure A.7.1. Printed collagen interfaces.  Collagen gels were printed using 10 
mg/ml collagen solutions that had been glycated with 0 or 100 mM ribose and mixed 
with red or green beads, respectively.  (A) The printed collagen interface between the 
collagen solutions is distinct.  Scale is 200 μm.  Zoomed in view of the printed 
interface (B) without and (C) with confocal reflectance  microscopy imaging shows 
the separate collagen regions.  Scale is 20 μm. 
 
 173 
 
transferred to a 37ᴼC, 5% CO2 incubator for 30 minutes to allow polymerization to be 
completed.  Confocal microscopy was used to visualize the interface that was created 
between the gels.  A distinct boundary between the gels was observed (Figure A.7.1).  
This technique may be useful to investigate how matrix stiffness heterogeneities 
within tissues influence angiogenesis. 
 
Additionally, to investigate how riboflavin cross-linking concentration and matrix 
density would influence collagen gel structure and mechanics, I worked Nithin Reddy 
and Timur Ozekcin in the Bonassar lab.  Riboflavin has been used in vivo to cross-link 
and strengthen corneal tissue
25,26
.  Additionally, riboflavin has been shown to 
modulate collagen gel mechanical properties in vitro
27,28
.  Collagen solutions were 
mixed with 0-0.5 mM riboflavin and neutralized to form 1.5 or 5 mg ml
-1
gels.  Gels 
were exposed to a UV lamp to cross-link the collagen and gels were polymerized for 
Figure A.7.2. Riboflavin cross-linking of affects collagen fiber structure and 
arrangement.  Collagen gels were mixed with 0 – 0.5 mM riboflavin, polymerized, 
then cross-linked with UV light.  Scale is 20 μm. 
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45 minutes at 37ᴼC 5% CO2.  Confocal reflectance microscopy was used to assess the 
internal fiber structure of the collagen gels.  We found that riboflavin visibly altered 
the collagen fiber structure in both the 1.5 and 5 mg ml
-1
 collagen gels.  Future 
experiments should be completed to determine the effects of adding riboflavin to 
collagen gels post-polymerization.   
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APPENDIX B 
 
PREPARATION OF GLYCATED COLLAGEN GELS 
 
Materials: 
Stock Collagen (10 mg/ml) 
0.1% Sterile Acetic Acid 
Hepes Buffer Solution (250 mM Hepes, 440 mM Sodium Bicarbonate, 1.1 g/L phenol 
red, in 10X PBS) 
Cell Suspension / Media 
1 N Sodium Hydroxide 
Excel file for the collagen density and glycation concentrations (see 1.5 mg/ml 
protocol table below for an example) 
 
Protocol: 
1. Mix collagen, acetic acid, and ribose solutions together in a 15 ml tube to 
achieve desired ribose and collagen concentrations. 
a. It is difficult to mix more than 3 ml of gel solution when using pipets 
(you can get around this limitation by using syringes) 
b. See table below for an example of 1.5 mg/ml collagen gel solutions. 
2. Incubate collagen solutions at 4ᴼC for 5 days to allow for glycation reaction to 
occur. 
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a. NOTE: This must be done 5 days before polymerization if you are 
glycating gels or comparing controls to glycated gels BUT if you are 
only using control (0 mM gels), you can proceed to step 3 immediately 
3. Add the HEPES buffer solution and mix well 
4. Add the appropriate amount of sodium hydroxide to the solution and mix well 
a. NOTE:  the table below displays an approximate volume for 1 ml of 
collagen solution but this will need to be adjusted until the collagen 
solution is approximately the color of complete medium (phenol red is 
a pH indicator and is present in the HEPES buffer solution) 
5. Add in the cell suspension (or complete medium) and mix well 
6. Pipet solutions into appropriate dish and allow to polymerize 20-60 mins 
dependent upon the collagen concentration (10 mg/ml collagen will polymerize 
much more quickly than 1.5 mg/ml collagen) 
a. Commonly used collagen gel volumes: 
i. 11 mm Mattek dish = 150 μl 
ii. 14 mm Mattek dish = 250 μl 
iii. 24 well Mattek dish = 500 μl 
b. NOTE: volume is an important determining factor of collagen fiber 
formation (see Carey et al., Biomaterials 2012) 
7. After the gel has polymerized, add complete medium to the collagen gel. 
8. Incubate with the media 1 hour and then remove media and add in fresh 
complete medium 
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a. NOTE:  This is especially important if using glycated collagen gels so 
that the excess ribose is rinsed out of the gel. 
  
 181 
 
 
 
 
  
To make 1 mL of collagen solution with the following glycation concentrations: 
  Initial Volume 0.846 ml     
  Final Volume 1 ml     
  Collagen 1.5 mg/ml    
  D-PBS 1 X HEPES 25 mM 
  Cells 50 k cells/ml NaHCO3 44 mM 
         
From the following stock solutions.      
  Cell Conc. 1000 k cells/ml     
  Collagen 10 mg/ml     
  D-PBS 10 X HEPES 250 mM 
  Ribose 500 mM NaHCO3 440 mM 
         
  Glycation (mix 5 days prior to 
polymerization and store at 4ᴼC) 
Polymerization Neutralize 
Cribose 
(mM) 
collagen (ml) Ribose 
(ml) 
0.1% 
Acetic 
Acid (ml) 
HEPES 
Stock 
(ml) 
Cell 
Suspension or 
buffer (ml) 
1N 
NaOH 
(ml) 
0 0.150 0.000 0.696 0.100 0.050 0.004 
25 0.150 0.042 0.654 0.100 0.050 0.004 
50 0.150 0.085 0.611 0.100 0.050 0.004 
100 0.150 0.169 0.527 0.100 0.050 0.004 
150 0.150 0.254 0.442 0.100 0.050 0.004 
200 0.150 0.338 0.358 0.100 0.050 0.004 
250 0.150 0.423 0.273 0.100 0.050 0.004 
 Collagen Density during Glycation: 1.773 mg/ml    
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APPENDIX C 
 
PREPARATION OF TRITC-LABELED COLLAGEN 
 
Materials: 
Lyophilized collagen 
0.1M Sodium bicarbonate at pH=9 
TRITC (Invitrogen: T490) 
Dimethylsulfoxide (DMSO) 
20000MW Dialysis tubing (Spectrum Laboratories: 131348) 
Sterile water 
Dialysis tubing clamps 
Large Beaker or Erlenmeyer flask (washed and autoclaved) 
Stir Plate 
**Note all materials and reagents should be sterile. 
 
Protocol: 
1. Determine the weight of the lyophilized collagen. 
2. Add cold 0.1 M, pH 9 sodium bicarbonate to the collagen to achieve a ﬁnal 
collagen concentration of 10 mg/ml (or 20-30 mg/ml depending on the stock 
concentration you desire). Shake the collagen solution to mix well. 
3. Add a 1:30 (mol collagen/mol TRITC) dilution of TRITC (at 10 mg/ml in 
DMSO). 
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4. Cover the collagen/sodium barcarbonate/TRITC solution with aluminum foil 
and place on a rocker at 4degC.  Incubate the solution and allow it to react for 
24 hours at 4degC.   
a. NOTE:  At this stage, the collagen will not look very homogeneously 
dispersed in the sodium bicarbonate, it will appear very clumped and 
aggregated due to the basic solution. 
5. Prepare sterile acetic acid solution for dialysis (you will need many liters of the 
0.1% sterile acetic acid for the dialysis).  Put the acetic acid in the cold room or 
refrigerator to chill it to 4degC. 
6. Prepare the dialysis tubing by soaking it in sterile water for about 30 minutes 
to remove the sodium azide preservative.   
a. NOTE:  Calculate the length of tubing you will need based on the 
diameter of the tubing and the volume of your collagen solution.  The 
manufacturer should have information regarding how to do this.  You 
will want some excess tubing at one end so that it can be suspended in 
the following steps. 
7. Load the collagen solution into dialysis tubing (you can use a serological 
pipette), secure both ends with dialysis tubing clamps and leave a small “head 
space” or air bubble at the top end of the tubing.   
8. Suspend the tubing within a large beaker or Erlenmeyer flask (I used a 5L 
flask) containing cold 0.1% sterile acetic acid.  Add a stir bar to the flask and 
place the entire setup onto a stir plate at 4degC.   
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a. NOTE:  Ensure that photobleaching of your labeled collagen does not 
occur by covering the entire flask setup with aluminum foil. 
9. Change the acetic acid after about 1 hour and then daily (or more if needed) 
until the acetic acid solution is clear (i.e. no more TRITC is leaving the 
collagen) and the collagen solutions look opaque and uniform (i.e. no clumps 
or aggregates are visible).  When I did this, it took about 8 days to get to this 
point.  
10. Once dialysis is complete, remove the collagen solution from the dialysis 
tubing and place in a 50 ml centrifuge tube.  Ensure that the tube is covered 
with aluminum foil to avoid photobleaching and store the collagen at 4degC 
until use. 
 
References: 
1. Mason B.N., A. Starchenko, R.M. Williams, L.J. Bonassar, C.A. Reinhart-
King.  Tuning 3D Collagen Matrix Stiffness Independently of Collagen 
Concentration Modulates Endothelial Cell Behavior.  Acta Biomaterialia, 
2013. 9(1):4635-4644. 
2. Hermanson GT. Bioconjugate techniques. New York: Academic Press; 1996 
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APPENDIX D 
 
SPHEROID GENERATION AND EMBEDDING 
 
Materials: 
MethoCult (H4100, 40 ml from Stemcell Technologies) 
Complete Medium 
Non-adherent 96-well round bottom plates 
Orbital shaker 
Collagen solutions (see glycated collagen protocol) 
24 –well, glass bottom plates that have been coated Rain-X 
Wide bore pipet tips 
 
Spheroid Timeline with Glycated Collagen Gels: 
Day 1: Prepare glycated collagen solutions 
Day 3:  Make spheroids 
Day 5:  Embed spheroids 
Days 6-10:  Monitor spheroid invasion 
 
Methocult preparation: 
1. Allow MethoCult to thaw at 4ᴼC overnight 
2. Add 98 ml complete media to the bottle.  Shake well to mix.  
3. Let the MethoCult stand to allow the bubbles to rise to the surface. 
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a. NOTE:  This 0.75% solution of MethoCult can be stored at 4ᴼC for up 
to 1 month. 
 
Spheroid Generation:   
NOTE: the numbers in this protocol will generate 1 plate of spheroids at 10,000 
cells/spheroid 
1. Pass cells according to protocol. 
2. Count the cells and determine the cell density. 
a. For 1 – 96 well plate with 10,000 cells/spheroid, ~1,000,000 cells are 
needed. 
b. Determine the volume of cell suspension needed  
3. In a 50 ml tube, mix the cell suspension with compete media to get 14.6 ml 
total.   
4. Add 7.3 ml of the 0.75% MethoCult and mix well. 
5. Transfer the mixture to a multi-channel pipet well.   
6. Pipet 200 μl of the mixture into each well using a multi-channel pipet. 
7. Centrifuge the plate at 1000RPM for 5 minutes. 
8. Place plate on orbital shaker for 2 hours at ~30-45 RPM.   
9. Culture cells for 2 days prior to embedding. 
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Spheroid Embedding 
1. Pipet up-and-down in a well with a spheroid using a wide bore pipet tip.  Find 
the spheroid in the media within the tip and isolate it into a small (~30 μl) 
volume of media on the lid of the well plate. 
2. Repeat for ~12-15 spheroids. 
3. Neutralize collagen solution 
4. Pipet up 30 μl of collagen solution and collect spheroid into pipet tip 
a. Find the spheroid in the bubble on the lid 
b. Gently depress a small amount of collagen from the tip and “draw up” 
the spheroid into the tip 
5. Deposit the spheroid and collagen onto the bottom of the 24-well glass bottom 
plate 
6. Repeat for the remaining spheroids in that plate. 
7. Move plate to the incubator.  Plates will need to be incubated right-side-up, 
inverted, and then returned to right-side-up.  The timing depends on the 
polymerization dynamics. I have found the following times to work well for 
1.5 mg/ml collagen gels glycated with 0, 50, or 100 mM ribose. 
Timing (min) 0 mM 50 mM 100 mM 
Right-side-up 2 4 4 
Inverted 4 5 8 
Right-side-up 2 2 5 
 
8. Add 450 μl of neutralized collagen per well.  Incubate for an additional 30 
minutes (right-side-up). 
9. Add 1 ml complete media per well.  Incubate 1 hour. 
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10. Exchange media for 1 ml of fresh complete medium (this step is important to 
wash away any excess ribose that may not have cross-linked within the gels). 
11. Image spheroids using phase contrast microscopy. 
12. Repeat step 11 for the rest of the experimental timing. 
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APPENDIX E 
 
CONFINED COMPRESSION TESTING OF COLLAGEN GELS 
 
Construct Fabrication: 
1. Assemble the following materials in the biosafety cabinet: 
 Collagen and neutralization solutions 
 24 well plate 
2. Neutralize collagen gel solutions according to protocol 
3. Polymerize 0.9 ml collagen per well for 1 hour at 37ᴼC and 5% CO2 
4. Add 1 ml media/well and incubate overnight at 37ᴼC and 5% CO2 
5. Remove media 
6. Freeze gels at -20ᴼC 
7. Cut constructs using 6 mm biopsy punch and place into individual 1.7 ml 
Eppendorf tubes 
8. Freeze constructs at -20ᴼC until use 
 
Mechanical Testing on Enduratec: 
Machine Setup 
NOTE:  Do all setup with machine OFF 
1. Screw 250 g for 1.5-5 mg/ml samples (or 1kg for 10-20 mg/ml samples) load 
cell onto the bottom, finger tight 
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2. Ensure load cell is connected to the controller (it should be plugged into the 
back of the console)  
3. Screw appropriate size confined compression disk (3, 4, 6, or 8 mm) into the 
tissue cup 
4. Screw the tissue cup onto the load cell 
5. Connect impactor to the top of the system with 4 screws 
a. Put screws in from the top-down 
b. Be careful not to move the top load cell much – very important and 
sensitive for measuring loads 
c. Tighten screws with hex key to make the impactor as flat as possible on 
the bottom 
6. Move stage up to comfortable position using black hatched pieces on the bars  
a. Note you will still be able to adjust height of tissue cup moderately 
using the rod and screw under the load cell 
 
Computer Setup 
1.  Turn on Enduratec power box and load cell controller 
2. Open the following on the computer  
NOTE: these files are pre-set to control the Enduratec and apply a 5% step-
wise strain for 1.5 mm thick samples and can be modified for each individual 
test setup 
a. Wintest 
b. C:ProgramFiles:Enduratec 
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c. Brooke_Confinedcompression 
NOTE:  Go to Meniscus1mm if something is deleted on your file and re-
save under your own name 
3. Turn on the top load cell by clicking the “Local” button (green button towards 
the top right) 
a. Select “High” 
b. Close 
4. Define the steps for confined compression 
a. 5% steps of sample thickness (originally set up for 2 mm samples) 
b. May need to change step size 
c. Need enough steps to go at least ½ way through normal thickness 
5. Click “Setup”  “Channels”  “Load 1” in dropdown 
6. “Tare” the load cell by bringing the load down in value on the main screen 
7. “Home” the system by pressing the Home button then clicking “OK” 
 
Sample Prep and Measurement 
NOTE:  It is generally easier to work with frozen samples; use PBS to gently transfer 
samples from the Eppendorf tube to a glass plate then into the tissue cup. 
1. Measure the height of the sample with a caliper and record 
2. Use PBS to hydrate and transfer the collagen construct (if cells are present, use 
a protease inhibitor in PBS) 
3. Find appropriate sized porous plug 
a. Want the plug to be VERY level 
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b. The plug will go on top of sample and is porous to allow liquid to move 
through 
c. The plug should be tight in the hole yet move relatively easily so you 
can do the testing and are measuring the load needed to compress the 
collagen 
4. Transfer the collagen construct into the tissue cup with some PBS 
5. Carefully move the construct into the compression disk hole using some PBS 
and a plastic pipet 
6. Gently place the porous plug on top of the collagen construct 
7. Bring the load cell and tissue cup up so that the top of the porous plug is 
almost touching the top piece 
8. Move micrometer and bring top piece down slightly until it is touching the 
porous plug and the green load line on the screen drops (and recovers) slightly 
9. Fill tissue cup with PBS so liquid level is above the porous plug 
10. “Tare” the system again so the load is near “0” 
11. Add up the amount of time the test will take  
a. Frequency  Time/step x # steps 
b. Max Scan Time = 1000 seconds 
c. # Scans = Total Time / 1000 
d. Figure out how much Time/Scan and set (overestimate!) 
12. Ensure that “Displacement” and “Load 1” are clicked 
13. Choose location to save files to 
14. Click “Start” (button will turn yellow when it starts recording data) 
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a. Allow the load cell to record for ~30 seconds to set the basal level 
15. Click green “Run” button to begin the loading program 
a. Click “0 – Start” 
b. Click “Yes” 
c. Click “Yes” 
 
Data Analysis – Matlab Code 
NOTE:  The analysis code was developed by the Bonassar lab and the commands that 
follow describe how process the data through the code to quantify the gel modulus.  
Preparing Data Folders 
1. For each data set, prepare a folder that contains the “analysis” and “steps” 
folders as well as the “info.txt” file. 
2. Label the data set “data.txt” so Matlab will recognize the file 
 
Command Codes 
1. File  Set Path  set to the Confined Compression Code folder (wherever 
you have it saved) 
a. Save and Close 
2. Set Directory to folder with data set you wish to analyze 
3. Commands: 
a. Chunkdata 
i. “0” enter 
b. SRcurvefit 
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i. close image 
c. dataanalysis 
i. “[x,y,z]” where x, y, z are rows that you want dropped or 
removed 
ii. when happy with the data, “0” enter 
iii. enter the linear region of the curve by  
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APPENDIX F 
 
ACTIVATION OF PLATES AND COVERSLIPS FOR COLLAGEN OR 
POLYACRYLAMIDE ATTACHMENT 
 
Materials: 
Glass-bottomed plate or glass to be activated 
Solution of 1% polyethylenemine (PEI) in water 
Solution of 0.1% glutaraldehyde in 1X PBS 
Distilled, Deionized (MilliQ) water for washing 
Pipets and Pipettors 
Appropriate waste containers (see note 3 above) 
 
Protocol: 
1.  Put plate into plasma cleaner.  Close the door to the plasma cleaner, check to 
make sure that the valve is closed, and turn on the vacuum pump to evacuate 
the chamber.   
a. Glass coverslips can be plasma cleaned in a petri dish.  5-6 glass 22x22 
mm coverslips will fit in a petri dish bottom and 2 dishes can fit in the 
chamber at a time. 
2. Once the pump has pulled a vacuum, turn the plasma cleaner onto the “high” 
setting.  When the plasma is on, a pink haze can be seen through window.  
Leave plate in plasma for 2 minutes. 
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3. Turn off plasma and vacuum pump.  Open valve to allow air to enter chamber 
and remove plate. 
4. Place plate into the chemical fume hood and add in the PEI solution 
a. For a 24 well plate, use 1 ml per well 
b. For a 96 well plate, use 0.2 ml per well (can use the multichannel pipet 
for this) 
c. For glass coverslips, ensure that glass is submerged in the PEI (~5ml / 
petri dish) 
5. Incubate the plates with the 1% PEI solution for 10 minutes.  
a. At this point, plates can be transferred to the Reinhart-King lab using 
secondary containment 
6. Remove the PEI solution and put it into the appropriate waste container in the 
chemical fume hood.  Rinse plates with water (3 x 5 minute incubations should 
work well) 
a. Remove the majority of the water from the plates and coverslips 
7. Add 0.1% glutaraldehyde solution to the plates and incubate for 30 minutes. 
a. The same volumes used in step 4 can be used here EXCEPT invert 
glass onto 200 ul drops of glutaraldehyde on parafilm. 
8. Remove the glutaraldehyde solution and put it into the appropriate waste 
container in the chemical fume hood.  Rinse plates with water (4 x 15 minute 
incubations should work well for plates, 3 x 5 minute incubations should work 
well for glass coverslips). 
9. Dry completely 
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10. If using for cell culture, UV the plate in the biosafety cabinet for at least 20 
minutes to sterilize.  
 
NOTES: 
1.  If you are using a Mattek dish/well plate, clean used plates with Alcanox and 
ethanol and rinse thoroughly with water before use. 
2. Polyethylenemine and glutaraldehyde solutions should be disposed of in their 
respective, labeled hazardous waste containers in the chemical fume hood. 
3. All items that are transported MUST be in a secondary container. 
4. Collagen will adhere to the wells/glass if it is polymerized directly on the 
activated surface (the surface will NOT bind to collagen that is placed on the 
surface after polymerization) 
5. Polyethlyenemine is VERY difficult to pipet but it can be kept in its diluted 
state until use.  I have found that it is easiest to make the 1% PEI solution in 
500 ml bottles.  In the chemical fume hood, use a 25 ml serological pipet to 
slowly draw up ~8 ml of PEI and put it into 500 ml of water.  I have found this 
to provide a good working concentration since much of the PEI is lost in the 
pipet. 
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APPENDIX G 
 
MEASUREMENT OF ENDOTHELIAL CELL PERMEABILITY USING THE 
ZEISS LSM700 CONFOCAL MICROSCOPE 
 
This protocol was modified from John Huynh’s protocol for the Leica upright 
confocal and expanded to include analysis instructions 
 
Materials: 
Timer 
Forceps 
50 mm Mattek glass bottom petri dishes (with a 30 mm diameter glass opening) 
10 μM 40 kDa FITC-dextran in Complete M199  
 
Protocol: 
1. Culture endothelial cells to 100% confluency on 18 mm circular 
polyacrylamide gels made on 18x18 mm glass coverslips in 6-well plates. 
a. NOTE:  it is important to use the 18x18 mm glass coverslips so that 
they fit inside of the 30 mm diameter opening in the Mattek dish 
2. Make enough 10 μM solution of 40 kDa FITC-dextran for all of your samples. 
Each sample requires 4 ml of dextran solution. For example, for 25 samples, 
make 100 ml of dextran solution. 
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a. NOTE: Dissolve 0.02 g 40 kDa FITC-dextran into 50 ml of Complete 
M199 to make a 10 μM solution. Media can be mixed by vortexing. 
b. The 40 kDa FITC-dextran solution is stored in desiccant at 4°C and 
should be allowed to warm to room temperature before opening 
because it is hydroscopic 
3. For each sample, aliquot 4 ml of dextran solution into a 50 mm Mattek petri 
dish. Place these petri dishes in the incubator to warm to 37°C. 
 
NOTE:  The following instructions are specific to the use of a Zeiss LSM700 
microscope equipped with an environmental chamber and Zen 2012 software. 
 
4. Warm the environmental chamber on the Zeiss LSM700 microscope to 37°C.  
Once warm, turn on the CO2 to 5%. 
5. Turn on the Zeiss LSM700 microscope (there is no need to turn on the 
fluorescent lamp). 
6. Start Zen software.   
a. Turn off the 405 nm and 555 nm lasers (we will only use the 488 nm 
laser). 
b. Move the objectives to the “Load position” and put the individual 
sample holder on the stage  
c. Select the 40X water immersion objective and place a small drop of 
MilliQ water on the objective. 
d. Prepare software 
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7. Using forceps or the back end of a cotton swab, move a gel from the 6-well 
plate into a dextran-filled 50 mm Mattek petri dish. Start a timer for 5 minutes. 
Place the plate into the incubator and bring the immersed sample to the 
microscope and place it on the stage. 
8. Prepare the microscope to acquire images of the gel. 
a. Locate the gel surface by doing a “Live” scan while moving the stage 
up and down in the z-axis and observing when the fluorescent intensity 
of the solution changes from being homogeneously bright to slightly 
dimmer (on gels with cells, you should be able to make out the cell 
outlines) 
b. In the XYZ mode on the touchpad, set the surface of the gel to “0” 
c. Move 100 um above the surface of the gel and set the point to be the 
upmost point of the z-stack 
d. Move 200 um below the surface of the gel and set the point to be the 
lowest point of the z-stack 
e. Check to make sure that your scan will encompass the entire gel by 
clicking “Start Experiment” 
f. Once the timer has reached 5 minutes, acquire 4 images in quick 
succession near the center of the polyacrylamide gel. 
9. Repeat steps 7-8 with all samples.  
10. Pro-tip: while waiting for timer to count down before step 8, you can place 
another gel in dextran and start a second timer to stagger your samples every 
~3 minutes. 
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For data analysis: 
Note that these analysis instructions assume that the intensity image is inverted such 
that the fluorescent solution appears to be at the bottom of the image with the gel at 
the top. 
 
Do the following in the program ImageJ 
1. Click on “Analyze” and choose “Set Scale”  
a. Check “Global”  
b. Press “Click to Remove Scale” 
c. Click “Ok” 
2. Click on “Analyze” and choose “Set Measurement” 
a. Select area, min & max, integrated density, mean gray value, and 
display label from the list 
3. Choose the rectangular selection tool 
a. Draw a box above the gel that is 400 pixels wide x 50 pixels high and 
place it about 50 pixels below the top of the gel (in the fluorescent 
region) 
b. Press “M” to measure 
c. Move the box to the other side of the endothelial cell monolayer such 
that the bottom of the box is just above the EC monolayer.  Drag the 
top of the box to encompass the entire gel. 
d. Press “M” to measure 
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4. Repeat step 3 for all data 
5. Copy the measurements from the results box and paste into Excel 
 
Do the following in Excel 
1.  Create a column next to the imported data and divide the “mean gray value” 
measurement from inside the gel with the value above the gel 
a. =(Mean Gray Value Inside)/(Mean Gray Value Above)=Normalized 
Gray Value 
2. Create another column to average the images from each gel together 
a. =AVERAGE[(Normalized Gray Value)1, (Normalized Gray Value)2, 
(Normalized Gray Value)3, (Normalized Gray Value)4]=Gel Averaged 
Gray Value 
3. Create another column to normalize the cell permeability values to their 
controls (i.e. divide the 10 kPa cells by the 10 kPa controls to normalize for 
any differences in the diffusion of the 40 kDa FITC-Dextran into the gel) 
a. =(Gel Averaged Gray Value Cells)/(Gel Averaged Gray Value Control) 
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APPENDIX H 
 
EMBRYONIC CHICKEN CHORIOALLANTOIC MEMBRANE MODEL OF 
ANGIOGENESIS 
 
This protocol was developed with Michael Mazzola.  Incubation and cracking 
protocols were modified from:   
Yalcin et al., J Vis Exp 2010; (44) e2154 
 
Timing Outline:  
Day 0: Put eggs in incubator  
Day 3: Crack Eggs 
Day 5: Glycate collagen  
Day 10: Preparation and implantation of collagen meshes 
Day 15: Mesh fixation 
Imaging and quantification  
 
Protocol: 
Day 0: Incubating Eggs 
1. Order fertilized chicken eggs.  In the Reinhart-King lab, we utilize the Cornell 
Poultry facility. 
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2. Label all eggs with your initials and the date.  Place eggs in a 37.5ᴼC, 60% 
humidity, rocking incubator.  Eggs are considered to be at embryonic Day 0 at 
the time of incubation. 
a. NOTE:  Eggs can be stored in a wine cooler at 13ᴼC to arrest 
embryonic growth for a few days prior to incubation.  Viability may 
decrease with the length of time stored so eggs should be used as soon 
as possible after delivery. 
3. At embryonic Day 2.5-3, eggs are ready to be cracked and embryonic 
development can continue ex ovo. 
 
Day 3: Cracking Eggs 
1. The following materials should be assembled into a laminar flow hood: 
 Absorbent pad (laid out to cover the surface) 
 Plastic cups, 9 oz 
 Warm water 
 Plastic wrap 
 Rubber bands 
 Petri dishes 
 Beaker or metal bucket (sharp edge for cracking eggs)  
 Paper towels 
 70% Ethanol 
 Autoclaved eggshells (ground to a powder using mortar and pestle)  
2. Fill cups approximately 2/3 full with warm water 
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3. Cut a piece of plastic wrap, lay it over top of the plastic cup, and push down 
the center slightly so that it touches the water.  Place rubber band around the 
cup to hold the plastic wrap in place (see photos 1 & 2). 
4. Repeat steps 2-3 to get enough cups for all eggs. 
a. Alternatively, make hammocks in sets (for example, ten hammocks) to 
avoid preparing more cups than successful cracks, as it is unlikely all 
cracks will produce viable cultures (see photo 3).   
5. Spray 70% ethanol onto the plastic wrap and allow it to incubate for at least 30 
seconds.  Dry plastic wrap with kimwipes. 
6. Retrieve eggs from incubator 4-6 at a time and spray with EtOH. 
a. NOTE: Lay eggs on their side in an egg carton to allow the embryo to 
rotate to the top (see photo 4) 
7. Gently crack the eggs on the edge of the beaker (see photo 6) and carefully 
deposit the egg onto the plastic wrap in a plastic cup.   
a. Tips for successful cracks:  
i. Softly crack until the shell membrane is broken and a small 
amount of albumin dribbles out of the egg.  
ii. After the shell membrane is broken, use the tips of your thumbs 
to separate the shell a bit further without completely cracking 
the egg. This will allow the egg shell to crack up the egg 
without releasing its contents so that crack will be more easily 
maneuvered.  
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iii. Swiftly separate the eggshell by pulling the crack apart. The 
swifter this motion, the less likely something (i.e. finger, egg 
shell) will puncture the yolk.  It helps to pull apart on a diagonal 
to avoid contact with the yolk.   
iv. Discard embryos whose yolks leak heavily, as they are unlikely 
to survive.  
8. Ensure that the embryo is on top of the yolk and that the heart is beating. If the 
embryo is not at the surface, use your finger to gently rub the top of the yolk 
swiftly and repeatedly until the embryo appears.  
9. Deposit a small amount of autoclaved eggshells (roughly a few grams) on the 
side of the hammock over the albumin.  
a. A plastic pipette with half its bulb cut off is a good way to transfer the 
eggshells from a conical tube to the albumin (see photo 5).  
10. Put the top or bottom of a plastic petri dish over the cup and label before 
putting the embryo in the incubator.  
11. Put plastic cups with water in the incubator to maintain incubator humidity.  
 
Day 5: Preparing Glycated Collagen Solutions  
1. Mix glycated collagen solutions and store at 4ᴼC for 5 days (for mesh 
placement at day 10).  
a.  Refer to the glycated collagen protocol for preparing these solutions.  
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Day 10: Preparation and Implantation of Polymerized Collagen Meshes  
1. Cut nylon meshes into 5 mm x 5 mm squares. Autoclave forceps and meshes 
before implanting. 
a. Meshes have square openings that are approximately ~200 μm square 
and can be ordered from Small Parts (#7050-1220-000-29) 
http://www.smallparts.com/dp/B0015H6LAK/ref=sp_dp_g2c_box 
2. The following materials should be assembled into a biosafety hood: 
 Petri dishes 
 Parafilm (to cover bottom of a petri dish) 
 Autoclaved forceps  
 Autoclaved 5 mm x 5 mm meshes  
 Glycated collagen solutions mixed on day 5  
 VEGF (100 μg/ml) stock 
 HEPES stock and 1 N NaOH for neutralization  
3. In the biosafety cabinet, line the bottoms of petri dishes with parafilm (one 
petri dish per condition).  
4. Using the autoclaved forceps, place sets of two meshes of equal sizes/shapes 
(stacked on top of one another) on the petridishes.  
5. Neutralize collagen solutions with HEPES and NaOH and mix well. 
6. Add VEGF to neutralized solutions for a final [VEGF] of 5 μg/ml. 
a. NOTE:  Substitute the PBS/Cell Suspension in the gel neutralization 
recipe for the 100 μg/ml VEGF stock solution.   
7. Add 30 μl of neutralized collagen per mesh.  
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8. Incubate meshes in 37ᴼC incubator for 30 minutes.  
9. Bring incubator with chick embryos and polymerized collagen meshes to 
location with laminar flow hood.  
10. Remove 1 chick embryo at a time.  In the laminar flow hood, place 5 
polymerized collagen meshes around the chicken embryo vitelline membrane 
using the autoclaved forceps. Record location and conditions of meshes for 
each embryo (see photo 7).  
11. Return chicken embryo to incubator after implantation.  
12. Allow angiogenesis to occur until Day 15. 
 
Day 15: Mesh Fixation  
1. In the laminar flow hood, inject approx. 200 microliters of 0.25% Texas-Red 
Dextran in PBS using a 30G x 1 needle into the vasculature under the 
chorioallantoic membrane (CAM).  
a. Target injections to forks in the vasculature.  
2. Return the embryo to the incubator. Allow 45 minutes for the dye to circulate. 
3. Add 10-15 mL of 3.7% formaldehyde in PBS on top of the embryo.  
a. Cover the cultures with paper towel or aluminum foil to limit their 
exposure to light, as exposure to light weakens the fluorescent signal 
over time.  
4. Remove the formaldehyde and dispose of appropriately in the hazardous waste. 
5. Using scissors, cut the mesh from the CAM and put into 24-well plate. 
a. Note: chick should be decapitated before disposal 
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6. Incubate meshes in 3.7% formaldehyde for 45 minutes on rocker. 
7. Wash 3x with PBS for 20 minutes on rocker.  
8. Store at 4ᴼC until imaging is completed.  
 
Imaging  
1. On a glass slide, position the mesh with the CAM up (opposite the glass).  
2. Using the 10x objective on the LSM, set up a tile scan that covers the mesh.  
3. Run a z-stack, spanning the top (CAM) of the mesh to the lowest plane of 
fluorescent signal.  
Quantification  
1. Choose a 6x6 mesh square area that covers the most angiogenic vessels (those 
that branch off the CAM into the collagen of the mesh).  
2. Count and record the number of squares within the 6x6 that have angiogenesis 
vessels.   
a. A max intensity z-projection on ImageJ (Image -> Stacks -> Z project) 
may help discern angiogenic vessels from CAM vessels by compiling 
the fluorescence from multiple z-planes  
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Photos: 
 
Photos 1&2: Images of the hammocks used for chick culture 
 
Photo 3: Make enough hammocks for each set of cracks. In this case, 6 eggs were 
removed from the incubator. 
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Photo 4: Lay eggs on side of cartoon so that embryo will float to the top before 
cracking the bottom side of the egg. 
 
Photo 5: Autoclaved and ground eggshells transferred via the bulb of a severed pipette 
bulb. 
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Photo 6: Metal beaker for egg cracking and disposal. 
 
Photo 7: Collagen meshes (top left) implanted over vitelline (middle right) 
  
 213 
 
APPENDIX I 
 
HISTOLOGY PROTOCOL 
 
Deparaffinization and Rehydration: 
1.  Label slides with conditions you will be using  
a. Pencil is best but lab markers can be used 
b. Include the markers you will be staining for and the date 
2. Bake slides at 60ᴼC for 10 minutes 
3. Cool slides at room temp for 5 minutes 
4. Place samples into a slide holder/carriage (1 slide per spot) 
5. Deparaffinize and rehydrate samples using the following washes 
a. 3X 5 min in 100% Xylene 
b. 1X 5 min in 100% Ethanol 
c. 1X 5 min in 95% Ethanol 
d. 1X 5 min in 70% Ethanol 
e. 1X 5 min in tap water 
NOTE:  When moving to next wash, gently move carriage up and down in the 
container 5-10 times.  Lift carriage and drain into container.  Briefly tap the 
carriage onto paper towels and place into the next container 
6. Move slide holder to a dish with water and exchange with water 5-6 times.  
Use tap water for the first 3-4 washes and DI water for the last 2 washes.   
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NOTE:  Make sure to add water to the dish then add the carriage to avoid 
damaging the samples  
7.  Fill container with DI water, place carriage inside and place on the orbital 
shaker. 
 
Antigen Retrieval: 
8. Fill a plastic Coplin jar (with a lid) with 10 mM Citrate Buffer (pH 6)  
9. Remove 1 slide at a time from the slide holder in the DI water.  Use a Kimwipe 
(nicely folded) to wipe off the back of the slide and around the tissue sample 
on the front of the slide 
NOTE:  DO NOT touch the tissue section with the Kimwipe 
10.  Place the slide into the Coplin jar with the citrate buffer.  Repeat for all slides 
NOTE:  Slides should have the tissue side faced inwards towards the buffer 
solution 
11. Microwave for 1 min on “high” power 
NOTE:  The microwave powers and times are for the Shuler lab microwave.  
These may need to be adjusted if a different microwave is used. 
12. Set the microwave to “warm” and microwave for 5 min. 
13. Rest for 5 min 
14. Microwave 5 min on “warm” 
15. Rest for 2 min 
16. Microwave 2 min on “warm” 
17. Cool for 20 minutes to RT on counter. 
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18. Wash off citrate buffer with PBST (1X PBS + 0.05% Tween20) 
19. Wash samples 2X 5 min with PBST on orbital shaker in the large Coplin jar. 
 
Blocking and Staining: 
1. Make blocking solution (usually 2-10% goat serum in 1X PBS) (will need 
approximately 100-200 ul/sample depending on area) 
a. For mouse-on-mouse staining, use the Vector Lab mouse-on-mouse kit 
blocking reagent  
2. Dry slide (but do not touch tissue), circle each sample with hydrophobic pen 
and apply blocking reagent 
3. Incubate in humidified chamber for 1 hour at room temperature or 37ᴼC  
4. Dilute 1ᴼ antibody in appropriate solution (usually 1:100 – 1:500 in 1% BSA 
in 1X PBS with 0.3% Triton-X) 
a. Note: can often mix multiple 1ᴼ antibodies together for staining at the 
same time 
b. For mouse-on-mouse staining, use the Vector Lab mouse-on-mouse kit 
diluent solution 
c. Briefly vortex and store at 4ᴼC until use 
5. Aspirate blocking solution 
6. Wash slides 3X 5 min with PBST  
7. Dry slide (but do not touch tissue) and apply 1ᴼ antibody solution 
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8. Incubate overnight at 4ᴼC or 1-2 hours at room temperature (as optimized for 
protocol) 
9. Aspirate antibody solution 
10. Wash slides 3X 5 min with PBST  
11. Dilute 2ᴼ antibody in PBS (usually 1:100-1:200 works well) 
12. Apply 2ᴼ antibody to tissue and incubate for 30 minutes at room temperature 
(covered with foil) 
13. Wash slides 3X 5 min with PBST  
14. Repeat as necessary for all 2ᴼ antibodies 
15. Wash slides 3X 5 min with PBST  
16. Mount slides using Vector Labs mounting medium and a coverslip (can use 
nail polish to seal) 
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APPENDIX J 
 
MICROFLUIDIC DEVICE SETUP 
 
Cell Seeding for 2D experiment:  Should be completed ~6-24 hours before 
beginning device setup  
1. Pass cells according to standard protocol 
2. Seed a microscope slide (with or without polyacrylamide gel hydrogel) with 
cells by creating a cell suspension “bubble” of media on top of the slide  
a. ~15,000 BAECs/slide worked well for my single cell experiments 
3. Incubate at 37ᴼC, 5% CO2 for at least 6 hours to allow cells to attach 
4. If not using cell slide immediately, fill petri dish with media and incubate until 
use  
 
Creating Agarose Mold of Features: 
1.  Assemble the following at the lab bench: 
 Silicon master 
 1 mm thick PDMS spacer 
 Agarose powder 
 1X PBS 
 Glass slide 
 Small beaker 
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2. Clean the silicon master, spacer, slide, and beaker using 70% ethanol.  If the 
spacer is dusty, clean by gently pressing scotch tape onto it 
3. Place spacer around features in silicon master and press down to seal 
4. Make a 3% agarose solution my mixing 0.3 g of agarose with 10 ml of PBS  
5. Heat the solution in the microwave with occasional mixing (mix by swirling) 
until the agarose is completely dissolved and solution is boiling 
a. NOTE:  Swirl the agarose in the small beaker to prevent bubble 
formation, sometimes boiling the solution can actually decrease the 
amount of bubbles in solution 
6. Pour the hot solution into the spacer and move any bubbles out from between 
the channels using a spatula 
7. Place the glass slide on top of solution in the spacer.  Press down on slide 
evenly to create a flat agarose mold of the microfluidic device features 
8. Transfer the silicon master and agarose mold into the biosafety cabinet 
 
Microfluidic Device Assembly: 
1.  Assemble the following in the biosafety cabinet: 
 Silicon master and agarose mold 
 Plastic tubing punch 
 Plexiglass microfluidic top 
 Stainless steel microfluidic bottom  
 Screws and screw driver 
 Glass slide or polyacrylamide gel on a glass slide seeded with cells 
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 Glass slides for transferring agarose 
 Sterile PBS 
 Large petri dish 
 Thin plastic lifter (can be cut from the bottom of a weigh boat) 
2. Remove slide from the top of agarose mold by sliding it off  
3. Punch holes corresponding to the microfluidic device ports using the plastic 
tubing punch 
a. NOTE:  Make sure to remove the agarose plugs from the mold 
4. Gently lift the agarose mold and spacer off of the silicon master, transfer 
feature-side-up onto a glass slide 
a. NOTE:  I have found it easiest to use the thin plastic lifter with some 
PBS 
5. Transfer mold to another slide so that the feature-side-down 
6. Align the mold ports with the microfluidic top ports and replace the spacer 
around the agarose 
7. Place the slide or polyacrylamide gel that has been seeded with cells in the 
microfluidic bottom 
8. Coat the slide with complete media  
9. Gently lower the agarose and microfluidic top onto the microfluidic bottom 
being careful to avoid bubble formation   
10. Apply gentle and even pressure to the device with one hand and alternate 
putting screws in with the other hand 
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a. NOTE:  do not over-tighten screws or you will collapse the 
microfluidic channels, this is especially important when assembling the 
device on top of a polyacrylamide gel 
11. Check to ensure that the ports are open by using a micropipette to flow 
solution through each of the channels 
12. Ensure that all channels are filled in media, put PDMS filled pipet tip plugs 
into each port, place device in sterile petri dish, and put into 37ᴼC, 5% CO2 
incubator until microscope is ready 
 
**If you are creating a 3D collagen suspension of cells in the center channel, allow the 
device to warm up in the incubator.  Prepare your cells suspension in the neutralized 
collagen solution on ice.  Inject collagen solution into both sides of the center channel.  
Plug channel ports with PDMS filled pipet tips so all collagen flow is stopped.  Place 
the microfluidic device in the incubator, turn device upside down partway through so 
that cells do not all sink to the bottom. 
 
Time Lapse Experiments: 
1. Make tubing for experiment 
a. Generally, 0.25 mm ID tubing should be used.  Most inlet tubing sets 
will be comprised of 3 parts – the peristaltic tubing with another tubing 
section connected to either end to connect to the microfluidic device 
i. Attach the peristaltic pump section to tubing connector sections 
with gel loading pipette tips. 
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ii. Pipette tips should also be used in tubing ends that will connect 
to the microfluidic device 
b. Make outlet tubing for microfluidic device (tubing should have pipette 
tip connector but not be connected to pump for passive outlet flow) 
2. Turn on heat in environmental chamber on microscope 
3. Label tubing with media condition using tape for markers, connect to 
peristaltic pump and place the pump near the back of the environmental 
chamber 
4. Prime tubing with 70% ethanol for ~5 minutes to sterilize 
5. Prime tubing with PBS for ~10 mins to get rid of bubbles and clear out the 
ethanol 
6. Prime tubing with media 
7. Once the environmental chamber is warm and tubing is primed with media 
(just use complete media here), turn the fan down to low and place the 
microfluidic device on the stage 
8. Set up positions and program to run time lapse microscopy 
9. Prime tubing with media of the appropriate condition 
a. Put the media tubes in the environmental chamber so that they will be 
temperature and CO2 controlled throughout the experiment 
b. It is best to run tubing through the sliding doors in the back of the 
chamber 
10. Connect inlet and outlet tubing to microfluidic device 
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a. Outlet tubing should run to a collection vessel outside of the 
environmental chamber 
11. Begin fluid flow at 5 ul/min (~0.66 RPM with 0.25 mm ID tubing) and note 
what time it is.  
12. Re-focus positions for time lapse, begin imaging as optimized for experiment; 
note what time it is relative to the start of the flow. 
 
Time Lapse Notes and Hints: 
 Since the channels are so small, it is extremely important to keep the light 
intensity low so as to not overheat/overexpose the cells.  I used a light intensity 
of ~1.03V with an exposure >1s. 
 Care should be taken to make sure that the device has stable fluid flow (with 
no fluid accumulation) at any of the ports before leaving it on the microscope 
 Keep the culture channel ports plugged with PDMS-filled pipet tips during the 
experiment to avoid media dehydration 
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APPENDIX K 
 
TRANSFECTION OF ENDOTHELIAL CELLS 
 
This protocol has been modified from Joe Califano’s protocol 
 
This procedure can be used for siRNA transfection of endothelial cells (bovine aortic 
or human umbilical vein) 
 
Timeline for siRNA knockdown verification 
Day -1: Plate cells in a vessel 
Day 0:  Transfect cells 
Day 1:  Collect Cell Lysate 
Day 2:  Collect Cell Lysate 
Day 3:  Collect Cell Lysate 
Day 4:  Collect Cell Lysate 
Run Western 
 
Materials: 
 Cells 
 For siRNA: cells in a 6-well dish 60-80% confluent 
 Lipofectamine 2000 
 Optimem 
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 siRNA  
 Sterile 15 mL centrifuge tubes 
 
Optimization Notes: 
 siRNA is administered at 10, 20, 50 pmol per well to optimize concentration 
 3 wells/condition/day of a 6 well plate are lysed for Western blotting 
 Control Fluorescein-conjugated siRNA is used to verify transfection efficiency 
and as knockdown control 
Procedure: 
1. The day before transfection, seed 
 For plasmids: 300k cells/well in a 6-well dish 
 For siRNA: 200k cells/well in a 6-well dish 
The day of transfection (Day 0) 
1. Add 250 L Optimem per well to 2 centrifuge tubes – 1 tube each for siRNA 
and lipofectamine dilutions 
2. Add to the siRNA tube 
 siRNA: 1, 2, or 5 L stock siRNA solution per well —mix and sit 5 
min RT 
 NOTE:  1 L per well of a 10 M stock will be 10 pmol of siRNA 
3. Add to the lipofectamine 
 For siRNA: 6 L Lipofectamine per well and sit 5-15 min RT 
 NOTE: Do not exceed 25 min 
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4. Mix the Optimem tubes together (lipofectamine and siRNA) 
 sit 20 min RT 
5. Was cells gently 2x with Optimem 
6. Add 1.5 mL Optimem to well 
7. Add the ~500 L siRNA/Lipofectamine/Optimem mix to each well (2 mL 
final volume per well) 
 - add dropwise to the well 
- swirl/rock to mix, avoid bubbles 
8. Put in incubator 4-6 h. Check cells every few hours for significant debris or 
vacuole formation 
9. Remove mix, wash 2x with sterile PBS 
10. Replenish fresh media 
 
Days 1-4 
1. Collect cell lysates for Western blot to verify knock down 
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APPENDIX L 
 
CELL INVASION ASSAY 
 
This protocol was developed with Sahana Somasegar 
Materials: 
Collagen solutions and neutralization materials (HEPES buffer solution, 1 N NaOH, 
etc.)  NOTE: see Appendix B 
Activated 96-well glass-bottomed plate (UV sterilize plate after activation for at least 
20 min) NOTE: see Appendix F 
Flask of cells that are ready to passage and appropriate passaging solutions (media, 
trypsin, etc.) 
 
Protocol: 
1. Neutralize collagen gels by adding HEPES and 1 N NaOH to each of the 
collagen gels and mix well (or other buffers according to your protocol) 
2. Pipette 100 μl of collagen gel mixture per well into activated 96-well plate – 
generally seed 6 wells per condition (0mM, 50mM, and 100mM) 
3. Place in 37°C incubator for 30 minutes to allow for collagen polymerization 
4. After 30 minutes, remove plate from incubator, carefully add 100 μl media on 
top of each gel, and place in incubator for another 1 hour to allow gels to 
hydrate. 
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5. During the 1 hour incubation step, passage your cells according to the 
appropriate protocol. 
6. Seed the hemocytometer by adding 10 μl of cell suspension to each side. 
7. Centrifuge the cells for 5 minutes at 1000 rpm  
8. While the centrifuge is running, count the cells using the tissue culture 
microscope and hemocytometer  
9. Determine the amount of media that will need to be added to the cell pellet so 
the density of the cell suspension is 500,000 cells/ml 
10. Remove sample from centrifuge and remove supernatant so that only the cell 
pellet is remaining 
11. Add media so that the cell concentration is 500,000 cells/ml (based on 
hemocytometer count) and mix well 
12. After 1 hour has passed since the 96-well plate was placed in the incubator, 
remove plate and remove media from each well 
13. Pipette 100 μl of the cell suspension solution with into each well 
14. Place in incubator for 24 hours. 
 
Data Collection and Imaging 
15. For the next 5 days, examine the 96-well plate under the microscope at 24 hour 
intervals 
16. When viewing under the microscope, zoom out to the top most layer of the 
microscope and zero the Z value. 
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17. Slowly zoom in, going deeper into the gel, to the last possible point when cells 
are clearly seen in focus. Record Z values for 5 positions within each well – 
left, center, right, top, and bottom of the well.  
18. Record this Z value. 
19. Repeat steps 21-23 every 24 hours for 5 days 
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APPENDIX M 
 
COLLAGEN CONTRACTION ASSAY 
 
Construct Fabrication: 
1.  Assemble the following materials in the biosafety cabinet: 
 16 mm inner diameter silicone O-rings 
 22x22 mm coverslips 
 forceps 
 beaker 
 paper towels (spread across cabinet surface) 
 petri dishes 
 1X sterile PBS  
 2% sterile gelatin in a petri dish 
 70% ethanol 
2.  Place O-rings in the beaker and cover with 70% ethanol, incubate at least 5 
minutes to sterilize. 
3. Aspirate ethanol and rinse the O-rings with the sterile PBS 
4. Place O-rings into 2% sterile gelatin petri dish 
5. Lay out 22x22 mm coverslips on the paper towels 
6. Select an O-ring out of the gelatin with the forceps and place it onto a glass 
coverslip.   
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a. NOTE:  If there is a bubble of gelatin in the middle of the O-ring, pop it 
with a vacuum aspirator.  
7. Repeat step 6 for all O-rings and coverslips. 
8. UV sterilize constructs for at least 30 min 
9. Place 4-5 constructs into each petri dish and incubate them at 4ᴼC for at least 1 
hr or until the gelatin had adhered the O-ring to the coverslip. 
a. NOTE: You can incubate them for up to a few days 
 
Collagen Gel Polymerization: 
1.  Assemble the following materials into the biosafety cabinet. 
 O-ring/coverslip constructs 
 Collagen and neutralization solutions 
 Cell flask and passaging solutions 
 6 well plates 
 forceps 
2. Place 1 construct/well into a 6 well plate 
3. Trypsinize and re-suspend cells to desired concentration in cold media 
a. NOTE:  If using glycated collagen gel protocol, re-suspend cells at 
5,000,000 cells/ml 
4. Neutralize collagen gel solutions according to protocol 
5. Mix cell suspension with collagen solution 
6. Pipet 500 μl of collagen/cells into the middle of the O-ring for each construct 
7. Polymerize collagen for 45 min at 37ᴼC and 5% CO2 
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8. Add 3 ml of complete media/well 
9. Carefully remove O-ring from collagen gel using forceps 
10.  Image the collagen gel in each well with a ruler next to the plate for scaling 
11. Repeat step 10 each day throughout the course of the experiment 
12. To analyze data, measure the area of the gel at each time point and normalize 
to the first time point. 
  
 232 
 
APPENDIX N 
 
ENDOTHELIAL CELL MICROCARRIER BEAD PROTOCOL 
 
Materials: 
Sigmacote 
Glass Bottle 
Cytodex 3 microcarrier beads 
PBS 
Complete Medium 
Cells ready for passage 
Collagen and neutralization solutions 
 
Sterilizing Microcarriers: 
1. Silanize a glass bottle by coating with Sigmacote 
a. Put a small amount (~1 ml) of Sigmacote into the bottle and turned 
bottle so liquid coated all sides of interior 
b. Put excess into other bottle and repeated 
c. Put the bottles into fume hood and allow to dry overnight 
d. Wash the bottles with detergent and water 
2. Suspend beads in PBS to allow them to swell 
a. Want ~10,000 beads/ml 
b. There are ~3,000,000 beads/g 
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c. 
      
     
  
       
         
     
 
                             
3. Autoclave the beads to sterilize and allow to cool before using. 
a. Note: I used a liquid cycle for 32 minutes because of the 500 ml PBS 
 
Seeding Microcarriers: 
1. Wash 1 ml of beads 2X with complete medium. 
a. Resuspend beads by swirling in the PBS prior to aliquoting 
b. Spin beads for 1 min @ 1000 RPM to pellet between washes 
2. Add the 1 ml of beads to a 35 mm petri dish. 
3. Pass cells and resuspend to 500,000 cells/ml. 
4. Add 2 ml of cell suspension to the 35 mm petri dish. (1,000,000 cells/dish; 200 
cells/bead) 
5. Place dish on orbital shaker and gently rock for ~4 hours to allow cells to 
attach. 
6. Remove cells from petri dish and place into centrifuge tube.  Spin for 1 min @ 
1000 RPM. 
7. Resuspend in a fresh media and a new petri dish 
8. Incubate overnight. 
Microcarrier bead coated with 
human umbilical vein endothelial 
cells in a 35 mm petri dish. 
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Suspending Microcarriers in Collagen gels: 
Note:  the microcarrier beads are pretty “heavy” and sink through the collagen gels 
easily.  I found this to be the easiest way to suspend the beads. 
1.  Spin the cells for 1 min @ 1000 RPM.  Resuspend in 1.5 ml  
a. I have found that this density gives me some isolated microcarrier 
beads even though some may be aggregated 
2. Neutralize a tube of collagen. 
3. Pipet 100 μl of collagen per well into a 96-well plate. 
4. Allow collagen to polymerize for ~5 min at 37ᴼC 
5. Neutralize another tube of collagen solution but replace the “media” 
component with the microcarrier bead suspension. 
6. Pipet an additional 50 μl of the microcarrier/collagen solution on top of the 
partially polymerized collagen. 
7. Allow collagen to polymerize for 30 min at 37ᴼC. 
8. Add 200 μl of complete medium to the polymerized gel. 
9. Incubate 1 hour. 
10. Exchange medium for fresh complete medium. 
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APPENDIX O 
 
 
GK-12 TEACHING MATERIALS 
 
O.1 Cornell BME CLIMB Module 
 
Blood Vessel Transport and Tissue Perfusion 
Author:   Brooke N. Mason and Laura V. Austen 
Date Created:  December 2012 
Subject:  Intermediate Level Science 
Level:  Middle/High School (Grade 8-11) 
Standards:  NYS Standards: The Living Environment Core Curriculum 
http://www.p12.nysed.gov/ciai/mst/pub/livingen.pdf 
Standard 1 
Key Idea 1 – Scientific Inquiry:  1.1a, 1.3b 
Key Idea 2 – Scientific Testing:  2.1, 2.3, 2.4 
Key Idea 3 – Analysis of Results:  3.1, 3.3 
Standard 4  
Key Idea 1 – Living Things: 1.2a,b,e,f,g 
Key Idea 5 – Dynamic Equilibrium: 5.2a,h, 5.3a 
Schedule:  2 days, 1-hour periods 
 
 
Objectives: 
     Students will learn about blood 
vessels and the tissue properties that 
influence the exchange of nutrients and 
wastes.   
     Students will also learn about how 
the foods they eat contribute to changes 
in blood sugar.  They will learn to use a 
glucose meter and discuss the changes 
to blood sugar regulation that occur in 
patients with diabetes.   
  
 
Students will: 
 
Vocabulary: 
Circulation 
Perfusion 
Tissue Density 
Hydrogel 
Glucometer 
 
 
Materials: 
For Each Group: 
 
Transport Lab 
•  Petri dishes  
•  Gelatin 
•  Straws 
•  Red food coloring 
•  Paper towels 
•  Pipettes or droppers 
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Transport Lab 
•  Simulate blood vessel perfusion  
•  Quantify the diffusion and describe 
how it will be influenced by tissue 
properties 
•  Predict what would happen if disease 
altered the density of a tissue  
 
Blood Sugar Lab 
•  Test for simple sugars using chemical 
indicators and a glucose meter 
•  Explain diffusion through a membrane  
•  Relate the process of digestion to the 
circulation of sugars in the blood 
•  Predict how foods will influence 
blood sugar levels 
 
•  Rulers 
Blood Sugar Lab 
•  Dialysis tubing 
•  Water, milk, soda, juice, 
sports drink  
•  Beakers 
•  Glucose meter 
•  Glucose meter test strips 
•  Pipettes or droppers 
 
Safety: 
Goggles 
Wash hands after experiments 
 
 
 
Science Content for the Teacher: 
 
Note:  This lab can be used to supplement the knowledge gained the NY State 
Laboratory “Diffusion through a Membrane” or can be used as a stand-alone module 
to discuss the concepts of diffusion and transport within our body. 
 
Part 1 – The transport of molecules and perfusion of tissues via the circulatory 
system 
The process of exchanging of oxygen, carbon dioxide, nutrients, and wastes is called 
tissue perfusion and occurs in small blood vessels called capillaries.  The effective 
perfusion of tissues is dependent upon a variety of factors including the number of 
capillaries, the flow rate of blood through the capillaries, the permeability (or 
leakiness) of the capillaries, and the density of the tissue.  For example, capillaries 
within many solid tumors tend to be leakier that blood vessels in healthy tissues.  This 
leakiness allows excess nutrients to leave the blood vessels and diffuse into the tumor 
tissue and ultimately facilitates tumor growth.  Interestingly, this process may also 
contribute to cancer cell metastasis (cancer cells leaving the tumor, entering the blood 
vessel, and making new tumors in different body sites) because the cells can enter the 
blood vessels easier.    
 
Tissue density is influenced by the amount proteins and other molecules in the space 
surrounding the cells called the extracellular matrix.  Tissue density is influenced by 
the function and type of tissue and can be altered during different diseases such as 
cancer.  These changes in density can have large effects on tissue perfusion and 
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nutrient transfer because it takes longer for molecules to move through tissues of 
increased density.  Since it more difficult to control the leakiness of a classroom-based 
vascular model, this lab focuses on the effects of tissue density on perfusion. 
 
Part 1 – Laboratory Goals and Procedures 
In this inquiry-based laboratory, students will design a set of experiments to test 
properties that influence tissue perfusion.  They will discover and discuss how 
diseases that change the density of tissue influence the ability of blood to perfuse the 
tissue.  Students will cut capillary structures into the tissue construct and then place 
red food coloring (simulating oxygenated blood) into each of the wells.  Students will 
then monitor the experiment, record their results, and analyze the data.   
 
Part 2 – The relationship of the food we eat and blood sugar levels 
When we ingest foods and drinks, they enter into the digestive system and are 
eventually converted into the nutrients our cells need to survive. What we eat directly 
influences the nutrients our body receives, uses, and stores as fat.  The process of 
digestion breaks down all of the usable nutrients from what we ingest so the 
nutritional content of the food we eat is very important.  Generally, people should eat 
foods that are low in oils and fat and high in vegetable and fruit content with moderate 
protein and grain intake.  Sugars can provide people with the energy they need to be 
active but, if people eat and drink too much sugar, the excess will be converted to 
glycogen or fatty acids and stored within the body.   
 
People with diabetes must be especially careful about the amount of sugar they ingest 
because they do not produce enough insulin or are resistant to the insulin they do 
produce.  In addition to controlling their dietary intake and exercising, diabetic 
patients also use insulin therapy to control their sugar levels.   The most common way 
to measure the amount of sugar in the blood is to use a small device called a 
glucometer (or glucose meter) with a small drop of blood from a pricked finger. 
 
Part 2 – Laboratory Goals and Procedures 
In this laboratory, students will investigate how different drinks can influence blood 
sugar levels.  Students will simulate the absorbance of nutrients into the blood stream 
from different liquids using dialysis tubing filled with fluid to model the blood vessel.   
They will test the amount of glucose that has entered the blood vessel using a glucose 
meter and compare between the conditions they chose. 
 
 
Preparation: 
 
Pre-lab lecture:  A day before the lab, the teacher should introduce the students to the 
concepts of diffusion, circulation, digestion, and transport.  Students should 
understand the basic principles of how the circulatory and digestive systems are 
related to each other.   
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Part 1:  Transport 
Materials 
• 2 petri dishes per group (at least 1 for each student) 
• 2%, 5%, and 15% (w/v) gelatin solutions 
• Straws (McDonald’s straws work well) 
• Red food coloring 
• Paper towels 
• Pipettes or droppers 
• Rulers 
 
Prepare Petri Dishes 
At least 1 day prior to the laboratory, instructors should: 
1. Dissolve gelatin in water to create 2%, 5%, and 15% solutions.   
Note: The water may need to be heated to get the gelatin to dissolve completely 
2. Pour gelatin into petri dishes and allow the gelatin to set in the refrigerator. 
Make sure to label the petri dishes with the % gelatin. 
 
Transport Laboratory  
Split the students into groups of 2-3 
 
(Day 1) 
1. Decide on gelatin density and vessel layout:  Each group must decide which 
2 gelatin conditions they will use and should determine the layout they plan to 
use for their vessel structures.   
Note:  If you are using having the students use the associated worksheet, they should 
complete Part 1, Questions #1-4. 
 
2. Cut the blood vessels:  Students should punch their capillary structures into 
the gelatin (tissue construct) using a straw or biopsy punch.  Ensure that the 
gelatin is completely removed from the center of the well and then have the 
Figure 1.  Example experimental setup 
and qualitative results of the transport 
laboratory.  As the density of the gelatin 
increases, the amount of diffusion is 
decreased over the course of 24 hours. 
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students place 1 drop of red food coloring into each of the wells that are 
created.   
 
3. Measure the diffusion of the food coloring from the wells:  Students should 
measure the amount of diffusion that has occurred immediately after placing 
the food coloring in the wells and at the end of the first lab period.     
Note:  If you are using having the students use the associated worksheet, they should 
complete Part 1, Question #5. 
 
4. Label petri dishes and store overnight:  Students should label their petri 
dishes and they should be stored in the refrigerator overnight so that the 
students can make observations during the next lab period. 
 
(Day 2) 
5. Measure the diffusion of the food coloring from the wells:  Students should 
measure the amount of diffusion that has occurred during the second lab 
period.     
Note:  If you are using having the students use the associated worksheet, they should 
complete Part 1, Question #6. 
 
6. Compiling results and conclusions:  Students should compile their results 
and graph the diffusion for the different density gels over time.  They should 
draw conclusions from their data and discuss how changes in the density of 
tissues could influence overall perfusion. 
Note:  If you are using having the students use the associated worksheet, they should 
complete Part 1, Questions #7-11. 
 
Part 2:  Blood Sugar 
Materials 
• Dialysis tubing 
• Water, milk, soda, juice, and sports drink  
• Beakers 
• Glucose meter 
• Glucose meter test strips 
• Red food coloring 
• Pipettes or droppers 
• Toothpicks  
 
Prepare Dialysis Tubing and Drinks 
Prior to the laboratory, instructors should: 
1. Prepare dialysis tubing by cutting it into ~15-20 cm long segments.  Place the 
dialysis tubing in a beaker of water to allow it to hydrate and facilitate 
handling. 
2. Every brand of glucose meter is different.  Instructors should determine the 
amount of dilution that is needed for the glucose meter to measure the amount 
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of sugar in the drink with the highest sugar content.  All other drinks should be 
diluted by the same amount (i.e. 100 ml into 1 L of water) such that the 
glucose meter will read the amount of sugar in all drinks and the measurements 
scale to the original sugar content of the drinks. 
3. Prepare a beaker of water with red food coloring to simulate the blood.  
 
Blood Sugar Laboratory 
Split the students into groups of 2-3 (can be same as the groups used above) 
 
1.  Decide on drink selection:  Students should choose 2 drink conditions that 
they would like to test.   
Note:  If you are using having the students use the associated worksheet, they should 
complete Part 2, Questions #1-4. 
 
2. Create Blood Vessels:  Students should create their blood vessels from the 
dialysis tubing.  Each student group should take 2 pieces of dialysis tubing and 
make a tight knot at one end of the tubing.  They should next use the 
pipettors/droppers to fill the dialysis tubing with red colored water and tie off 
the other end of the dialysis tubing in a tight knot.   
 
3. Expose the vessels to the different liquids:  Students should place each of 
their dialysis tubing blood vessels into separate beakers and add their chosen 
liquid solution to the beaker until it just covers the blood vessel. 
 
4. Measure the “blood sugar”:  Towards the end of the class period (or at least 
30 minutes after the vessels have been placed in the different liquids), students 
should make qualitative observations about the blood vessels in the beakers 
(i.e. the blood has diffused out of the vessel because we can see the red color in 
the rest of the liquid).  Students should then remove their vessels from the 
beakers and rinse them briefly in water.  They should prepare the glucose 
meter with a test strip, puncture the dialysis tubing with a toothpick, and place 
a small amount of the liquid from inside the tubing onto the test strip. 
Note:  If you are using having the students use the associated worksheet, they should 
complete Part 2, Question #5. 
 
5. Recording results and conclusions:  Students should record the quantitative 
measurements from the glucose meter, compare between the conditions they 
chose, and draw conclusions.  Instructors should facilitate a class discussion 
about all of the different conditions in class and ask the students to relate how 
the different drinks tested changed the blood sugar conditions.  They should 
speculate as to how their results relate to overall health and nutrition.  
Note:  If you are using having the students use the associated worksheet, they should 
complete Part 2, Questions #5-8. 
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Classroom Procedure: 
 
Engage (Time: 20 min over 2 days) 
 
Introduce the lab by going over the information in the “Circulatory System 
Worksheet” and discussing the general procedure that they will be using.  Explain to 
the students that they are using the same scientific process as real researchers and will 
be testing their own hypotheses, developing their own protocols, and collecting their 
own data. 
 
Explore (Time: 70 min over 2 days) 
 
Allow the students to work through the “Circulatory System Worksheet.”  Students 
should discuss their hypotheses with their lab group and develop methods to test their 
hypotheses.  Instructors should move from group-to-group and check to make sure that 
the methods they have chosen are appropriate for the experiment but should not give 
them specific methods to perform.  Once the instructor has checked to make sure that 
they are on the right track, students should start the experiments and complete their 
worksheet. 
 
Explain (Time: 20 min over 2 days) 
 
Work with the students to help them answer critical thinking questions and discuss 
data that their classmates have obtained.  Ask the students to discover the overall 
trends and results of the experiment. 
 
Expand (Time: 10 min over 2 days) 
 
Discuss the implications of their findings to overall human health and disease and 
relate the information they gathered to other material covered in the class.  Ask 
students how they would change their experimental methods if they were to run the 
experiment again. 
 
 
Assessment:  
 
The following rubric can be used to assess students during each part of the activity. 
The term “expectations” here refers to the content, process and attitudinal goals for 
this activity. Evidence for understanding may be in the form of oral as well as written 
communication, both with the teacher as well as observed communication with other 
students. Specifics are listed in the table below. 
1= exceeds expectations  
2= meets expectations consistently  
3= meets expectations occasionally  
4= not meeting expectations 
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 Engage Explore Explain Expand/Synthesis 
1 
Shows high 
level of 
interest in the 
material, asks 
thoughtful 
questions 
relevant to 
the material 
Prepares the lab 
well, is able to take 
accurate 
measurements and 
provide in-depth 
observations.  Data 
is well organized 
and student 
constructs several 
plots clearly 
expressing data 
trends 
Provides 
thoughtful, 
detailed answers to 
discussion and 
worksheet 
questions, and is 
able to clearly see 
correlations 
between data 
trends and 
overarching 
themes of diffusion 
and transport 
concepts. 
Integrates knowledge 
gained from the 
experiment and asks 
questions that 
demonstrate deep 
understanding of the 
concepts as they 
relate to overall 
human health 
2 Shows 
interest in the 
material, 
participates in 
the discussion 
while 
attempting to 
understand 
key concepts 
Well organized 
and on-task and 
takes some 
measurements but 
needs some 
assistance to get 
started plotting 
data 
Takes part in 
discussion and 
provides correct 
answers to 
worksheet 
questions 
Understands the 
concepts being 
discussed and asks 
questions that 
demonstrate a basic 
understanding of how 
they relate to human 
health 
3 
Minimal 
discussion 
and 
participation 
but is on-task 
and is able to 
understand 
the concepts 
and material 
Needs assistance 
on some parts of 
the lab but is 
making an effort to 
participate, 
attempts to take 
measurements and 
plots data but 
needs some help 
Makes minimal 
effort to join 
discussion, 
provides answers 
to mostly correct 
answers to 
worksheet with a 
few minor 
misconceptions 
still evident 
Minimal integration 
of knowledge from 
laboratory with 
concepts of human 
health 
4 Does not take 
interest in the 
material and 
refuses to 
take part in 
the discussion 
Does not 
participate in the 
experiments and 
does not attempt to 
understand 
concepts 
No effort is made 
in the discussion, 
the worksheets are 
incomplete or 
incorrectly 
completed 
No effort to 
understand how the 
concepts from the 
laboratory are related 
to course material 
 
Extension Activities: 
Part 1 – Transport 
Additional demo materials can be made and used during the explore portion of this 
activity: 
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1. Extra petri dishes can be provided to the students and instructors can allow 
them to create artistic designs with the wells and different color food coloring.  
These can be observed over the course of the experiments to reinforce the 
concepts of diffusion and tissue perfusion. 
2. Blood vessels made of dialysis tubing can be encapsulated within gelatin (clear 
plastic containers work well).  The dialysis tubing can be filled with a 
concentrated solution of red food coloring and water (note, it should be filled 
during gelation so that it doesn’t collapse and such that fluid can be pushed 
through).  Students can observe how the food coloring diffuses out of the 
dialysis tubing in 3D, similarly to how it would occur in the body. 
 
Part 2 – Blood Sugar 
Additional demo materials can be made and used during the explore portion of this 
activity: 
1. The nutritional information on the beverages can be used to determine the total 
amount of sugar per volume of the drinks.  White sugar can be weighed out 
into bags and used visually illustrate the differences in sugar content between 
the drinks. (i.e. weigh out the amount of sugar per liter of each beverage into 
separate bags to show the students during the discussion section) 
 
Supplemental Information: 
Circulatory System Pre-Test 
Circulatory System Pre-Test Answers 
Circulatory System Worksheet 
 
Safety:  
 Safety goggles while in the laboratory. 
 While all the laboratory chemicals used are non-toxic, all direct contact with 
them should be avoided. 
 Students should be careful not to cut themselves when puncturing the dialysis 
tubing with the toothpick in the blood sugar laboratory.  Instructors may want 
to assist their students with this procedure.     
 Do not eat or drink in the laboratory. 
 Everyone should wash their hands and work area when completed with the 
laboratory experiments or before leaving the classroom. 
 
Acknowledgments: 
Shivaun Archer, Chris Schaffer, and Cynthia Reinhart-King, Department of  
Biomedical Engineering, Cornell University  
Nev Singhota, Cornell Center for Materials Research  
National Science Foundation Cornell GK-12 Program: DGE 0841291  
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O.2  Circulatory System Pre-Test             Name:_____________________________ 
 
Fill in the blank 
 
1.  _______________________ is the process in which blood vessels exchange 
nutrients and oxygen in tissues. 
 
2.  _______________________ is one of the primary components of the 
extracellular matrix. 
 
3. _______________________ is can be used to model tissue structures and is 
primarily composed of denatured collagen. 
 
Multiple Choice:  Choose the correct answer(s) 
 
4. ______________________ are the primary blood vessel structures that 
exchange nutrients and wastes in tissues. 
a. arteries 
b. veins 
c. capillaries 
d. ventricles 
 
5.  Blood brings ___________________ to cells in the body and removes 
_____________________  ___________________ that have accumulated 
within the cells. 
a. oxygen 
b. carbon 
dioxide 
c. sugar 
d. toxins 
 
Circle True/False for the following questions. 
 
6. True or False:  The number of blood vessels is the only important factor in 
getting nutrients to tissues. 
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7. True or False:  What we eat and drink influences the amount of sugar in our 
blood. 
 
 
Short Answer: be sure to write your response in complete sentences. 
8.  How does the density of the tissue influence perfusion? 
 
 
 
 
 
 
9. What structures absorb nutrients from the digestive system and transport them 
to tissues?  
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10.  The diffusion of nutrients through tissues can be simulated by watching the 
diffusion of food coloring through a hydrogel.  The distance of diffusion has 
been measured using a ruler on the diagram below.  Graph the amount of 
diffusion occurring over time. 
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O.3 Circulatory System Pre-Test Answer Sheet 
 
Fill in the blank 
 
1.  _Perfusion or Transport or Diffusion_ is the process in which blood vessels 
exchange nutrients and oxygen in tissues. 
 
2.  __Collagen___________________ is one of the primary components of the 
extracellular matrix. 
 
3. __Gelatin____________________ is can be used to model tissue structures 
and is primarily composed of denatured collagen. 
 
Multiple Choice:  Choose the correct answer(s) 
 
4. __C, Capillaries___________________ are the primary blood vessel 
structures that exchange nutrients and wastes in tissues. 
e. arteries 
f. veins 
g. capillaries 
h. ventricles 
 
5.  Blood brings _A, Oxygen and C, Sugar________ to cells in the body and 
removes _B, Carbon Dioxide and D, Toxins______ that have accumulated 
within the cells. 
e. oxygen 
f. carbon 
dioxide 
g. sugar 
h. toxins 
 
Circle True/False for the following questions. 
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6. True or False:  The number of blood vessels is the only important factor in 
getting nutrients to tissues. 
There are many other factors that are important including the density of the 
tissue, the flow rate of blood through the capillaries, and the 
permeability/leakiness of the endothelial cell layer that makes up the capillaries. 
 
7. True or False:  What we eat and drink influences the amount of sugar in our 
blood. 
 
Short Answer: be sure to write your response in complete sentences. 
8.  How does the density of the tissue influence perfusion? 
Oxygen and nutrients will diffuse a shorter distance in a tissue that is more dense 
 
9. What structures absorb nutrients from the digestive system and transport them 
to tissues?  
Nutrients are absorbed by the capillaries in the digestive system and transported 
throughout the rest of the body.  
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10.  The diffusion of nutrients through tissues can be simulated by watching the 
diffusion of food coloring through a hydrogel.  The distance of diffusion has 
been measured using a ruler on the diagram below.  Graph the amount of 
diffusion occurring over time. 
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Alternate question that could be used. 
1. Use numbers to order the following steps in the scientific method (1 is the first 
step, 8 is the last step). 
___1_ Define Problem 
___8_ Redesign experiment and repeat process 
___7_ Develop conclusions 
___2_ Learn about the topic 
___3_ Develop a hypothesis 
___5_ Gather Data and Results 
___4_ Design Experiment 
___6_ Interpret results 
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O.4 Circulatory System Worksheet            Name:____________________________ 
 
Lab #_______________ 
 
Part 1 – The transport of molecules and perfusion of tissues via the circulatory 
system 
Circulation is the term used to describe the movement of blood through tube-like 
structures in the body called blood vessels.  There are two primary categories of blood 
vessels:  arteries and veins.  Arteries transport blood away from the heart and carry 
oxygen and nutrients to the rest of the body and veins transport blood to the heart and 
help carry carbon dioxide and wastes away from the cells.  The two exceptions to this 
are the pulmonary artery, which carries deoxygenated blood to the lungs, and the 
pulmonary vein, which carries oxygenated blood back to the heart.  The process of 
exchanging of oxygen, carbon dioxide, nutrients, and wastes is called tissue perfusion 
and occurs in small blood vessels called capillaries.   
 
The effective perfusion of tissues is dependent upon a variety of factors including the 
number of capillaries, the flow rate of blood through the capillaries, the permeability 
(or leakiness) of the capillaries, and the density of the tissue.  Tissue density is 
influenced by the amount proteins and other molecules in the space surrounding the 
cells called the extracellular matrix.  Tissue density is influenced by the function and 
type of tissue and can be altered during different diseases such as cancer.  These 
changes in density can have large effects on tissue perfusion.   
 
In animals, the most abundant protein component of tissues and the extracellular 
matrix is collagen.  Collagen can be isolated from tissues and is commonly used to 
create hydrogels (a gel-like polymer that contains a high amount of water) for tissue 
engineering and research purposes.    Gelatin is a made of denatured collagen can 
form a hydrogel when it is mixed with water and can be used to model tissue 
structures.  
 
Laboratory Goals and Procedures 
In this inquiry-based laboratory, you will design a set of experiments to test properties 
that influence tissue perfusion.   Your goal is to perfuse the entire tissue construct (a 
gelatin coated petri dish) with the least number of capillaries (modeled by punching 
holes into the gelatin).  You and your partner(s) will choose 2 tissue constructs that 
have been coated with a 2%, 5%, or 15% gelatin solution and determine the number of 
capillaries you think will be necessary to perfuse the entire tissue.  You will cut your 
capillary structures into the tissue construct using a straw or biopsy punch and then 
place 1 drop of red food coloring (simulating oxygenated blood) into each of the wells 
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you create.  You will monitor your experiment, record your results, and analyze your 
data.   
 
Objectives 
By the end of this laboratory, you should be able to:  
 measure and graph the diffusion properties for tissues of different densities 
 describe how the density and porosity of a tissue will influence diffusion 
 predict what would happen if the density of a tissue were to be altered (as in 
some diseases) 
 
Materials 
 35 mm petri dishes coated with 
2%, 5%, or 15% gelatin 
 6 mm biopsy punch or straw 
 red food coloring 
 paper towels 
 pipettes or droppers 
 
Safety 
 Wear safety goggles while in the laboratory. 
 While all the laboratory chemicals used today are non-toxic, all direct contact 
with them should be avoided.  The food coloring will stain.   
 Do not eat or drink in the laboratory. 
 Wash your hands and work area when completed with the laboratory 
experiments or before leaving the classroom. 
 
 
1.  State the objective of this experiment.  What problem are you trying to 
examine or solve? 
 
_____________________________________________________________________ 
  
_____________________________________________________________________ 
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2.  Propose a hypothesis.  What do you think is going to happen during your 
experiment? 
 
_____________________________________________________________________ 
 
 
_____________________________________________________________________ 
 
3.  How will you test your hypothesis?  Write down your methods and fill in 
the diagrams with your proposed capillary layout (include the density of 
the gelatin you will test, how many capillaries you will make in each dish, 
where you will put the capillaries, etc.) 
 
 
 
 
 
 
 
  
 
 
 
Write down the details of your methods here: 
 
_____________________________________________________________________ 
 
 
_____________________________________________________________________ 
 
 
_____________________________________________________________________ 
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4. What method will you use to determine the extent of diffusion that occurs 
from the capillaries into your tissue constructs?  How do you plan to 
measure the differences in diffusion between tissue constructs of different 
densities? 
 
_____________________________________________________________________ 
 
 
_____________________________________________________________________ 
 
5.  What are your initial (day 1) results and observations? 
 
Sample Density Observations 
Measurement of 
Perfusion 
Other 
    
    
 
Use the diagram below to draw your samples: 
 
 
 
 
 
 
 
 
 
6.  What are your final (day 2) results and observations? 
 
Sample Density Observations 
Measurement of 
Perfusion 
Other 
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Use the diagram below to draw your samples: 
 
 
 
 
 
 
 
 
 
7.  Plot your results on the following graph.  Be sure to put a title on the 
graph and label the axes.  (Hint, use a line graph with a legend to plot the 
two different conditions over time) 
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8. What conclusions can you draw from your results? 
 
 
_____________________________________________________________________ 
 
 
_____________________________________________________________________ 
 
9. In the body, how could changing the density of your tissues change the 
diffusion of nutrients into the tissue? 
 
 
_____________________________________________________________________ 
 
 
_____________________________________________________________________ 
 
10.  If the density of your tissues were to increase, what could you do to make 
sure that it remains well-perfused?  (Hint:  What could you change about 
your blood vessels so that they could perfuse the tissue more effectively?) 
 
_____________________________________________________________________ 
 
 
_____________________________________________________________________ 
 
 
_____________________________________________________________________ 
 
11. What other physical factors are present in the vasculature that could 
influence the perfusion of tissues? 
 
_____________________________________________________________________ 
 
 
_____________________________________________________________________ 
 
_____________________________________________________________________  
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Part 2 – The relationship of the food we eat and blood sugar levels 
When we ingest foods and drinks, they enter into the digestive system and are 
eventually converted into the nutrients our cells need to survive. The foods in our diet 
are mechanically degraded into smaller molecules in our mouth and stomach and 
chemical degradation is initiated.  Once the food leaves the stomach (as a thick 
mixture called chyme) and enters the small intestine, the majority of chemical 
digestion occurs and the nutrients begin to be absorbed directly into the blood 
stream.  Once in the blood, those nutrients travel throughout the whole body and are 
delivered to the cells via perfusion from capillaries.   
 
What we eat directly influences the nutrients our body receives, uses, and stores as fat.  
The process of digestion breaks down all of the usable nutrients from what we ingest 
so the nutritional content of the food we eat is very important.  Generally, people 
should eat foods that are low in oils and fat and high in vegetable and fruit content 
with moderate protein and grain intake.  Sugars can provide people with the energy 
they need to be active but, if people eat and drink too much sugar, the excess will be 
converted to glycogen or fatty acids and stored within the body.   
 
People with diabetes must be especially careful about the amount of sugar they ingest 
because they do not produce enough insulin or are resistant to the insulin they do 
produce.  In addition to controlling their dietary intake and exercising, diabetic 
patients also use insulin therapy to control their sugar levels.   The most common way 
to measure the amount of sugar in the blood is to use a small device called a 
glucometer (or glucose meter) with a small drop of blood from a pricked finger. 
 
Laboratory Goals and Procedures 
In this laboratory, you will investigate how different drinks can influence blood sugar 
levels.  You and your partner(s) will simulate the absorbance of nutrients into the 
blood stream from different liquids using dialysis tubing filled with fluid to model the 
blood vessel.   You will choose 2 different types of drinks (water, milk, soda, juice, or 
sport’s drink) and put them into a beaker.  To complete the setup, you will add a blood 
vessel made out of dialysis tubing and allow the nutrients to diffuse into the vessel.  
After about 1 hour, you will test the amount of glucose that has entered the blood 
vessel using a glucose meter and compare between the conditions you chose. 
 
Objectives 
By the end of this activity, you should be able to:  
 demonstrate how to test for simple sugars using chemical indicators and a 
glucose meter 
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 explain diffusion through a membrane simulating the vascular wall 
 relate the process of digestion to the circulation of simple sugars in the blood 
stream 
 predict how foods will influence blood sugar levels 
 
Materials 
 dialysis tubing 
 water, milk, soda, juice, sports 
drink  
 beaker 
 glucose meter 
 glucose meter test strips 
 pipettes 
Safety 
 Wear safety goggles while in the laboratory. 
 While all the laboratory chemicals used today are non-toxic, all direct contact 
with them should be avoided.   
 Do not eat or drink in the laboratory. 
 Wash your hands and work area when completed with the laboratory 
experiments or before leaving the classroom. 
 
1. State the objective of this experiment.  What problem are you trying to 
examine or solve? 
 
_____________________________________________________________________ 
 
 
_____________________________________________________________________ 
  
2.  Propose a hypothesis.  What do you think is going to happen during your 
experiment? 
 
_____________________________________________________________________ 
 
 
_____________________________________________________________________ 
 
  
  
 259 
 
3. How will you test your hypothesis?  Write your methods here. 
 
 
_____________________________________________________________________ 
 
 
_____________________________________________________________________ 
 
4. What method will you use to compare the amount of blood sugar that 
diffuses into you blood vessel from the test solution? 
 
 
_____________________________________________________________________ 
 
 
_____________________________________________________________________ 
 
 
5. What are your results and observations? 
 
Test Solution Observations 
Blood Sugar 
Measurement 
Other 
    
    
 
 
_____________________________________________________________________ 
 
 
_____________________________________________________________________ 
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6. Plot your results on the following graph.  Be sure to put a title on the 
graph and label the axes.  (Hint, use a bar graph to plot the two different 
conditions) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
7. What conclusions can you draw from your results? 
 
 
_____________________________________________________________________ 
 
 
_____________________________________________________________________ 
 
 
 
8. People with diabetes must maintain their blood sugar at a relatively 
constant level and avoid large changes in blood sugar.  Based on your 
data, what drinks should diabetics avoid? 
a. water 
b. milk 
c. juice 
d. sports drinks 
e. soda  
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O.5  Turkey Time Lesson Plan 
 
Background: 
Food scientists and nutritionists investigate the properties of the food that we eat and 
design meals that contain the essential vitamins and nutrients that our bodies need to 
function properly.  Generally, people should eat foods that are low in oils and fat and 
high in vegetable and fruit content with moderate protein and grain intake.  
ChooseMyPlate is a tool designed by nutritionists to help people determine the 
proportion of foods they should be eating to stay healthy.  The diagram below shows 
the approximate breakdown and recommended intake of the primary food groups. 
 
 
Project Motivation and Goals: 
Thanksgiving dinner is delicious tradition but recent studies have found that the foods 
served during the holiday season can lead to weight gain, increased risks of cardiac 
events, and an overall decrease in health.   You are a nutritional scientist at Good Food 
for You, a company that is responsible for creating and distributing healthy, well-
balanced meals.  Good Food for You is competing against other companies to win the 
rights to provide meals for next year’s Thanksgiving meal and will be judged on the 
quality and composition of the food you produce.  Before you send off samples of 
food to the national competition, you decided it would be a good idea to test the food 
you make to determine what it is comprised of.  Your goal is to determine what is 
currently in the foods you produce and modify them to create a healthy, well-balanced 
meal so that you can win the competition. 
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Note:  Much of the following information has been taken from or adapted from: 
http://www.accessexcellence.org/pizza/pdf/fcbook.pdf 
Food Chemistry Experiments; Institute of Food Technologists. The Society for Food 
Science and Technology. 
 
Definitions and Vocabulary: 
Polymers (the prefix “poly” means many) contain two or more monomers. Starch is a 
polymer of the monomer glucose.  Protein is a polymer of amino acids. 
 
Glucose is a simple sugar and the primary source of energy for all mammals and many 
plants.  It is also known as dextrose, grape sugar, and corn sugar.  The chemical 
structure is C6H12O6 and a diagram of the molecule is shown below (Figure 1).   
 
Figure 1:  This ball and stick diagram depicts a molecule of glucose. 
Carbohydrates/Starches: 
Polysaccharides are formed when many single sugars are joined together chemically. 
Polysaccharides include starch, glycogen (storage starch in animals), cellulose (found 
in the cell walls of plants), and DNA. 
 
Starch is the predominant storage molecule in plants and provides the majority of the 
food calories consumed by people worldwide.  Starch is a polymer of simple sugar 
molecules such as glucose (see above).  Animals store energy in the muscles and liver 
as glycogen (a storage starch in animals).  For longer-term storage, animals convert 
the food calories from carbohydrates to fat.   
 
Figure 2:  This ball and stick diagram depicts starch.  Starch is a polysaccharide 
formed from multiple monosaccharides. 
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Lipids and Fatty Acids:  
Lipids include fats, oils, waxes, cholesterol, other sterols, and most steroids.  Lipids 
are biologically important for making barriers (membranes of animal cells), which 
control the flow of water and other materials into a cell.  
 
Fats and oils make up 95% of food lipids and phospholipids, and sterols make up the 
other 5%.  Animal fats are found in meats (beef, chicken, lamb, pork, and veal), milk 
products, eggs, and seafood (fish oil).  Plant (vegetable) oils come from nuts (peanuts), 
olives, and seeds (soybean, canola, safflower, and corn).  We use lipids for flavor 
(butter and olive oil), to cook foods (oils and shortening), to increase the palatability 
of foods by improving the texture or “mouthfeel” (cakes, creamy ice cream), and in 
food processing (emulsifiers).  
 
Fatty acids are generally long, straight chains of carbon atoms with hydrogen atoms 
attached (hydrocarbons) with a carboxylic acid group (COOH) at one end and a 
methyl group (CH3) at the other end (Figure 2). These long, straight chains combine 
with the glycerol molecule to form lipids. 
In the body, fat serves as a source of energy, a thermal insulator and cushion around 
organs, and an important cellular component.  Since fats have 2.25 times the energy 
content of carbohydrates and proteins, most people try to limit their intake of dietary 
fat to avoid becoming overweight.  The food industry has a big market for low-fat and 
non-fat foods.   
 
 
Figure 3:  This ball and stick diagram depicts stearic acid.  It is a saturated fatty acid 
found in foods from animal and plant sources. 
Amino Acids and Proteins: 
Amino acids contain carbon, hydrogen, nitrogen, and sometimes sulfur and serve as 
the monomers for making peptides and proteins.  Amino acids have a basic structure 
that includes an amino group (NH2) and a carboxyl group (COOH) attached to a 
carbon atom (see Figure 1A).  This carbon atom also has a side chain (an “R” group).  
This side chain can be as simple as an -H or a -CH3, or even a benzene group.  
 
There are twenty amino acids found in the body.  Eight of these amino acids are 
essential for adults and children, and nine are essential for infants.  Essential means 
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that we cannot synthesize them in adequate quantities for growth and repair of our 
bodies, and therefore, must be included in the diet.  
Amino acids are linked together by a peptide bond in which the carboxyl carbon of 
one amino acid forms a covalent bond with the amino nitrogen of the other amino acid 
(see Figure 1B).  Short chains of amino acids are called peptides.  Longer chains of 
amino acids are called polypeptides 
 
 
Figure 4:  This ball and stick diagram depicts lysine, an essential amino acid we must 
get from our diet. 
Proteins are complex polymers composed of amino acid monomers, and are 
considered to be the primary structure of all living organisms.  Some examples of 
protein are muscle, hair, skin, hormones, and enzymes.  Body builders and football 
players eat a lot of protein (eggs, cheese, and meat) to build muscle mass.  You have 
probably seen protein-enriched drinks and protein-enriched foods (power bars) at the 
supermarket.  
 
Proteins are the most complex and important group of molecules because they possess 
diverse functionality to support life.  Every cell that makes up plants and animals 
requires proteins for structure and function.   
 
Figure 5:  This complex ball and stick diagram depicts the structure of DNA.  Notice 
that the structure is much more complex than a single amino acid. 
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Methods for Analyzing Food Components: 
1.  Testing for Glucose – Benedict’s Test 
How the Benedict’s Test Works 
Benedict Solution is light blue because it contains copper sulfate. When it is mixed 
and heated with a sugar, such as glucose, which has electrons available to donate, the 
copper will accept the electrons and become reduced, which turns it brownish-orange. 
During this process, the blue copper (II) ion is reduced to a red copper (I) ion. While 
the copper is being reduced, the glucose gives up an electron and is oxidized. Because 
glucose is able to reduce the copper in Benedict Solution, we call it a reducing sugar. 
 
Reducing Sugars 
Glucose is not the only reducing sugar. Any sugar that is structurally capable of 
donating electrons to Benedict Solution (or a similar reagent) falls into this category. 
Aldehyde-based sugars that are in their linear, acyclic form are able to donate 
electrons and reduce other molecules. Some sugars are "locked" into their cyclic form 
and structurally unable to open into their linear form. These are most commonly non-
reducing sugars. Other examples of reducing sugars include ribose and sucrose. 
 
Uses 
The most common use for Benedict Solution is the detection of glucose in urine for 
the diagnosis of diabetes. Diabetics excrete glucose into their urine because they are 
unable to properly absorb it into their cells. After a positive diagnosis, additional tests 
are needed to quantify the amount of glucose excreted. 
 
Method 
1.  Fill a test tube with a few ml of your test solution and add an equal amount of 
Benedict's Solution (20 drops of your test solution + 20 drops of Benedict’s 
Solution).  
2. After briefly mixing, heat the tube for a few minutes in the hot water bath. 
3. Determine if your test is positive or negative.  A positive result will produce a 
brownish-orange precipitate and a negative result will produce no change to 
the solution. If your tube turns a muddy green, your initial glucose 
concentration was likely so low that only some of the blue copper (II) ions 
reacted (this is still considered a positive test). 
 
Read more: The Effect of Benedict Solution on Glucose 
http://www.ehow.com/about_6584528_effect-benedict-solution-glucose.html 
  
2. Testing for Protein – Biuret Test 
How the Biuret Test Works 
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The Biuret solution is a mixture of 5% copper(+2) sulfate in 10% sodium hydroxide.  
Substances containing two or more peptide bonds (three or more amino acids) form a 
purple-violet complex with copper salts in alkali solution.  The nature of the color is 
probably due to the formation of a tetra-coordinated cupric ion (Cu+2) with amino 
groups (the Cu+2 ion is surrounded by amino groups). A light blue color indicates a 
negative response, a purple/violet color a positive response. 
 
Uses 
The Biuret test can be used to detect the presence of proteins in a solution.  The Biuret 
test can also be used to quantify the amount of proteins used in a solution when used 
with a spectrophotometer. 
 
Method 
1. Fill a test tube with a few ml of your test solution and add an equal amount of 
Biuret Solution (20 drops of your test solution + 20 drops of Biuret Solution).  
2. Swirl mixture to mix and allow the mixture to stand for 5 minutes. 
3. Determine if your test is positive or negative.  A positive result will produce a 
pink or purple solution and a negative result will produce no change to the 
solution.  
 
Read more about the Biuret Test 
http://www.brilliantbiologystudent.com/biuret_test.html 
 
3.  Testing for Starch – Iodine Test 
How the Iodine Test Works 
A complex interconnected series of sugar molecules (saccharides) comprise starch 
molecules. To test for the presence of these polysaccharides (many sugar) structured 
starches you will need iodine. The iodine acts as an indicator, changing color when it 
combines with starches. A color change occurs from the complex network of starches 
trapping the iodine molecules, revealing a blue-black color. The iodine will not change 
color in reaction to simple sugars, such as sucrose or fructose, because these do not 
retain iodine between the sugar molecules the way starches do. 
 
Uses 
The Iodine test can be to test for the presence of starch within food samples.   
 
Method 
1. Fill a test tube with a few ml of your test solution and add an equal amount of 
Iodine (20 drops of your test solution + 20 drops of Iodine).  
2. Swirl mixture to mix and allow the mixture to stand for 5 minutes. 
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3.  Determine if your test is positive or negative.  A positive result will produce a 
dark blue-black solution and a negative result will produce no change to the 
solution (it will remain an amber color).  
 
Read more: How to Test Yogurt for Starch With Iodine  
http://www.ehow.com/how_5682963_test-yogurt-starch-iodine.html#ixzz2BkLPp0sQ 
 
4.  Testing for Lipids – Paper towel or “floating” test 
How the Paper Towel test Works 
The Grease Spot test can also be used identify the presence of lipids in a sample. 
Lipids make unglazed paper, such as the outside of a paper bag, translucent. 
 
How the Floating Test Works 
Lipids do not dissolve in water since lipids are nonpolar molecules.  When water and 
lipids are mixed together, the two solutions will separate and the lipids will form a 
layer or film on top of the water. 
 
Method for the Paper Towel Test 
1.  Use a cotton swab to apply a few drops of the sample to the paper towel. 
2.  Allow the sample to dry on the bag for several minutes. 
3.  Hold the paper bag up to a light after the sample has dried completely. If a 
grease spot remains, the sample contains lipids (positive result). 
 
Method for the Floating Test 
1. Fill a test tube with a few ml of your test solution and an equal amount of 
water (20 drops of your test solution + 20 drops of water).  
2. Swirl mixture to mix and allow the mixture to stand for 5 minutes. 
3. Determine if your test is positive or negative.  If the result is positive, the two 
solutions will form distinct layers and the lipids will float on top of the water 
solution.  If the result is negative, no layer will form on top of the water 
solution.  NOTE:  The lipids can be easily viewed if the solution is cooled (the 
lipids will form a solid-like film on top of the water). 
 
Read more about How to Test for Lipids 
http://www.ehow.com/how_4829982_test-for-lipids.html#ixzz2BkLkIBsX 
 
5.   Testing for pH – pH strips 
How the pH test works 
The pH of a solution can be tested in a number of ways including the use of 
colorimetric indicators like pH test strips.  When the pH strip is dipped into an acidic 
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solution, the acid donates a proton (H+) and a color change occurs on the strip.  
Likewise, when the pH strip is dipped into a basic solution, the base accepts a proton 
(H+) and a color change occurs on the strip.  The pH of the solution can be determined 
by matching the color of the strip with the indicator legend. 
 
Method for pH testing 
1. Fill a test tube with a few ml of your test solution. 
2. Briefly dip the pH strip into the solution and determine which indicator color 
the strip matches. 
 
 
 
The following websites contain more information about the recommended 
allowances for a healthy diet: 
http://www.choosemyplate.gov/ 
http://www.livestrong.com/article/555621-sugar-fat-protein-starches-used-in-the-
human-body/ 
http://www.livestrong.com/article/288657-the-recommended-daily-intake-of-
calories-carbs-fat-sodium-protein/ 
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Turkey Time Worksheet     Name: 
 
Lab #__________ 
 
Use the packet to fill in the following table about testing methods: 
Material Testing Test Name Positive Result Negative Result 
Starch    
 Biuret   
  
Brown-orange 
precipitate 
Light blue solution 
pH    
 
Paper towel or 
floating test 
  
 
What is the purpose/objective of this lab?  What will you be testing for?   
 
 
 
 
Choose 3 of the following foods and develop hypotheses for the different components 
that will be in each (write hypotheses below). 
 Turkey 
 Mashed Potatoes 
 Gravy 
 Bread 
 Candied Yams 
 Pumpkin Pie 
 Apple Pie 
 Lemon Meringue Pie 
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Hypotheses: 
1.   
 
 
  
2.   
 
 
 
3.  
 
 
 
 
 
Experimental Design and Methods:  
Write out the procedure you will use to test the composition of these foods. 
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Results: 
List your results (positive or negative) for each test in the table below: 
Food 
Tested 
Biuret Test Benedict Test Iodine Test pH Test 
Paper 
Towel or 
Floating 
Test 
      
      
      
 
Write any additional results or observations here: 
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Conclusions:  What can you conclude about the foods from your results? 
 
 
 
 
 
 
 
 
 
Consider the proportions and dietary suggestions given by the food pyramid.  What 
types of foods are healthiest for you to eat? 
 
 
 
 
 
 
 
 
What could you do to make the “unhealthy” foods better for you to eat (what could 
you add to or remove from the foods)?  
 
 
 
